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SUMMARY
The project investigated any role of sulphydryl groups in the biochemical 
pathways which contribute to normal phagocyte function and which may be a 
point for therapeutic control of tissue damage in rheumatoid arthritis (RA). 
Neutrophils (PMN) and monocytes (MNC) were compared, and with each cell 
type comparison was made between the following groups: normal volunteers; 
patients with rheumatoid arthritis (RA) on non-steroidal antiinflammatory drugs 
(NSAID), on D-penicillamine (Dpen) or auranofin (aur), and patients with 
psoriatic arthritis (psor arth).
The choice of stimuli was designed to follow activation pathways stimulated at 
cell surface receptors, using FMLP and IgG, at a cytosolic receptor site, protein 
kinase C using PMA, and at a point between the two, namely G-proteins, using 
fluoride. The involvement of sulphydryl groups (SH) was investigated by 
external blockade with parahydroxymercuriphenylsulphonic acid (PHMPSA). 
The effect o f PHMPSA was examined in assays for the release o f superoxide 
(C>2 “), hydrogen peroxide (H2 O2 ), myeloperoxidase and for the elevation of 
internal calcium. Also, G-protein involvement in the pathways leading to 02" 
production was investigated using the islet-activating protein of Bordetella 
pertussis (IAP).
PMN and MNC from patients on second line therapy showed a significantly 
enhanced spontaneous peroxide response in the presence of exogenous calcium 
but not in its absence.
All groups showed an inhibition of both the peroxide and O2 " responses to
FMLP and heat aggregated IgG (HAGG) after SH blockade; the MNC peroxide 
response to PMA was inhibited, and the PMN 0 2 ' response was enhanced. 
PHMPSA inhibited the fluoride O2 '  response o f MNC from all groups, but the 
PMN response was significantly enhanced in the patient groups but in the 
normal group in cells from male donors only.
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PHMPSA inhibited basal and stimulated levels of internal calcium release from 
normal PMN but enhanced myeloperoxidase release.
IAP inhibited the FMLP 0 2 ' response in PMN and MNC from all groups. It 
had no effect on the PMA responses. Fluoride 02" response was inhibited in 
both PMN and MNC from the normal group and in MNC from the D-pen 
group.
The modulatory effects of PHMPSA demonstrated that there are surface thiols 
involved at the point of receptor-G-protein interaction in pathways to NADPH 
oxidase activation, which do not appear to be modulated by the inflammatory 
disease process in rheumatoid arthritis, and which may be different or 
differentially accessible in PMN and MNC.
IAP inhibited the fluoride response of normal PMN and MNC, and o f MNC 
from the Dpen group but not those of the NSAID group. It did not affect the 





This introduction has been designed to give a broad picture of phagocytes and 
o f RA, and to give a more detailed description of the elements of the phagocyte 
cell concerned with activation which have been used in experiments, and to 
indicate where SH groups may be important. Production of 0 2 “ and H2 O2  have
been used as the main model functions for investigating the role of SH in cell 
activation. Phagocytes were used for investigation for a number of reasons: 
they are easily obtained in sufficient quantity from peripheral blood; they 
produce reactive oxygen metabolites which can be measured unambiguously by 
simple biochemical assay; there is literature to document the receptors known to 
activate H2 O2  and 0 2 “ production; they persist at sites of damage in RA and
they form part of the immune system which may be defective in RA.
PMN were purified from other leukocytes to >95%. Experiments investigating 
azurophilic enzyme release were restricted to PMN only. Monocytes were not 
usually separated from lymphocytes mainly to minimalize time-induced 
deterioration o f PMN and to reduce the loss o f cells through extra 
manipulations. Monocytes were considered to be the overriding contributers to 
the H2 O2  and O2 " production in the mixed cell preparation. Thus, MNC refers
to the mixed cell population whilst assuming that the monocyte population alone 
has contributed significantly to the result. Some preliminary experiments 
investigating internal calcium release were undertaken using purified  
monocytes.
The mobilization of internal calcium was monitored in PMN as w as 
myeloperoxidase release to see if  these pathways were altered by SH blockade 
in a manner which paralleled the effect on H 2 O 2  and 0 2 “ production.
Monocytes did not produce enough MPO to make the assay practical for them 
with the limitations dictated by the amount of blood obtainable. Similarly the 
calcium mobilization assay was mainly restricted to PMN both for reasons of
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cell number and because in a MNC preparation lymphocytes would also 
contribute to the estimation of total calcium which is assessed by cell lysis.
In this project immediate use of PMN and MNC assumed that each cell type had 
been subjected to minimal activation, and that the MNC monocyte population 
was immature in terms of macrophage characteristics. The similarities in PMN 
and MNC functions were exploited and the implications of the results discussed 
in the light also of their differences.
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A . SIG N A L TRAN SD U CTIO N  PATHW AYS
Cells can communicate with their surroundings including othe'r cells by contact 
with specific receptors borne in their plasma membranes, and which are 
exposed at the external surface. On ligand binding, information is relayed to the 
inside of the cell in a manner dependent on the receptor and on the cell type. 
Understanding these signal transduction pathways may enable them to be used 
as sites for therapeutic modulation, or lead to a clearer picture o f drug 
interactions which cause unwanted side-effects for instance and so allow better 
targetting.
Pathways involved in the control of granule release or of O2 '  production from 
phagocytes may be interrelated and each may have multifaceted control sites for 
the production o f second messengers and other molecules (such as 
inflammatory mediators). Pathways include those for cyclic AMP production, 
for protein kinase C activation, for calcium release and for production of 
arachidonic acid metabolites. Diagram A gives an outline of separate PMN 
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Refinements in control may include the interaction of different stimuli such as 
may be found in heterologous priming o f responses such as those of TNF-alpha 
and PMA (Berkow et al 1987) or GM-CSF and FMLP (Corey and Rosoff 
1989); a dual or biphasic dose response to an external ligand, such as the 
regulation of PAF receptor expression by PKC activation (O’Flaherty et al 
1987), differential affinity states of a receptor depending on the state of the cell 
(Fletcher and Gallin 1980); subtypes of G-proteins, which control the positive 
or negative nature o f the signal and which may interact with more than one 
receptor or effector mechanism (Burch et al 1986); isozymic effector 
mechanisms such as protein kinase C (Nishizuka 1988) and compartmentalized 
intracellular substrate availability for second messenger production. These 
elements in control may be cell type specific, such as protein kinase C isozymes 
(Nishizuka 1984; 1986; 1988) and phospholipases C which are both cell type- 
and species-specific and may be altered by cell activation or differentiation 
(Hommaetal 1989).
Activity of adenylate cyclase and of PLC or PLA2  are usually considered to be 
mutually exclusive events, adenylate cyclase activity requiring higher calcium 
levels which also activate calmodulin-specific protein kinases, the cAMP and 
calmodulin-dependent phosphorylating events forming down-regulation for 
those induced by an initial signal via one of the other two pathways. However 
all three pathways may be interrelated in a single stimulation event, Fc receptor- 
mediated stimulation involving both PLC and PLA2  for instance (Sakata et al
1987) and FMLP activating adenylate cyclase as well (Bokoch and Gilman 
1984).
A picture of the mechanisms activated by the receptors used in this project is 
necessary before the receptors (namely those for FMLP and the Fc receptors for 
IgG) can be described with clarity, and so the next two sections introduce 
effector enzymes and their modulation.
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i. Adenvlate cvclase.
Widespread finding of dual G-protein-mediated regulation of adenylate cyclase 
by hormonal and adrenergic stimuli in different cell types has made this a much 
studied effector mechanism (Ross and Gilman 1980) which will be outlined in 
the section on G proteins. It is regulated intracellularly by phosphorylation 
(Katada et al 1985) and by calcium concentrations (Lim et al 1983) and may 
regulate other phagocyte signal transduction pathways. Cyclic AMP is 
consistently reported to be transiently elevated in FMLP stimulation of PMN 
(Simchowitz et al 1980), an event to which no definite function has yet been 
ascribed. The relative speeds at which FMLP products arise suggest that cAMP 
is necessary for an early event. Its elevation is independent of 02" production
and degranulation (Simchowitz et al 1983). It may be related to the need for 
exogenous calcium for maximal effect of FMLP stimulation and is independent 
of inhibition of Gi-like proteins by pertussis toxin (IAP) (Okajima and Ui 
1984). However the increase in internal calcium is IAP inhibited (Verghese et al
1986). Lipocortin inactivation is dependent on phosphorylation by a cAMP- 
dependent protein kinase (Hirata et al 1981), and so cAMP may be required for 
activation of PLA2 - Adenylate cyclase has not been found to be activated by Fc
receptor-mediated events,
ii. Phospholipase A?
In PMN plasma membranes PLA2  is a neutral, calmodulin-dependent, 
phosphatidylcholine-specific enzyme which cleaves arachidonic acid in 
particular from the sn-2 ester bond, phosphatidylcholine (PtCh) being supplied 
by transmethylation of phosphatidylethanolamine (PtEth) (Hirata 1979). Its 
active site has structural similarities with PKC (Maragore 1987). The PLA2
inactivator lipocortin is, in turn, inactivated by phosphorylation by a  tyrosine 
kinase, as seen following FMLP activation (Hirata 1981), although it may also
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be phosphoiylated by seryl-threonyl-specific kinases, and thereby its regulation 
may depend on the stimulus (Pepinsky and Sinclair 1986). PLA2  activity can
be stimulated for instance by FMLP receptor occupancy (Duque et al 1986) and 
by stimulation o f complement receptors with opsonized zymosan 
(Maridonneau-Parini et al 1986). The products of this activity are arachidonic 
acid and lysocholine, both of which may be further metabolised or may be 
active in their own rights as second messengers. The important products of 
arachidonic acid metabolism are those of the cyclooxygenase (prostaglandins) 
and lipoxygenase (leukotrienes) pathways, which may be regulated by the 
interaction of protein kinase C or its products (McColl et al 1987). Lysocholine 
has no known second messenger activity as such, but may be further 
metabolised to DAG, and able to activate PKC. It may also be metabolized to 
platelet activating factor (PAF), which is a powerful chemotaxin for phagocytes 
and which is released by monocytes (Elstad et al 1988). PtEth is a normal 
cytoplasmically oriented constituent of the plasma membrane and PtCh resides 
in the outer side and is not available to membrane PLA2 . Thus before PLA2 
activity occurs transmethylation takes place. A second, acidic PLA2  resides in 
azurophil granules, being released to the extracelluar space on degranulation 
(Balsinde et al 1988), an event which would promote local acidity. Control of 
this enzyme and its substrate specificity may be relevant to PLA2  activity in
disease and its modification by antimalarial drug therapy (Hurst et al 1986), 
especially as it has been found to show a substrate preference for arachidonic 
acid - bearing phospholipids in RA synovial fluid compared with OA synovial 
fluid (Loeser et al 1988).
Activation of (plasma membrane) PLA2  by FMLP may be indirect through PLC 
(Matsumoto et al 1988). Substrate availability may be altered by peroxidative 
damage (van Kuijk et al 1987) which, in turn, could result in altered substrate 
availability to the lipoxygenase and cyclooxygenase pathways. PLA2  has been
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suggested to play a preventative role in peroxidative damage (van Kuijk et al 
1987) which may divert it from its normal activity. Again in abnormal 
conditions, arachidonic acid may be released into the external environment 
where it may activate phagocytes directly (Naccache et al 1989). Arachidonic 
acid induces an initial rise in internal calcium similar to that seen with FMLP, 
but it also induces a slower more sustained rise. PLA2  activity is also governed
by extracellular viscosity, which may be lowered in disease states, promoting 
activity (Yedgar 1987). One would expect lowered extracellular viscosity to 
increase membrane fluidity and this increases transmethylation (Lenaz et al 
1983) and thereby PLA2  substrate availability. However, it may also alter
substrate specificity (Gonzalez-Buritica et al 1989). An alteration in activity in 
this manner is unlikely to be restricted to only one activation system.
iii. Activation of protein kinase C - The PIP2 Pathway.
Stimulation of G-protein-mediated activation o f a phosphatidylinostol 
bisphosphate-specific phosphodiesterase, PLC, causes the hydrolysis of PIP2 
to diacylglycerol (DAG) and inositol trisphosphate (IP3 ). DAG activates protein 
kinase C by lowering its calcium requirement to basal levels (Wolf et al 1985). 
Pathways which involve activation of protein kinase C can be investigated by its 
direct stimulation with phorbol myristate acetate (PMA) (Nishihara et al 1985) a 
non-metabolizable analogue o f DAG; thus an activation process can be 
stimulated at a site distal to plasma membrane constituents thought to be 
involved in the physiological activation o f PKC such as receptors and G- 
proteins, and effector enzymes such as PLA2  or PLC. When investigating 
pathways to O2 " production, if  blockade does not inhibit the response to PMA it 
can be deduced that no blockade occurs from PKC activation onwards and that 
PKC is involved in the activation pathway. PKC is a tissue-specific family of 
kinases which are differentially activated by PMA and inactivated by calpain and 
which have different requirements for calcium (Nishizuka 1988). They have
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variable regions in their structure which may indicate different substrate 
specificities. In phagocytes they do not need internal calcium above basal levels 
for activation by DAG but do require translocation to phosphatidylserine in the 
plasma membrane where the catalytic fragment is cleaved by calpain and 
released into the cytosol (Nishizuka 1988). A tissue has yet to be found which 
contains only one subtype of PKC ( Carpenter et al 1987).
PMA is a potent stimulus of the respiratory burst (Ohta et al 1985) and o f the 
release of specific but not azurophilic granules (Wright et al 1977). The 
phosphorylation profile of cells is altered by stimuli which activate NADPH 
oxidase, including PMA (Andrews and Babior 1983), and the pattern o f this 
includes PKC phosphorylation of the alpha subunit of G-proteins (Matsumoto 
et al 1986), of inositol phospholipids (Cockroft et al 1985), of the proton pump 
(Moolenaar et al 1984), and of a subunit of the NADPH oxidase complex itself 
(Gennaro et al 1985). (Other substrates for PKC are tabulated in Nishisuka
1986). The exact function of all the phosphorylation events is unknown but in 
the case o f the G-protein alpha subunit, phosphorylation may increase the 
affinity of the subunit for the other subunits and promote GTPase activity, 
forming a negative feedback signal as phosphorylation only occurs o f the 
dissociated (that is, activated) alpha subunit (Matsumoto et al 1986). 
Phosphorylation is known to be a negative feedback mechanism for beta- 
adrenergic receptors so that they no longer interact with their G-proteins (Sibley 
et al 1987). PKC activation has been suggested to be a negative feedback 
mechanism for both PLC (Muldoon et al 1987), and for PLA2  (Fuse and Tai
1987) although inhibition of PLA2  i^as ^een found to inhibit PMA-induced 0 2 ” 
production (Duque et al 1986), and PMA stimulates release o f labelled 
arachidonic acid from methylated phospholipids (Hirata 1979). As arachidonic 
acid itself can activate the release of O2 ’, the PLA2  connection maybe a feed 
forward event. PKC is an integral part of 02" production by at least one
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pathway, but it is difficult to determine precisely how, probably because it is 
involved in a number of interrelated events which may regulate or occur at the 
same time as the process. Inhibitors of PKC such as H7 (Kawamoto et al 1984) 
are also used to delineate its effects, and a natural inhibitor of PKC has been 
found to be associated with specific granule membranes on their association 
with the plasma membrane (Balazovich et al 1986).
Physiological production of DAG involves concomitant release of inositol 
trisphosphates (IP3), of which mainly 1,4,5-IP3 releases calcium from 
intracellular stores (Spat et al 1986; Berridge and Irvine 1989). The use of PMA 
has established that calcium need not be elevated above basal levels for O2 "
production. Use of a PKC-blocking agent has also established that PKC 
activation is not essential for 02" production by FMLP or C5a for instance
(Gerard et al 1986) and that there are therefore at least two pathways to this end. 
PKC activation occurs in FMLP stimulation (Ohta et al 1985) and FcR-mediated 
stimulation (Sakata et al 1987) and may function to regulate the metabolic 
products o f arachidonic acid release, causing the preferential synthesis of 
lipoxygenase products by PMN (McColl et al 1987). PKC activation causes a 
drastic change in PMN morphology and this may be a function of the calcium- 
and pH-independent promotion of actin assembly (Sheterline et al 1986). PKC 
activation of actin assembly can be induced independently of its kinase activity 
by an otherwise inactive analogue of PMA (White et al 1984). Others have 
found actin assembly also with FMLP stimulation, but to no significant degree 
with phorbol esters (Bengtsson et al 1986).
iv.Calcium.
Activation of PKC by arachidonic acid is dependent on calcium but not on 
phosphatidylserine (McPhail et al 1984), suggesting that calcium may be 
necessary for accessibility of membrane components to each other, perhaps by
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modifying the local charge distribution. The calcium ionophore A23187 induces 
low levels of 02" from PMN (Simchowitz 1983; Ohta et al 1985), arachidonic
acid release and degranulation (Bokoch and Gilman 1984) and production of 
LTB4  (Sellmayer et al 1987). A23187 does not mobilize PIP2  but does induce
an IAP-insensitive accumulation of inositol phosphates by an unidentified route 
(Ohta et al 1985) and acts synergistically with low concentrations o f a 
diacylglycerol analogue, OAG, to promote a O2 ’ response from PMN at doses
at which neither stimulus alone would be active (Penfield and Dale 1984). 
Alone, A23187 activates PLA2 t0  release arachidonic acid metabolites as can be 
seen using the PLA2  inhibitor mepacrine (Bokoch and Gilman 1984), which 
suggests that FMLP-stimulated cells require activation of PLA2  by exogenous 
calcium for full activity. External calcium is necessary for maximal O2 " release 
by FMLP but in the presence o f EGTA FMLP still stimulates PLC but the 
nature o f the inositol phosphate isomers differs from those found in the 
presence of calcium (Dillon et al 1987). As the concomitant release of DAG 
activates PKC, the isomeric nature of the inositol phosphates may be concerned 
more with pathways other than 0 2 " activation, such as degranulation. This 
could also be indicated by the fact that the O2 " release is greater with calcium,
FMLP receptors being upregulated by degranulation. Hexadecyl methylglycerol 
is a PKC inhibitor which prevents 0 2 '  release by FMLP without affecting IP3
release or calcium mobilization (Kramer et al 1989), further reinforcing the view 
that calcium mobilization is not an activator of 0 2 * release, either directly or by
activation of another pathway independent of PKC activation. More evidence is 
supplied by the enhanced phosphorylating rate and activity seen in response to 
PMA in the presence of calcium (White 1984). The roles o f calcium differ 
depending on the pathway concerned, and where activation appears to be o f 
more than one by a single stimulus such as FMLP, with no clear picture of the 




An important family of GTP-binding proteins (G-proteins) mediate many 
receptor-activated pathways such as those involving adenylate cyclase 
(Stemweis and Gilman 1978), guanylate cyclase (Manning and Gilman 1983), 
phosphatidylinositol metabolism or PLA2  activation (Fuse and Tai 1987), all of
which control the release of second messengers within the cell. G-proteins are 
best explained taking adenylate cyclase regulation as an example (and can be 
seen diagrammatically in Diagram B). The role of G-proteins in activation by 
the specific stimuli used in this project will be described in appropriate sections.
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DIAGRAM  B
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Adenylate cyclase, as reviewed by Ross and Gilman (1980) and by Gilman 
(1987), is an almost ubiquitous enzyme in eukaryotes, which catalyses the 
formation of cyclic AMP, an important second messenger. Generally, binding 
of a specific ligand to its receptor promotes the exchange of GDP for GTP on a 
G-protein subunit, and this regulates adenylate cyclase activity. Whether this 
ligand-binding stimulates or represses adenylate cyclase activity depends on the 
receptor and on the G-protein it modifies, there being both stimulatory and 
inhibitory receptors which activate different G-proteins.
Detailed analysis of G-proteins has revealed a similar trimeric structure in both 
types which regulate adenylate cyclase, the most useful physiological difference 
being that the stimulatory type, or Gs, is ADP-ribosylated by Cholera spp. 
toxin (Schleifer et al 1982) and the inhibitory type, or Gj, is ADP-ribosylated
by the islet-activating protein (LAP) of Bordetella pertussis (Bokoch et al 1983). 
The Gs and Gj nomenclature has been retained when referring to G-proteins
identified elsewhere, and has been supplemented by other ”G” subscripts for 
systems in which the two toxins are not active, such as Gp for a placental G- 
protein (Evans et al 1986) and G0  for that from bovine brain (Higashijima et al
1987). In brief, the toxins irreversibly ADP-ribosylate the G-alpha subunits 
which causes them to dissociate from their beta-gamma complexes, and renders 
them impervious to receptor-mediated control. In the case of adenylate cyclase 
regulation either toxin results in permanent activation of the enzyme. It is worth 
stressing that Gs and Gj G-proteins in systems other than adenylate cyclase are
identified by their ADP-ribosylation whilst not presuming their mode of action; 
whereas this nomenclature is now generally accepted, other subscripts may vary 
depending on the reference.
18
The G-protein heterotrimer consists of three subunits, alpha, beta and gamma. 
The alpha and gamma subunits are each a single peptide but the beta subunit 
consists of two peptides. The approximate molecular weights are 41KD(alphaj) 
or 45KD(alphas) (Bokoch et al 1983), 35KD and 36KD(beta) (Northup et al 
1983), and 8 KD(gamma) (Kuhn 1980). Ligand-activated receptor associates 
with the alpha subunit and promotes the exchange of bound GDP for GTP; this 
has been suggested to be by a phosphoenzyme transferring a phosphate to 
GDP (Ohtsuki 1987). The presence of magnesium supports this activation step, 
being found particularly as a cofactor for phosphate transfer reactions in many 
systems (Macdonald and Martin 1988). Association of all three G-subunits is 
necessary for efficient receptor-catalyzed nucleotide exchange (Gilman 1987). 
In membrane preparations this is also dependent on the presence of magnesium 
ions. This exchange lowers the affinity o f the receptor for its ligand and also 
causes dissociation o f the G-protein alpha subunit from the beta-gamma 
complex. The alpha subunit has intrinsic GTPase activity which slowly 
catalyses the GTP to GDP conversion, increasing the affinity o f the alpha 
subunit for the beta-gamma complex and they reassociate. The GTPase reaction 
is a slow one, which is preceded by the regulation of adenylate cyclase by the 
GTP-alpha subunit. The association of the GTP-alpha subunit with the cyclase 
in its turn promotes the GTPase activity. In purified Gq preparations from
bovine brain, GTP binding causes a conformational change enhanced by the 
presence of magnesium ions, and which declines slowly as GTP hydrolyses to 
GDP (Higashijima et al 1987). The slow hydrolysis allows a build-up of active 
alpha subunits whilst the receptor is occupied, amplifying the single signal.
In a second mode o f regulation which could be the pathway o f inhibitory 
modulation of adenylate cyclase, rather than direct action of the alpha subunit on 
the adenylate cyclase, subunit dissociation could allow an excess of beta-gamma 
complexes to ”mop up” alpha subunits, thereby preventing activation. It has not
19
been proved conclusively what the regulatory mechanism is in the case of 
inhibition of adenylate cyclase. The possible deactivation by the beta-gamma 
complex has not been ruled out and it has been suggested as the active 
participant for other G-protein systems, such as in the regulation of potassium 
gating (Logothetis et al 1987). In a short review, Bourne (1989) notes that 
PLA2  figures largely in evidence for the beta-gamma complex in positive
effector activation, and that yeasts found to be genetically deficient in the G- 
alpha genes demonstrate a complete reversal of the conventional G-protein 
model by the beta-gamma mediated activation of their pheromone response 
lacking negative control. This indicates a broad diversity in G-protein 
mediation, as yet only partly explored.
Human PMN contain G-proteins which are substrates for both cholera toxin 
and for IAP (Gierschik et al 1986); by using monoclonal antibodies, two 
different substrates for the latter have been identified. cDNA analysis identified 
two Gj-alpha subunit subtypes (Didsbury and Snyderman 1987); Suki and
workers (1987) found three nonallelic genes by this method for subtypes of 
Gj-alpha subunits, with little difference between species of mammal, with
expression possibly being cell type-specific. It was suggested that the different 
subtypes could be used to identify the effector enzyme they modulate in vivo, 
type 1, (41KD), activating PIP2 -specific phospholipase C, for instance. 
However, it has also been found that the different Gj-alpha subtypes can all
activate potassium channels (Yatani et al 1988). Mattera et al (1989) identified 
three splice variants of the adenylate cyclase-regulating Gs-alpha. In this work it
was demonstrated that three of their splice variants (produced by expressing 
cDNA in E. coli) could each activate both adenylate cyclase and calcium 
channels in cell-free systems and in membrane vesicles. It may be that if  the 
splice variants exhibit no specificity in the effector activated, that the variability 
is concerned with the specificity of receptor-G-protein interaction. Beta-
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subunits are expressed more uniformly than the alpha-subunits, but the two 
peptide chains are coded for by different genes (Fong et al 1986), those from 
different systems not only being functionally interchangeable between G-protein 
systems in vitro, but being in fact identical on protein analysis; this has been 
found for the beta-subunits of the bovine brain G-protein G0  and those of 
retinal transducin (Pines et al 1985). However, in a reconstituted system, Gs
alpha discriminated between beta/gamma subunits from transducin and from 
bovine brain G0  but Gj-alpha did not (Hekman et al 1987). Diversity o f G-
protein subunits has been found to be due to different genes (Suki et al 1987), 
and to alternative splicing of mRNA (Northup et al 1983) and it may also be due 
to post-translational modification.
It could be important to see how expression of G-subunit genes varies with 
development and with cellular differentiation. It is reasonable to presume that 
this could relate to oncogenesis, in which cells are seen to revert to a less- 
differentiated phenotype and to have aberrant control mechanisms. The G- 
protein-like ras genes are commonly expressed in an constitutive fashion in 
tumour cells, changes have been found in G-proteins expressed in the 3T3-LI 
cell-line as it differentiates for instance (Gierschik et al 1986), and similarly in 
rat brain (Milligan et al 1987), and in a regionally-specific manner in the chicken 
heart (Luetje et al 1987).
The G-protein regulation of activation pathways involves specific receptors, one 
or more G-proteins with (tissue-specific) subunit subtypes, and a number o f 
effector enzymes or gating mechanisms. So far, investigations have not 
determined whether binding of a single specific ligand activates only one G- 
protein subtype, nor whether the G-protein/s once activated normally regulate 
one or more effector mechanisms at the same time in whole cells - i f  they do 
not, then the interchangeable action of subunits from various sources in in vitro 
work suggests that spatial organization within the membrane must be very well
21
defined. The main focus o f work has been on the receptor-alpha subunit 
interaction; the beta and more especially the gamma subunits have not been 
investigated in so much detail.
Two proteins considered to be related to the G-protein family are transducin, 
which is found abundantly in retinal rod outer segments and which mediates 
between light-activated rhodopsin and guanylate cyclase (Yamazaki et al 
1987a;b), and the p21 ras oncogene products which are small molecular weight 
G-alpha-like proteins, thought to mediate growth factor promotion and which 
are commonly found as mutations in human tumours (Pai et al 1989). 
Transducin has the classic model heterotrimeric structure but with only a single 
peptide in its beta subunit. Transducin is especially useful because a large 
amount is available and is easily purified, and it has a high degree of sequence 
homology with Gs and Gj (Manning and Gilman 1983). Whereas transducin is
sensitive to both cholera toxin and to IAP, p21 is sensitive to neither. The p21 
ras protein mutants are valuable in G-protein functional analysis (e.g. Tong et al 
1989). Bearing in mind the frequency of finding mutant p21 in tumours, 
perhaps a certain amount of caution should be used when including G-subunit 
variants in a "normal” list, when they have been identified from cDNA made 
from immortalized cell lines - such as those found in HL60 (Didsbury and 
Snyderman 1987).
Genetic analysis and peptide sequencing of the receptors found to be modulated 
by G-proteins (Dohlman et al 1987) allows extrapolation of information from 
work on different systems. The membrane-spanning regions o f several G- 
protein-linked receptors contain a particularly high degree o f sequence 
homology, across four species (three mammalian, one avian), and between 
receptors from different tissues; their structure as suggested by peptide analysis 
is very similar, and genetic analysis has shown none of them to contain introns. 
Reconstitution experiments have shown that each of these receptor proteins can
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interact with more than one type of G-protein. The Beta2 ~adrenergic receptor
has the group structure for instance (Dohlman et al 1987) and it has been shown 
in unilamellar phospholipid vesicles to be able to activate Gj. In whole cells it is 
seen to activate Gs (Asano et al 1984). The homologous regions lie in the 
presumed membrane-spanning regions, with extramembranous loops formed 
by the regions in between which are not particularly homologous.
In PMN and MNC (both in monocytes and macrophages), G-proteins have 
been identified which mediate chemotactic receptor-activated pathways to the 
hydrolysis of PIP2  by its specific PLC (Okajima et al 1985 and Verghese et al 
1986 respectively). They have been identified as Gj-like because they are IAP-
sensitive, but the effect they mediate is stimulatory, the hydrolysis yielding two 
second messengers, inositoltrisphosphate (IP3 ) and diacylglycerol (DAG).
They may also exert control over calcium gating, but whether or not this effect 
is by the G-proteins themselves or by second messengers which they cause to 
be released is uncertain. Work with FMLP receptors on both PMN (Snyderman 
and Pike 1984) and MNC (Koo et al 1983) has demonstrated that whilst ligand 
binding promotes the GDP/GTP exchange reaction on G-alpha subunits, 
receptor binding to the G-alpha subunit decreases the receptor affinity for 
ligand. Thus the G-proteins have a two directional controlling role in cell 
activation, in the interior of the cell on effector mechanisms, and at the cell 
surface on receptor affinity. The association o f PIP2 -specific PLC activity
which is inhibited by IAP, seems to be unique to phagocytic cells.
Receptor-mediated activation of these pathways has been effected in this project 
by use of FMLP and HAGG, and fluoride has been used to activate G-proteins 
directly. These ligands and their receptors are described after an introduction to 
phagocytes.
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B. PH A G O CY TES.
This overview of PMN and monocytes is focused on the respiratory burst and 
phagocytic activities which they have in common and which have been 
exploited in this project, and the receptors which have been used to stimulate 
their activity.
i. Generally.
Neutrophils (PMN) and monocytes originate from the myeloid branch o f the 
haemopoietic stem cells in bone marrow.
Monocytes are large cells with an oval or kidney-shaped nucleus, endoplasmic 
reticulum (ER), many cytoplasmic granules, a golgi apparatus and obvious 
mitochondria (Roos and Balm 1979). Monocytes leave the marrow as 
precursors of tissue macrophages, still capable of division and differentiation, 
and at the same time operating in their own right in antigen presentation and the 
release of immunomodulatory secretory molecules and in locating, ingesting 
and digesting particles such as tissue debris, including PMN containing foreign 
matter (Johnston 1988). Monocytes spend 3-4 days in the circulation before 
migrating to the tissues and differentiating further into one of a number of cell 
types depending on the tissue in which they take up residence. There they may 
survive for many months (Hurst and Nuki 1981).
PMN are also large cells (10-15uM), have a very distinct lobed nucleus with 
marginated heterochromatin, highly granulated cytoplasm with little ER, and 
few mitochondria (Scott and Horn 1970). Normally PMN enter the circulation 
as mature end cells, designed to locate and ingest foreign matter such as cell 
debris or bacteria, and to release chemical mediators concerned with 
inflammation and immune regulation. PMN have a half life of only a few hours 
which is normally spent in the circulation either freely or as marginated cells
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adhering to blood vessel walls, eventually being removed by kupfer cells in the 
liver.
Table 1 indicates the proportion of phagocytes found in the cell population of 
normal human blood.








3.9-6.5 x 106/mm3 
2.5-7.5 x lO^/mm^
1.5-3.5 x 103/mm3 
2 - 8  x l()2/mm3
0.4-4.4 x lO^/mm^
0.15-1 x 102/mm3
On stimulation by inflammatory mediators, PMN and monocytes adhere to 
blood vessel endothelial cells, move out of the vasculature and migrate towards 
a site o f damage or inflammation, where they may release factors which 
contribute to the inflammatory condition such as free radicals or the products of 
degranulation. Whereas PMN are able to migrate in direct response to chemical 
signals, monocytes may require a signal from PMN which are at the 
inflammatory site (Doherty et al 1988).
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iii. The Respiratory Burst.
The process activated in phagocytes in which reactive oxygen metabolites are 
produced is termed the respiratory burst. It includes an increase in oxygen 
consumption, changes in cell shape, volume and density, an increase in internal 
pH, activation o f a proton pump and the hexose monophosphate shunt, and 
activation of the NADPH oxidase complex which generates superoxide (O2 ") 
and results in H2 O2  formation. It is absolutely dependent on extracellular 
oxygen (Cumutte and Babior 1975). (NADPH oxidase will be described fully 
later). Alterations which may be seen at the same time include changes in the 
phosphorylation profile of cell proteins and lipids, changes in internal calcium 
levels, cyclic nucleotides and of lipids and phospholipids. These events can be 
activated by a number of different stimuli, some of which are dependent on 
exogenous calcium ions, are sometimes dose-dependent and which may also 
involve the differential regulation of degranulation (Richter et al 1989). The 
activators of the respiratory burst are diverse and despite it being reported as 
being independent of degranulation, degranulation has not been reported to 
occur without the production of reactive oxygen metabolites. Investigation of 
the respiratory burst includes the plasma membrane and cytoplasmic events as 
well as the NADPH oxidase enzyme complex itself. In this project the pathways 
to activation which may have been involved are described fully in the sections 
on the various stimuli used. These pathways include activation o f 
phospholipase A2 , of PIP2 -specific phospholipase C, of protein kinase C, of
internal calcium release and of primary granule release.
PMN release an array of reactive oxygen metabolites which may modify the 
function of plasma constituents such as alpha- 1 antitrypsin, and granule 
enzymes (such as elastase and collagenase) which may destroy extracellular 
tissue. Upon activation, monocytes may undergo further maturation and
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include accessory cell functions such as antigen presentation aswell as those 
similar to PMN, and may also release factors such as TNF-alpha (Renz et al
1988), IL -1 (Johnston 1988), and LTB4  (Elstad 1988), which modify PMN
function. As activated PMN have a net destructive role, their regulation by 
monocytes may be critical in the resolution o f an inflammatory lesion. 
Monocytes release TNF-alpha which may control the manner of PMN death, 
containing their toxic contents until phagocytosis can remove the cells (Laster et 
al 1988).
PMN and monocytes have receptors in common, such as those for FMLP 
(Snyderman and Pike 1984; Niedel et al 1979), IL-1 (Parker et al 1989), IgG 
(Huizinga 1989) and complement factors (Wright and Silverstein 1982; Henson
1977). These cells may be able to respond also to more general stimuli which 
bind to carbohydrate subunits on the cell surface - an event mimicked in vitro by 
plant lectins and which may be effected in vivo by bacterial cell walls or aged 
glycoproteins and glycolipids (Vlassara et al 1987).
PMN have limited protein synthetic ability, so expression of receptors at the cell 
surface is restricted to those already present and those which can be released 
from intracellular stores, namely those on granule membranes (Gardner et al
1986), although synthesis of new mRNA has been reported (Lindemann 1988). 
Given time however, activated monocytes can also alter gene transcription and 
synthesise new molecules (Navarro et al 1989). Common receptors between 
cell types do not preclude uncommon functions which may depend on the 
transduction mechanism within the cells; for instance, stimulation o f the 
receptors for the Fc portion of IgG molecules, Fc-gamma R (FcR in this 
thesis), is inhibited in PMN by pertussis toxin (IAP) and by cholera toxin (CT) 
whereas that of monocytes is not affected by CT (Brown et al 1987), although 
FcR stimulation induces a respiratory burst in both cell types, as will be 
described later. Monocytes and PMN may respond to the same stimulus
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differently; BFN-gamma induces FcRl expression on PMN (Petroni et al 1988) 
whilst it also regulates IL -6  synthesis in monocytes (Navarro et al 1989) 
demonstrating that the IFN-gamma signal transduction pathways differ. Both 
also have receptors for complement factors which can act in concert with 
binding o f IgG to FcR (Malbran et al 1987). Either FMLP or IgG may activate 
cells on their own but there are a number of agents which do not appear to do so 
on PMN or monocytes but which ’prime’ the cell to effects of other stimuli. 
This suggests sophisticated internal regulation of signalling to coordinate a 
response with either dose or combinations of factors. For instance TNF-alpha, 
which is slightly chemotactic for both cell types, inhibits the chemotactic 
response of both to FMLP, but enhances the O2 " response of PMN whilst not
affecting that of monocytes (Kharazmi et al 1988). The priming mechanism may 
suggest a degree o f synergy between the cell types. For instance, TNF-alpha 
from monocytes upregulates complement receptor expression on PMN (Berger 
et al 1988), and monocyte IL-1 primes PMN for an enhanced reponse to FMLP 
(Sullivan et al 1989); similarly PMN-released oxygen metabolites control 
prostaglandin production by monocytes (Flescher et al 1989).
The contents of phagocyte granules is diverse (Kane and Peters 1975; Segal and 
Peters 1977; Johnston 1988; Rice et al 1987). The marker enzymes assayed for 
PMN azurophilic, specific and tertiary granules usually being myeloperoxidase, 
vitamin B 1 2 -binding protein and beta-galactosidase respectively (Kane and
Peters 1975). Release o f granule contents may be independent of free radical 
generation and may be controlled by regulation of internal calcium concentration 
(Perez et al 1987). Monocytes do not have specific granules; also, as they 
differentiate into the macrophage phenotype their granule constituents alter and 
they lose myeloperoxidase in particular.
Investigations of respiratory activity (Roos and Balm 1978) determined that the 
relative dependence o f each cell type on a particular energy supply delineated the
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priority of PMN activity to be bactericidal and that of monocytes to be digestive, 
and the energy for phagocytosis of mitochondrial origin in monocytes but from 
the Embden-Meyerhof pathway in PMN (Reis and Roos 1978). Monocytes and 
PMN both have the respiratory burst enzyme complex NADPH oxidase but in 
monocytes it is not found to have any activity in granule membranes as they 
have no specific granules. 02* production in response to concanavalin A is
dependent on activity of serine (acid) proteases in PMN but less so in 
monocytes (Kitagawa et al 1980). Some o f the differences between the cell 
types are typified by different receptors, such as FcR for monomeric IgG 
(FcRl) on monocytes and not usually on PMN, and also in the contents o f  
granules, their membranes and their release. The serine protease requirement of 
C>2 " production reflects this, and thus the degranulation induced by activation is
an integral part o f the activation process. Experiments suggesting that 
degranulation does not occur may reflect an absence o f the particular product 
being assayed, not a total absence of degranulation, granules being released in a 
highly specific manner (Richter et al 1989). Similarities in part of the activation 
process, such as the production of O2 '  in the two cell types, need not
necessarily include degranulation. In both cell types a transient increase in 
calcium appears necessary for stimulation of O2 " by FMLP but the release of 
02* does not correlate with this transient rise (Kemmerich et al 1988; Ohta et al 
1985). This suggests that the internal mechanism for activating NADPH 
oxidase is probably the same, but concurrent degranulation events need not be 
so, especially as granules differ between the cells, and stimulation by fluoride, 
which inhibits degranulation, occurs in both cell types. The respiratoiy burst 
may be an independently activated process, depending on the nature and 
strength of the stimulus. Concurrent degranulation may depend also on the cell 
type. Thus the findings which hold true in this thesis for the production of 02* 
or H2 O2  may not include regulation o f degranulation. This is particularly 
pertinent when considering the effect of free radical generation both on enzymes
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type. Thus the findings which hold true in this thesis for the production of O2 '  
or H2 O2  may not include regulation of degranulation. This is particularly 
pertinent when considering the effect of free radical generation both on enzymes 
released during degranulation and on controlling factors of these in the 
extracellular fluid, as will be described later in the section on free radicals.
The production of adhesion molecules has different significance on PMN and 
on monocytes; PMN may increase expression of these molecules after adhesion 
from intracellular stores (granule membranes), but monocytes adhere poorly 
without increasing their expression first, a process taking several hours and 
requiring new protein synthesis (Tonnesen 1989). Thus expression of the same 
surface protein has a different mechanism and priority in activation of the two 
cell types. The availability of these receptors at the time of activation may be 
significant because they include cysteine-rich subunits which could be 
vulnerable to free radicals; modification of these molecules may not be relevant 
in either cell type in the initial phase of activation - in PMN because they are not 
essential for adhesion, and in MNC because they are not present - but may be 
so in more chronic conditions.
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C. A C TIV A TIN G  LIG A ND S.
i. Fluoride
The fluoride ion was discovered to stimulate the respiratory burst (Sbarra and 
Kamovsky 1959). Uniquely among the halides, fluoride ion stimulates C>2 ’
production in PMN (Cumutte et al 1975); an effect reversed by washing and 
repeated on restimulation o f the cells. It acts indiscriminately on all G-proteins, 
but, importantly, means that the response o f a system can be further defined by 
specifically leaving out the receptor-ligand interaction. Fluoride does not induce 
phagocytosis or the release of azurophil granules (Cumutte et al 1987). 
Inhibition of the effects of fluoride by ADP-ribosylation of G-proteins indicate 
that they are the site o f fluoride activation. For instance, in whole guinea pig 
PMN IAP inhibited fluoride-induced translocation of PKC to the membrane 
(Toper at al 1987), and in human platelets IAP inhibited thromboxane but not 
IP3  release by fluoride (Fuse and Tai 1987).
Fluoride's mode of action has been suggested to be a substitution for the third 
phosphate group to GDP bound to alpha subunits o f G-proteins, causing a 
GTP-like subunit dissociation (Cockcroft 1987). The atomic sizes of aluminium 
and phosphorus are similar, the van der Vaals radii of fluoride and oxygen are 
the same and the bond lengths of Al-F and P -0  are almost the same (Bigay et al
1985). Its general action on all G-proteins means that the activity seen is the 
sum of a collection o f stimulatory and inhibitory signals to all G-protein-linked 
second messenger systems, so the lack of degranulation or phagocytosis does 
not necessarily mean that these processes are not G-protein linked, but that the 
net effect of the fluoride stimulation is inhibitory on these processes. Similarly, 
aluminium fluoride was not seen to induce inositol phospholipid-specific PLC 
activation in mouse B lymphocytes (Harnett and Klaus 1988), which could be 
because of overriding stimulation of other G-protein-linked inhibitory paths, 
nor did it induce the phosphorylation profile found by other stimuli which 
activate the respiratory burst (Andrews and Babior 1983). It has been suggested
31
however that at concentrations over lOmM fluoride preferentially stimulates Gi- 
like rather than Gs proteins (Katada et al 1984).
It has not been proved conclusively whether or not fluoride requires the 
presence o f aluminium to exert its effect, but the ”ps eu d oph osphat e group” 
model suggests aluminium fluoride as the active species. Work in which there 
has been no added aluminium is unlikely to be totally aluminium-free, as in the 
presence of fluoride at least it can be leached from glassware (Stmad et al
1986), and in work using reconstituted systems it may form a contaminant of 
commercially prepared reagents (Stemweis and Gilman 1982). Another theory 
suggests that fluoride is required to negate the charge on aluminium for 
transportation across the plasma membrane, after which aluminium ion acts as a 
magnesium analogue (Macdonald and Martin 1988). There is a lag time for 
activation of the O2 " response to fluoride of several minutes which could be
accounted for by the time taken for it to cross the membrane. Neither theory 
approaches the question of why fluoride should be required in such large 
quantities - 18-20mM being the usual concentration range used in work with 
whole cells, a sharp peak of reactivity at these concentrations being seen in O2 "
production (Cumutte at al 1979;Stmad et al 1986; Hurst et al 1988) and in the 
release of calcium from intracellular stores (Stmad and Wong 1985). In cell free 
systems the effect of fluoride on the activation of NADPH oxidase has been 
found to be the same as when GTP-gamma-S was added (a non-hydrolysable 
GTP analogue) and the two together had no cumulative effect, suggesting that 
fluoride and GTP act at the same site (Gabig et al 1987). This activation was 
totally and specifically dependent on magnesium, suggesting that aluminium 
does not act as its analogue in this reaction.
As a general G-protein activator therefore, fluoride may be used to stimulate a 
reaction to investigate possible G-protein involvement, in conjunction with 
toxin-induced inhibition. But it has to be bom in mind that effects may 
accumulate due to G-protein mediated pathways being stimulated which have
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indirect effects on the process under investigation, and that a lack of stimulation 
or inhibition by fluoride may again be an effect of indirect interaction from 
unrelated pathways. Also, G-protein links are likely to be cell-type specific and 
so effects seen in one cell type may not be reproduced in another. Fluoride also 
inhibits ATP synthesis by the Emden-Meyerhof pathway (Roos and Balm
1978), is used as an enolase inhibitor (Cumutte and Babior 1975), and has been 
found to suppress protein phosphorylation (Palomares et al 1987), events not 
proven to be directly related to its G-protein-mediated effects,
ii. N-Formvl-Methionvl-Leucvl-Phenvlalanine.
FMLP is an analogue of the principal chemotaxin of E. coli(Goetzl and Pickett 
1980). It is also a product of mammalian mitochondria, and may get released by 
damaged cells (Carp 1982). It is a formylated tripeptide which activates both 
PMN and MNC. The nature and degree of response obtained on stimulation 
with FMLP may depend on the dose, the availability and affinity state o f the 
receptors, and also on the contents of the surrounding environment. The 
specificity of FMLP resides in the formyl end, non-formylated tripeptides being 
ineffective as stimuli (Lehmeyer 1979). FMLP activates both PLA2  and PLC
(Duque et al 1986; Cockcroft et al 1985b), G-proteins are involved (Okajima 
and Ui 1984), it increases filamentous actin concentrations in an IAP-dependent 
manner (Bengtsson et al 1986) and entry of exogenous calcium (calciume) is
necessary for a maximal response (Lehmeyer et al 1979). SH dependence o f 
FMLP-stimulated production of peroxide by PMN has been found (Maslen 
1985). The complexity of the response to FMLP lies in the receptor-bearing cell 
and in particular in the associations the ligand-bound receptor can make in the 
membrane and with the cytoskeleton. These events dictate the type of second 
messenger signal which then follows and the response obtained.
FMLP responses studied include:
Protein synthesis (Hughes et al 1987);
Phosphorylation (Huang et al 1984,1987; Hirata et al 1984);
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Expression of new antigens (Emery et al 1988);
Aggregation (Boxer et al 1979; Ingraham et al 1987; Kowanatzki et al 1987); 
Adhesion (King et al 1986; Boxer et al 1979; Kowanatzki et al 1987); 
Association with the cytoskeleton (Jessaitis et al 1988);
Actin polymerization (Yassin et al 1985);
Arachidonic acid release (Bokoch and Gilman 1984); Phosphoinositide turnover 
(Bradford and Rubin 1985; Cockcroft et al 1985);
H2 O2  production (Maslen 1985);
Azurophilic- and specific-granule enzyme release (Dahlgren 1988);
Change in oxygen consumption (Bass et al 1987);
Chemotaxis (Boxer et al 1979);
O2 " production and calcium influx (Okajima and Ui 1984);
Internal calcium (Palmblad et al 1988). vr '
The FMLP receptor is a 60-70KD monomeric glycoprotein (Painter et al 1982) 
Which is thought to have a large enough stokes radius (38 to 40A°- Allen et al 
1986; 47A°-Huang et al 1984) to allow it to span the plasma membrane (about 
60A°- Stryer 1981). This latter view is supported by the finding that if  cells are 
stimulated before extraction, the receptors co-isolate with the cytoskeleton 
(Jesaitis et al 1988). The extraction procedure of Allan et al (1986) suggested 
that the receptor was closely associated with lipids, and Huang et al found it 
closely associated with tyrosine kinase activity. There is a degree of variation in 
the number of FMLP receptors thought to reside in PMN membranes, with 
reports of 15x10^ per cell (Tennenberg et al 1988); 5 -8x 10^ per cell (Painter et 
al 1982); and 1.2 x 10^ per cell (Niedel et al 1979). The discrepancies may well 
depend on the method of isolation and extraction, because a pool of FMLP 
receptors resides in the membrane of specific granules (Fletcher et al 1983; 
Gardner et al 1986). Either contamination with granules or the promotion of a 
fusion event would alter receptor number. The transient nature of the effect o f 
FMLP stimulation may be due to rapid receptor-ligand ingestion (Boxer et al
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1979), with the FMLP ligand being rapidly digested (Niedel et al 1979); 
although internalization would in theory leave the receptor free to be returned to 
the plasma membrane, these workers did not find recycling of receptors or 
exposure of new ones. The brevity of response has been noted with release of 
IP 3  and lysozyme (Bradford et al 1985a); with microtubule assembly and
chemotaxis (Boxer et al 1979); and with internal calcium release (Palmblad et al
1988).
As a chemotaxin ]n vivo. FMLP must induce directional motility, followed by a 
secondary response in the appropriate area. That is, the cell must move towards 
the site o f FMLP production (namely an invasion of bacteria) and only then 
release bactericidal agents and indulge in phagocytosis. Thus is explained the 
reason for various responses to FMLP being dose-dependent. The responses to 
FMLP are obtained in the nanomolar range; Lehmeyer et al (1979) found that 
whereas only 10-2 0 % o f receptors needed to be occupied for chemotaxis to 
occur in human PMN, a 50-fold concentration was required to elicit O2 " release 
(E.D .5 0  lOnM). Very low concentrations of FMLP induce chemotaxis, ligand 
binding itself being the directional signal, and as the concentration of FMLP 
increases with the approach towards the site of its production, the threshold of 
binding concentration for, say, degranulation is reached - a response which 
would be inappropriate at the time when chemotaxis was initiated. The finding 
of Nieldel et al that there was no renewed exposure of FMLP receptors is not 
consistent with the finding of receptors on granule membranes, and it would be 
essential that the number of receptors be maintained for the threshold to be 
reached at the appropriate site. This makes a recycling mechanism logical, 
because it would mean that no secondary response (i.e. degranulation) need be 
induced at the same time. Concentrations required for different responses 
depend on the presence o f divalent cations and, in vitro, on whether or not 
cytochalasin B is used as a prelude to FMLP stimulation. For instance, in the 
work of Lehmeyer et al (1979), the responses o f 02" production, specific-
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granule enzyme release and chemiluminescence, were significantly enhanced by 
either the addition of calcium to the reaction mixture or by preincubation with 
cytochalasin B. Measurement of oxygen consumption with and without these 
additions showed that the calcium addition could cause an actual increase in cell 
activity, as there was an increase in oxygen consumption, whereas w ith 
cytochalasin B there was not. The PKC activated by FMLP is one which 
predominantly phosphorylates cytosolic proteins (Pontremoli 1986), and for 
which membrane proteins are poor substrates. But cytochalasin B enhances the 
translocation of PKC to the membrane (Pike et al 1986) - an effect of which is 
to increase the phosphorylation of 46KD membrane protein thus enhancing the 
FMLP C>2 " response. The effect of exogenous calcium may also be to enhance
translocation of PKC (Burnham et al 1989).
A functional cell-type specific interaction of PLC and actin has been described 
(van Haelst et al 1988). These findings are significant because a) in the 
physiological environment, calcium would be present and b) because 
cytochalasin B is routinely used in vitro to enhance the FMLP response.
An enhancing effect on the FMLP response has been noted with agents which 
in themselves do not elicit the response seen. These include the effect of prior 
stimulation, or ’priming*, with platelet activating factor (PAF) (Ingrahm et al 
1987) or with tumour necrosis factor (TNF-alpha) (Berkow et al 1987). This 
suggests secondary control of the response stimulated by the main activating 
ligand, namely FMLP. It was noted in work with guinea pig macrophages that 
those elicited from the peritoneum had a lower 02" response to FMLP than
those from the model inflammatory site, which could not be explained by any 
difference in receptor number (Snyderman and Pike 1980). This effect could 
indicate that priming has occurred in macrophages from inflamed tissue. FMLP 
does not usually induce significant LTB4  synthesis in PMN (Sellmayer et al
1987), however, after GM-CSF or PAF priming it does (Wirthmueller et al
1989). This important finding demonstrates altered responsiveness to FMLP.
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In the first few seconds after FMLP stimulation, there is a transient rise in the 
level of cyclic AMP (Bokoch and Gilman 1984; Okajima and Ui 1984) which is 
thought could be due to an FM LP-induced inhibition o f cAMP 
phosphodiesterase (Verghese et al 1985) but this may not be so (Iannone et al
1989). There are G-protein regulatory mechanisms in FMLP-activated 
pathways and those controlling adenylate cyclase which may have mutually 
exclusive activation depending solely on the distance between the two 
mechanisms, proximity allowing the brief interaction seen. In purified plasma 
membrane preparations FMLP can be used to inhibit adenylate cyclase (Lad etal
1985) an effect which is abolished by IAP, suggesting a close relationship 
between the regulatory mediators in the two systems, but not necessarily any 
cooperative use in whole cells. However it could be that an increase in cyclic 
AMP (cAMP) allows activation o f a cAMP-mediated event, such as 
phosphorylation of lipocortin by a cAMP-dependent tyrosine kinase as 
previously mentioned (Hirata et al 1981). The cAMP rise is independent of 
degranulation and 0 2 " production, its inhibition not affecting these events
(Simchowitz et al 1983). The FMLP- induced rise in cAMP is not inhibited by 
IAP (Okajima and Ui 1984). The increase in cAMP could come from a) 
inhibition o f cAMP-specific phosphodiesterase b) activation o f adenylate 
cyclase by the Gi-like G-protein of the FMLP receptor, or c) by prevention of 
adenosine inhibition of adenylate cyclase via the ’F  site (Bushfield et al 1989). 
FMLP stimulation of PIP2  hydrolysis in human plasma membrane preparations
is GTP-dependent and is inhibited by IAP. Smith et al (1985) found no 
formation of lysophospholipids, and therefore no PLA2  activity. This work 
demonstrated FMLP activation of PIP2  hydrolysis linked by G-proteins. In 
isolating the membrane preparation, it is possible that PLA2  activity was lost,
and so the negative result from these experiments is not conclusive. The 
inhibitory effect of IAP on FMLP-induced PIP2  hydrolysis has been found also
in whole PMN (Ohta 1985; Bradford et al 1986). In whole PMN also, FMLP-
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induced arachidonic acid release has been found to be via the PLA2 -mediated 
hydrolysis of phosphatidylcholine synthesized by the transmethylation pathway 
(Hirata et al 1979) and this arachidonate synthesis was found to be IAP 
sensitive (Ohta et al 1985). Both PLA2  activation and PLC activation by FMLP
are IAP sensitive. This does not help to elucidate which pathway is activated at 
any one time or whether or not they are mutually exclusive in this respect. The 
dose-dependent activation of two different pathways for alternative second 
messenger release has been shown for glucagon, which at lower doses activates 
a PLC pathway and at higher doses activates adenylate cyclase (Wakelam et al
1986). And to indicate another possibility, PLA2  is activated in retinal rod outer
segments by the beta-gamma subunit of transducin (Jelsema et al 1987), the 
alpha subunit of which activates guanylate cyclase.
The PLA2 -specific inhibitor p-bromophenacylbromide (pBPB) inhibited 
FMLP-induced activation and it inhibited 02" production induced by PMA 
(Duque et al 1986). This may suggest that PLA2  is indeed activated by FMLP 
but indirectly, by PKC phosphorylation. This effect, too, may be indirect - such 
as phosphorylation of the kinase which phosphorylates lipocortin! This theory 
is suggested because arachidonic acid release is dependent on internal calcium 
above basal levels and is inhibited by TMB8 , an internal calcium antagonist 
(Ohta et al 1985) and because PKC itself is not dependent on a rise in cytosolic 
calcium.
The fine regulation of the internal effects of FMLP stimulation may depend on 
calcium levels within the cell as controlled by a combination o f release of 
calcium from intracellular stores and of passage of exogenous calcium, both of 
which are inhibited by IAP (Ohta et al 1985; Okajima and Ui 1984). These 
workers found that inhibition of calcium mobilization, whilst not affecting PIP2
hydrolysis, did inhibit arachidonic acid release, and that in the absence o f 
exogenous calcium arachidonic acid release was only about 25% of that in its 
presence.
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The number o f receptors occupied is a control mechanism for the response 
elicited by FMLP and cAMP elevation may regulate the initial pathway 
activated. Further control o f the effects of FMLP can be seen in changes in 
binding affinity and in cytoskeletal involvement A number of events have been 
seen to alter FMLP binding affinity, such as an increase in plasma membrane 
fluidity which can be induced, in v itro , by increasing the saturated or 
monounsaturated fatty acid content of the membrane (Tanaka et al 1988) or by 
addition of alcohols (Yuli et al 1982). An increase in fluidity not only increases 
the affinity of FMLP binding but also has divergent effects on the response - 
chemotaxis being enhanced and C>2 " production and lysosomal enzyme release
being inhibited without altering receptor number (Yuli et al 1982), coincident 
with a lack of PKC stimulation (Pike et al 1986). These two papers combine to 
make a case for chemotaxis and secretion being modulated by different effector 
enzymes. Similarly, in PMN membrane preparations G-protein interaction with 
the ligand-bound receptor lowers the ligand-receptor binding affinity (Koo et al 
1983). The changes observed in receptor affinity are a combination o f an 
increase in numbers of low affinity receptors exposed at the cell surface by 
degranulation, and a change in the affinity o f receptors already at the cell 
surface. Products of the signal transduction event could feed back to induce the 
changes in fluidity (assuming no competing metabolic pathway to be one 
hundred per cent efficient). Free arachidonic acid is a product of both PLA2
and PLC activity, and the alcohol inositol triphosphate of the latter. Thus a cycle 
could be envisaged in which on FMLP binding to a few, high affinity receptors, 
chemotaxis could be induced; the increase in the affinity induced by cytoskeletal 
interaction could simultaneously repress the secretory functions until the 
concentration of FMLP was high enough to ensure a large degree of ligand 
binding to low affinity receptors to override this; following PLA2  activation,
released arachidonic acid could raise membrane fluidity and again induce 
conditions more conducive to chemotaxis. I f  the concentration of FMLP was
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high enough to induce PLC activation, both arachidonic acid and inositol 
triphosphate would also contribute to an increase in fluidity. As well as feeding 
back to stop the O2 " and secretory responses, this latter event could be a means
o f ensuring that the chemotactic response was not lost after a high concentration 
o f FMLP had been encountered. This may be more significant in the case of 
MNC activation than of PMN, the latter being less able to sustain prolonged 
involvement in stimulatory conditions.
FMLP binding induces an increase in cytoskeleton-associated actin and rapid 
and transient association o f the receptor with the cytoskeleton at chemotactic 
doses (InM), in a manner inhibitable by IAP (Sha’afi et al 1987). It has been 
suggested that the cytoskeletal association segregates the FMLP-bound receptor 
from its interactive G-proteins (Jesaitis et al 1988). Inhibiting actin 
polymerization with cytochalasin B to enhance degranulation and O2 ”
production could also prevent internalization of receptors and prolong possible 
interaction with G-proteins. Cytochalasin B reduces phosphatidylinositol 
phosphate kinase activity, so microfilaments probably facilitate PLC activity by 
controlling the site of substrate production (Pike et al 1988). This suggests that 
the PLC pathway may be concerned with negative feedback in the 02*
response, and the disruption of this could be responsible for the enhancement 
seen in the FMLP response with cytochalasin B.
iii. The IcG Fc Receptors.
(Fc-gamma-R:- FcR in this thesis).
There are currently three classes of human IgG Fc receptor; these are 
summarized in Table 2. Polymorphisms have been found within each class of 
FcR. In the case of FcRl 11 for instance, two polymorphic types have been 
attributed to differences in primary amino acid structure (Ory et al 1989) and 
Ravetch et al (1989) identified two distinct F c R ll l  genes on human 
chromosome 1; also the location of the three genes for FcRl 1.
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The receptors have epitopes in common on lymphocytes, monocytes and on 
PMN, all labelling with monoclonal antibody (Mab) KuFc79 (Vaughan et al 
1985), which precipitated molecules o f molecular weights 42KD, 33KD and 
70KD, with extensive microheterogeneity of molecular weight suggested to be 
due to variation in carbohydrate content. The carbohydrate side chains (CHO) 
may introduce further, functional, heterogeneity among the FcR. Concanavalin 
A (which is alpha-mannoside-specific) binds to FcRl 11 and not to FcRl 1, and 
alters the binding of FcRl 11-specific Mab 3G8 (Kimberly et al 1989). Any 
alteration of CHO may therefore affect receptor function. In RA the sialic acid 
content of many plasma proteins is seen to be altered, including that on IgG 
(van Eijk et al 1986). I f  this extends to FcR, which seems likely, this may have 
important consiquences for cell activation. Recently it has been found that IgG 
isotypes and not alterations in CHO affect rheumatoid factor binding (Newkirk 
etal 1990).
O f the three types of receptor, only FcRl demonstrates any significant binding 
o f monomeric IgG. FcRl 1 and FcRl 11 require cross-linking for binding and 
activation (Bijsterbosch and Klaus 1985). Activation of FcRl can be mimicked 
in vitro by preincubating cells with monomeric IgG under conditions which 
prevent internalization o f receptors (such as incubating at 4^c) followed by 
addition of F(ab)2  fragment of a second antibody to the first one. Alternatively
monomeric IgG can be heat-aggregated and used as a one-step stimulant of all 
three receptor sub-types. The work using these two methods can be cross 
referenced for work on cell activation and used separately for studying specific 
Fc receptors. It has been found that heteromeric cross-linking is possible 
(Malbran et al 1987). The complement component C3 has a high affinity for 
IgG. If  the complement cascade is activated, C3b binds to IgG covalently in the 
0^3 region. This heterodimer can then bind to both FcR and CR1, mimicking
homologous cross-linkage with subsequent cell activation and internalization of
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the complex. A third method for cross-linking has been described in which 
IgG-coated beads were used (Fitzharris et al 1987).
Anchorage of Fc receptors in the plasma membrane differs, which has 
important implications for the response that they can induce. FcRl 11 on PMN 
is anchored by a phosphatidylinositol (PI) linkage, and has no transmembrane- 
spanning region, but it is not found to be Pi-linked in cultured monocytes 
(Huizinga et al 1988) or in NK cells (Ravetch et al 1989). Ravetch and workers 
determined that the FcRl 11 in PMN and monocytes were each the product of a 
different gene. In patients with paroxysmal nocturnal haematuria (PNH) where 
there is known to be defective Pl-linkage, PMN were deficient in FcRl 11 
expression but cultured monocytes were not. Activation o f PMN was 
unaffected by this deficiency. It was noted that normal PMN in serum-free 
medium released FcRl 11 on stimulation with FMLP. Investigation of receptor 
expression may depend on the invitro conditions. McGuire and Sandilands
(1987) demonstrated that release of FcR from normal monocytes was an 
artifactual event in vitro and was completely absent in the presence of serum, 
which supplied essential protease inhibitors. However in PNH, as FcRl 11 are 
synthesised normally and simply not linked to the cell membrane, they probably 
are released into the extracellular space, with unknown consequences. It is also 
possible that in RA synovial fluid the unidentified protease is not active or is 
absent. Kurosaki and Ravetch (1989) found FcRl 11 Pl-linkage to be 
determined as a post-translational event, dependent on simultaneous expression 
of another protein. Absence of the second protein results in cleavage of the 
carboxy terminal end of the FcR molecule and Pl-linkage. There is evidence that 
differing receptor linkage may be a fairly common way of altering receptor 
function from one cell type to another (Cross 1987), and that alterations in 
linkage may occur in malignancy (Conzelmann et al 1986). Release of 
diacylglycerol on receptor hydrolysis is likely also to be functionally relevant
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Considering the constitutive expression o f FcR on PMN and monocytes, in 
experiments using cells directly from whole blood FcRl 1 and FcRl 11 can be 
involved in activation events in PMN, and FcRl and F cR ll can be with 
monocytes. Any differences in the responses seen in the two cell types may be 
attributed to FcRl activity in monocytes or FcRl 11 in PMN. The expression of 
FcRl 11 on monocytes in culture is indicative of their attaining macrophage-like 
characteristics (Huizinga et al 1988).
a. FcR Activation.
The ability of FcRl to bind monomeric IgG does not preclude its activation by 
cross-linked IgG such as immune complexes. FcRl may transmit a negative 
signal; in mouse B lymphocytes it inhibits proliferation induced by cross-linked 
anti-surface-bound IgG (Bijsterbosch and Klaus 1985). In keeping with the 
idea of a negative signal, Hammerling and Hoffmann (1987) suggest that Fc on 
antigen-presenting cells down-regulate T helper cell function. FcR have been 
found to be functional in T cell locomotion (Wilkinson and Higgins 1987) and 
proliferation (Boot et al 1989); in NK cell ADCC (Selveraj 1989), specifically 
on an NK T cell subset (Lanier et al 1985; 1989); in B lymphocyte PLA2
activity (Suzuki et al 1980) and surface Ig function (Bijsterbosch and Klaus 
1985); in platelet clearance (Clarkson et al 1986) and are found to be expressed 
on endothelial cells after viral infection (Cines et al 1982).
b. FcR on PMN and Monocvtes.
Human PMN produce C>2 ‘ in response to heat-aggregated IgG (HAGG) and
undergo degranulation and phagoytosis (Roos et al 1976). Preincubation with 
cytochalasin B (inhibiting phagocytosis) results in enhanced O2 " production and
granule enzyme release, indicative of cytoskeletal involvement. Willis et al
(1988) used Mab to demonstrate that cross-linking FcR on PMN induced 
lysosomal enzyme release and O2 ’ production. IgA} or IgG} induced
significantly more beta-glucuronidase from PMN than other Ig subclasses, and 
IgG 1 did so from monocytes; effects doubled after cytochalasin B treatment
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(Ferreri et al 1987). The release could be blocked by monomeric IgG, 
demonstrating that cross-linking, and not just receptor occupancy, is required 
for FcR activation. Cross-linking of FcR-FcR or o f FcR-CRl results in 
transduction o f an activation signal and internalization of the receptor-ligand 
complex, in a down-regulation mechanism in common with other receptors. 
This is not seen to happen with monomeric binding, and in these circumstances 
the fate of ligand-bound FcRl remains unclear (Jones et al 1985). It maybe that 
FcRl is involved with normal clearance of circulating IgG. In monocytes, 
adhesion of bound IgG to an antigenic surface can mimick cross-linking under 
conditions precluding internalization (Jungi et al 1987). This modified both 
receptor expression on the rest of the cell surface and cell function. In vivo this 
could be envisaged to occur with IgG bound to damaged cells (Hansson et al
1987) or with tissue-bound autoantibody.
Identification of the relative roles of FcRl 1 and FcRl 11 ascertained that there 
were 15-16x1 O^FcRll/PMN and 110-120xl0^FcRll 1/PMN (Tosi and 
Berger 1988). Stimulating with HAGG and blocking with Mabs IV.3 and 3G8 
respectively, these workers concluded that the role of FcRl 1 was to transduce 
the activation signal and that of the more numerous FcRl 11 was to bind ligand, 
thus ensuring a plentiful supply for FcRl 1. This model is reinforced by the 
finding that Mab CRB-FcR/Granl to FcRl 11 blocked all IgG binding to PMN 
whereas Mab C1KM5 to FcRl 1 only reduced it (Huizinga et al 1989a). These 
workers also found on blocking FcRl 1 that they were unable to activate the 
respiratory burst or phagocytosis with small immune complexes bound to 
FcRl 11, and vice versa, but that large complexes could activate FcRl 1 when 
FcRl 11 was blocked (Huizinga et al 1989b), suggesting that the lower numbers 
o f FcR 11 are spatially distributed in such a way that cross-linking is not 
accomplished by small complexes, a deficiency which may usually be made 
good by the relative abundance of FcRl 11. If  this dual binding is mediated by 
only one of the two receptor types having a signal transduction mechanism, it
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must strongly suggest that in the other instances of heterologous cross-linking 
(FCR-CR1 for instance) the necessity is again a spatial one. It also suggests that 
direct interaction between the transducing receptors (e.g. F cR ll)  is not 
necessary because they will be separated by the many FcRl 11 molecules. The 
capping seen by fluorescence experiments indicates that bound receptors do 
polarise. Capping could just be for the removal of the receptor-ligand complex 
with the loss of as little plasma membrane, and associated molecules, as 
possible. If, however, this is indeed to bring signal transducing receptors into 
apposition, then release of FcRl 11 would promote this. Its hydrolase could 
also provide a means of regulation. In other cell types FcRl 11 may have a 
different function. Current work by Huizinga and workers is investigating a 
possible signal transducing mechanism from FcRl 11 on PMN (verbal 
communication).
In work with Mab to FcRl 1, Feister et al (1988) found that the O2 ’ response of 
human PMN was abolished by preincubation of cells with IAP. However the 
degranulation response was only partially inhibited, indicating that there are at 
least two pathways activated by FcR cross-linking, of which only that to C>2 ’
was totally regulated by an IAP-sensitive G-protein. The degranulation 
response was not completely immune to G-protein regulation. This could 
suggest that both the nature of the response arid the degree may be mediated by 
G-proteins.
Fitzharris et al (1987) demonstrated that FMLP-primed PMN could be induced 
to release LTB4  both extra- and intracellularly by cross-linking Fc receptors
with IgG-coated beads. The fact that it is synthesised but not released in 
response to higher doses of FMLP alone (Sellmayer 1987) may suggest that 
FcR activation induces an essential membrane perturbation which does not 
occur with FMLP stimulation.
Monocytes synthesise arachidonic acid metabolites on FcR stimulation and this 
could be derived directly from FcR if they, too, bear the intrinsic PLA2  activity
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which has been found in FcRl 1 of B lymphocytes (Suzuki et al 1980). PLA2  
activity has been found to inhibit adenylate cyclase activity, and adenylate 
cyclase to inhibit binding to Fc-gamma 2bR (human FcRl 1 homologue) in the 
mouse macrophage cell line p388Di (Hirata et al 1987), and, in the same cell 
line, this could be blocked by inhibiting prostaglandin production and involved 
G-protein regulation (Nitta et al 1982). In work with guinea pig elicited 
peritoneal macrophages, FcR-mediated stimulation o f 02" release was 
inhibitable by a PLA2  inhibitor and partially by a PKC inhibitor (Sakata et al
1987), direct stimulation with arachidonic acid not being inhibited by PKC 
inhibitor; suggesting that FcR-mediated activation may be by more than one 
pathway perhaps depending on the receptor subtype, those activated in the 
guinea pig macrophage not being distinguished here. To determine if there is 
activation o f more than one pathway by the same receptor subtype requires 
activation by cross-linking subtype-specific monoclonal antibodies. Using an 
IgGl Mab to FcRl 1 (Mab C1KM5) and comparing its effect with IgG2a Mab 
also to FcRl 1 (2E1), MacIntyre et al (1988) demonstrated that tripartite binding 
by C1KM5 could induce calcium mobilization in human monocytes, but 
divalent binding by its F(ab’) sites could not. A much less effective response 
was obtained by cross-linking the 2E 1 F(ab’)2  fragments. 02" production could
not be induced by C1KM5 unless the monocytes were primed by IFN-gamma, 
and not at all by cross-linked 2E1 fragments. Preliminary work with other types 
o f cell (including B lymphocytes and PMN) suggested a different response to 
C1KM5, indicating that the epitope on monocytes may be cell-type specific or 
that the mechanism of activation is not precisely the same.
In some instances FcR binding triggers a cell-mediated cytotoxic event (Fanger 
et al 1989). FcRl 11 could not mediate this event on PMN, but could do so on 
NK cells, in which they are not Pi-linked, indicating the cell-type specificity of 
the receptor subtype functions, as may be regulation of receptor expression; 
IFN-gamma induction of FcRl on PMN can be inhibited by the synthetic
46
glucocorticoid dexamethasone (DEX) (Petroni et al 1988), but DEX enhances 
the effect of IFN-gamma on FcRl expression in monocytes (Girard et al 1987). 
FcR in RA will be considered in a later section.
In this project use has been made of the HAGG system for stimulating FcR in 
both PMN and MNC without discriminating between the receptor sub-types, in 
the presence or absence of SH-blockade. Some preliminary work has been 
carried out also using purified IgG and the monoclonal antibodies 1V.3, 3G8 
and also 32+22, an FcRl-specific Mab.
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Table 2. Human Fc-gamma-R Sub-Tvpes.
Receptor Cell Type IcG Specificity Mabs Approx. Mol Wt. 
FcR l Monocyte Ig G i« Ig G 3 > IgG 4  32.2 70
U 9 3 7 ;H L 6 0  FR51
M a cro p h ag e  
NK  cell 
♦P M N
F c R ll Monocyte IgG j* Ig G 3 > Ig G 2  IV.3 40
PM N and  Ig G 4  K u F c 7  9
eosinophil 2E1
B cell C1KM5
U 9 3 7 ; H L 6 0  
K 5 6 2 ;D a u d i ;
R a j i
FcRl 11 Macrophage Ig G j* Ig G 3 3G8 50-70
PM N  B 7 3 .1
eosinophil L e u l l a , b ,c .
NK cell
Note: * = only PMN preincubated in IFN-gamma.
(Abbreviated from:- Anderson and Looney 1986; Unkless et al 1988; Fanger et
al 1989)
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D. REA CTIV E OXYGEN.
Stimulation by the systems so far described, using specific ligands such as 
FMLP or HAGG, using non-surface-receptor ligands such as fluoride or PMA 
results in 0 2 ' production and thereby also to H2O2  from activation of NADPH
oxidase.
i. NADPH Ovidflsft.
The NADPH oxidase complex is the source of O2 ’ generated when phagocytes 
undergo the respiratory burst, and as such is a key element in the bactericidal 
response of these cells. It has an absolute requirement for extracellular oxygen, 
and in anaerobic conditions is completely inactive (Cumutte and Babior 1975). 
It is also dependent on a fully operational proton pump (Henderson et al (1988). 
Its function is to convert molecular oxygen into O2 ' ,  which it does at the
expense of NADPH supplied by the hexose monophosphate shunt (HMPS). 
HMPS
1G 6P+12N A D P+ > 6 C 02  + 12NADPH + 12H 1" + Pf
NADPH oxidase 
12 NADPH + 24 0 2 ------------ > 12NADP+ + 12 H+ + 24 0 2 “
The CO2  produced by the HMPS is hydrated to H2 CO3  and this subsequently 
supplies the protons for secretion (Borregaard et al 1984).
Activation is thought to be of an electron transport chain, which includes a 
cytosolic subunit with an unidentified role, but which may be translocated to
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the plasma membrane on activation; a non-covalently-bound FAD associated 
with a 45-48KD protein which may be a substrate for protein kinase C; and a 
cytochrome b. The evidence for these assumptions has been gathered largely 
from analysis of PMN, both whole and fractionated, from animals or from 
man. The membrane components suggested have midpoint potentials which 
make a logical 'chain' for electron transport;
NADPH/NADP+ = -320mV 
FADH2 /FAD+ = -280Mv
cyt h/cyt b+ = -245mV 
O2 /O2 - = -160mV
Investigations of O2 '  production necessarily combine both that o f the 
stimulatory pathways to activation, and the enzyme complex itself. There seems 
to be no dispute that, whatever the activation mechanism, or the stimulus 
employed, the enzyme complex activated is the same one. In 1979, Tauber and 
Goetzl first isolated NADPH oxidase activity from human PMN fractions. They 
identified NADPH oxidase activity in both the plasma membrane and also in 
another particulate fraction. The work o f Clarke et al (1987) found enzyme 
activity in the plasma membrane fraction, but three times as much in the fraction 
containing specific granule membranes. They also found that there was a 
soluble factor required, with magnesium, for activation of the membrane bound 
fractions, a factor which was noted by Tanaka et al (1988) either to be inactive 
or not present in the cytosol once activation had taken place. Cumutte et al 
(1987a and b) found a similar requirement for magnesium with the cytosolic 
cofactor, but their isolation procedure separated activity in two fractions of 
molecular weights 250KD and 50KD. The molecular weight of the cytosolic 
factor identified by Clarke et al was 10KD, which precluded its being protein
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kinase C, because the smallest active fragment of PKC they found was 50KD. 
Activation occurs simultaneously with changes in protein phosphorylation 
(Andrews and Babior 1983; Gennaro 1985; Hayakawa et al 1986).
The most important discovery for the elucidation of this enzyme complex has 
been the finding that patients with chronic granulomatous disease are deficient 
in both C>2 " production and in some of the proteins suggested as elements in the
oxidase complex. The disease has been genetically subdivided into groups, 
depending on the factor missing in the fractionation o f PMN. The X-linked 
disease has been associated with normal levels of cytosolic factor, but no 
cytochrome b5 5 g, as has a group o f autosomal recessive-linked disease
(Cumutte et al 1987). There is another autosomal recessive group, which does 
have the cytochrome but has been found to be deficient in the cytosolic factor 
(Cumutte et al 1988), and other subgroup deficiencies may come to light. 
Carriers of the disease demonstrate only partial efficiency of O2 ” production.
Activation o f the oxidase by FMLP, PMA or by Con A was found to be 
coincident with phosphorylation of a 45KD membrane protein (Ohtsuka et al 
1987), an event lacking in some autosomal recessive CGD patients (Segal et al 
1983). Hayakawa et al (1986) identified phosphorylation o f a 48KD protein 
associated with NADPH oxidase activation, which was not found to the same 
extent in CGD patients, and found labelling seen with PMA stimulation, of a 
cytosolic 48KD protein which was not found in the CGD patients. It seems that 
phosphorylation of a 45-48KD protein occurs in conjunction with NADPH 
oxidase activation, and is considered as a substrate for the PKC. However, 
when activation of this kinase is blocked by an isoquinoline derivative (Bass 
1987), activation of NADPH oxidase still occurs in response to the receptor- 
mediated ligand FMLP, indicating either that another kinase activated by FMLP 
stimulation can phosphorylate the 45-48KD protein, or that oxidase activation is 
not dependent on phosphorylation alone. Diphenyliodonium (DPI) inhibits
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PMA-stimulated O 2 ’ production. Inhibition o f NADPH oxidase by 1 125.
labelled DPI was seen to inhibit NADPH reduction of FAD, and of 
cytochrome b245, whilst labelling a 45KD protein (Cross and Jones 1986),
suggesting that DPI inhibited the PKC phosphoiylation site.
The location of the enzyme complex is dependent on the ability of preparative 
techniques to separate fractions, plasma membrane and specific granule 
membrane in particular, without inducing a fusion event or the activation of 
resting cells. (For example, Cumutte and workers (1987) point out membrane 
aggregation as a hazard of their preparative procedure). The location of subunits 
of the oxidase in resting cells is therefore not fully resolved. Amit et al (1988) 
found almost no cytochrome b5 5 9  in plasma membrane, and found activity not
dependent on its presence at all. Borregaard et al (1983) located the cytochrome 
to the specific granule membrane and reported translocation of 75% of it to the 
plasma membrane on activation, and in 1984 reported that the flavoprotein was 
found not to be an intergral membrane protein in specific granule membranes, 
whereas the cytochrome b was. It is possible to inhibit degranulation and still 
invoke O2 ” production, with fluoride for instance (Cumutte et al 1979), so there
may be no obligatory subunit residing solely in specific granule membranes.
Lipids form an essential part in the NADPH oxidase complex. Tauber and 
Goetzl (1979) used deoxycholate instead o f phospholipids in their suspension 
buffer, finding no activity with the absence o f both. Activation o f NADPH 
oxidase in whole cells has demonstrated a role for arachidonic acid which has 
yet to be clarified. Whilst it activates NADPH oxidase in m em brane 
preparations (Tanaka 1988; Bromberg and Pick 1983; Amit et al 1988; Clark et 
al 1987) it is toxic to whole cells if  added exogenously (Cohen et al 1986). As a 
preferential substrate in PLA 2  cleavage o f phosphatidylcholine, an event
activated by opsonized zymosan-stimulated cells for instance (Maridonneau- 
Parini et al 1986), and as a product of diacylglycerol catabolism after PLC
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activation (Ohta et al 1985), it is an important metabolite in two pathways 
known to be linked to NADPH oxidase activation. Saturated an d  
monounsaturated fatty acids were found to activate the oxidase in membrane 
preparations without the nonspecific increase in oxygen consumption that 
arachidonic acid induced (Tanaka et al 1988). Removal of fatty acids by the 
addition of albumin inactivated the enzyme system. These results may suggest 
a role for lipids in regulating the juxtapositioning of the subunits of the enzyme 
complex. In membrane fractions the oxidase has also been found to be activated 
by negatively-charged detergents such as SDS (Cox et al 1987), a process 
dependent on an unidentified cofactor and inhibited by increasing concentrations 
o f phospholipids (Aviram and Sharabani 1989). PLC and PKC were also 
activated in membrane preparations in the presence of a cytosolic cofactor by 
negatively-charged phospholipids, and preapplication of phosphoinositides 
prevented the stimulation of NADPH oxidase by SDS (Aviram and Sharabani 
1989).
An effect of low doses of stimuli such as FMLP, PMA,(Bass 1987) LPS 
(Sasada 1983) PAF (Ingraham et al 1987) or TNF-alpha (Berkow et al 1987), 
is to enhance the C>2 ~ response induced by a second, different, stimulus, even 
when the first, as in the case of TNF-alpha or PAF, does not induce O2 * itself 
at any dose. Bass and workers identified the PMA priming effect as the 
translocation of PKC to the membrane; the work of Sasada’s group showed that 
the effect of PMA priming was to increase the rate of NADPH oxidase activity 
and to lower the binding constant for NADPH on subsequent stimulation by a 
different ligand. This suggests that there are regulatory steps at the oxidase end 
of 0 2 * production as well as at earlier stages of signal transduction.
The role of the cytoskeleton in NADPH oxidase activation or regulation is 
unknown but the enzyme does co-sediment with the actin-rich cytoskeletal 
membrane vesicle fraction (Jesaitis et al 1988). As mentioned, the inclusion o f
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cytochalasin B before FMLP stimulation is common practice, and has an 
enhancing effect on O2 * production (Simchowitz et al 1983; Lemeyer et al 1979;
Dahlgren 1988). Whether this is solely due to an effect on FMLP-receptor 
regulation, or if  it also includes regulation of the NADPH oxidase complex has 
not yet been determined.
Recently work has suggested that the elements for O2 " production can be found
and activated in certain populations of B lymphocytes and in some EBV- 
transformed B cell lines (Maly et al 1988; 1989). The tiny amount of 02" elicited
from normal B cells was in response to extremely large doses o f stimuli, 
however it has to be admitted that the active enzyme system is present in these 
cells.
The consiquence of NADPH oxidase activation is the generation of reactive 
oxygen species to the outside of the cell and in the phagocytic vacuole.
ii. Free Radicals and Reactive Oxygen Species.
a. Production.
Oxygen-derived free radicals are normal metabolites in a number of biochemical 
pathways where they may form an unwelcome byproduct to be removed as 
soon as possible or they may be essential end products. Some are highly 
reactive and rapidly initiate peroxidation in proteins and lipids.
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The formation of free radicals is described diagrammatically below 
C>2 + e > 0 2 ’ 1 .
202- + 2H+ ------ > H2O2  + O2 2
Metaln+
O 2 " + H2 O2  ------> 0 2  + OH' + OH* 3.
I ' + H 202   > HOI + HO’ 4.
MPO
H 2 O2  + Cl’  > OC1- + H2 O 5a.
0C1- + H2 O2  ------> H2 O + Cl’ + IO2  5b.
OC1' + RNH2  -------> RNHC1 + HO’ 5c.
OC1- + RNHC1 -------> RNCI2  + HO’ 5d.
(from Fantone and Ward 1985)
The formation of oxygen-derived free radicals and their metabolites begins with 
the one electron reduction of oxygen to form O2 " (equation 1). In the presence 
o f SOD this is dismutated to hydrogen peroxide (H2 O2 ) and oxygen, which
may also happen spontaneously, if  quite slowly (equation 2 ). Catalase can 
convert H2O2  to water and oxygen. However, hydroxyl radicals (OH*) can be
produced by the Haber-Weiss reaction; in the presence of transition metal ions 
called the Fenton reaction (equation 3). I f  H2 O 2  becomes available to
myeloperoxidase from phagocyte granules, hypochlorite can be produced 
(equation 5a). A chain of reactions may follow (equation 5b-d) in which 
chloramines are produced - the chain length depending on what is available in 
the surrounding environment. Optimal pH for MPO hypochlorite-generating 
activity is acidic, but in alkaline conditions it catalyses the conversion of H2 O2
to oxygen and water. Singlet oxygen, an intermediate intracellular product 
which is detectable in vitro as chemiluminescence, has an indeterminate role 
physiologically. The iron-iodide system for the formation of radicals (equation 
4) may be of limited physiological relevance being dependent on iodide ions - 
which are not widely distributed.
In all aerobic cells radicals can be removed by catalysts such as superoxide 
dismutase (SOD), catalase and glutathione peroxidase. In purine breakdown, 
the conversion o f xanthine to uric acid is catabolized by xanthine oxidase, with 
release of 0 2 ", and this enzyme may be released by damaged cells following 
ischaemia. In electron transport chains, 0 2 ' may be released; in mitochondria 
they are, for instance, a byproduct in mitochondrial oxidative phosphorylation 
and these organelles contain SOD and catalase to render it harmless (Fantone 
and Ward 1985). Van Kuijk et al (1987) demonstrated a protective role for 
PL A 2  in the selective removal o f peroxidized fatty acyl chains from
phospholipids for reduction with glutathione and glutathione peroxidase. In 
phagocytic cell specific granule and plasma membranes O2 '  is the end product
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of the short electron transport chain, NADPH oxidase, previously described, 
which is designed specifically for its formation as an important factor in 
destruction of phagocytosed particles (Cumutte and Babior 1975). O2 " may be
released as a direct initiator of chemical modification designed to damage or kill 
phagocytosed particles (Babior et al 1979), but much of it is also dismutated 
and released as H2 O2 .
Peroxide products differ depending on the stimulus; those released by FMLP 
and heat-aggregated IgG being about 90% and 30% catalase-inhibitable (i.e. 
H2 O2 ) respectively (Maslen et al 1987). In MNC activated by heat-aggregated
IgG it has been shown that the major lytic agent in destruction of unsensitized 
red blood cells is OC1", and that inhibition of 02* with SOD had much less 
effect than inhibition of H2O2  with catalase or OH* with mannitol (Geffner et 
al 1987). Both ascorbate and MPO provide examples of agents the control of 
whose activity may bring about dramatically different effects. When azurophilic 
degranulation occurs in conjunction with the production of reactive species in 
activated phagocytes, MPO is released which, with chloride ions, can form 
highly toxic OC1". Even in the presence of high (>0.2uM) concentrations of free 
iron, MPO can compete successfully and totally for H2 O2 , resulting in a
complete absence of OH* formation (Winterboum 1986), and MPO-derived 
oxidants can inactivate PMN enzymes such as lysozyme, beta-glucuronidase, 
collagenase and gelatinase, only elastase being resistant (Vissers and 
Winterboum 1988). Winteiboum also mentioned that ascorbic acid can act as an 
electron donor in the Haber-Weiss reaction, substituting for 0 2 ‘ in the reduction
o f ferric to ferrous ions. This raises the point that a deficiency in the ascorbate 
transport mechanism would not only deplete the intracellular environment of an 
important free radical scavenger, but would also promote in the extracellular 
surroundings a plentiful supply for the Haber-Weiss reaction. It also 
demonstrates that MPO, which has been described as a system for producing
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lethal bactericides (0C1';N-C1) and as an enzyme activator, may also serve a 
protective role. Although OC1’ may be a most potent effector of free radical 
damage, MPO deficiency is not usually fatal, but a deficiency in the 0 2 ’ -
generating system, such as is found in chronic granulomatous disease, results 
in recurrent infections which are eventually insurmountable.
b. Functions.
As well as their destructive role, radicals may be necessary to activate certain 
enzymes when appropriate; cyclo-oxygenase has been shown to require 
peroxides for activation for instance (Hemler et al 1979), with peroxide levels 
governing the preferred final product (Warso and Lands 1983), and collagenase 
released from specific granules on PMN degranulation requires modification by 
OCL* to activate it (Weiss et al 1985). Others, such as the plasma anti-elastase 
enzyme, are inactivated by free radicals (Test and Weiss 1986). So a certain 
level of peroxidation is necessary for some functions of cells and tissues.
c. Damage.
Normally, highly reactive radicals are well contained. For instance, when 
introduced in vitro to a monolayer of vascular endothelial cells which have been 
invaded by Candida hyphae, PMN can selectively destroy the hyphae from 
around and within the endothelial cells with no damage to the monolayer 
(Edwards et al 1987). But stimulated PMN can kill suspensions or monolayers 
of endothelial cells in vitro, by a H2 0 2 *dependent mechanism (Weiss et al
1981), which is insensitive to SOD, and not blocked by MPO inhibition.
Damage by free radicals is deleterious to most of the normal functioning of cells 
and an investigation of the exact molecular nature of the damage caused to 
proteins has been undertaken by Davies and workers (1987a-f). They subjected 
a number of different isolated proteins, and bovine serum albumin in particular,
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to different free radical-generating systems with and without selective 
scavengers, and followed this treatment with exposure to red blood cell extract. 
They concluded that exposure to free radicals led to the proteins being degraded 
at a faster rate, and by a different (non-ATP-requiring) system, compared to 
unexposed proteins. Most of the damage incurred by exposure to radicals could 
be prevented by mannitol (an OH* inhibitor) as opposed to SOD, and damage 
was greatest in the presence of OH* or OH* with O 2 ", rather than with 0 2 ’
alone, and in the presence of oxygen rather than nitrogen. In examining what 
damage the pretreatment induced which increased the rate of proteolysis, an 
increase in hydrophobicity correlated well and this was induced in bovine serum 
albumin by formation of covalent bonds by exposure to OH* and by formation 
of non-covalent bonds by exposure to 0 2 “. This could be prevented by urate, a
physiological scavenger, as efficiently as by mannitol. As the exposure to free 
radicals was undertaken in the absence of lipids, the damage was not an indirect 
effect of lipid peroxidation followed by a chain reaction. In work on exposure 
of proteins to lipid peroxides, it was found also that the proteins decreased in 
solubility - demonstrating an increase in hydrophobicity (Roubal and Tappel 
1966).
In vivo lipids form the essential hydrophobic barrier which retains the cells’ 
controlled intracellular environment, whilst also providing a fluid environment 
in which enzymes, regulatory proteins and other lipids can move both laterally 
across the cell surface and rotationally, from the cytoplasmic to the extracellular 
side. This potential for interaction of membrane constituents is far greater than 
could be expected from a static membrane and may include complex interactions 
o f control of transport and regulation mechanisms within the bilayer. The 
functional integrity of the membrane can be compromised by lipid peroxidation, 
which may result in cross-linking of phospholipid fatty acid side chains, in their 
fragmentation, or in alteration o f fatty acid mobility by alteration o f covalent
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bonding. Lipid peroxides are not as reactive as free radicals, therefore they are 
longer lived, and, due to the inherent mobility of the membrane, literally in a 
position to have more widespread effects.
d. Iron.
In biological systems, iron is kept tightly bound both in transport by transferrin 
molecules and in storage bound to ferritin or in haemosiderin. However O2 " has
been found to utilize iron from physiological concentrations of ferritin in liver 
microsomes to form lipid peroxides (Koster and Slee 1986). Other workers 
have shown ascorbate to stabilize the ferritin shell, preventing accessibility of 
iron (Bridges and Hoffman 1986). Iron is also present in proteins such as the 
cytochromes and haemoglobin. Iron may be utilized for the Fenton reaction 
while still protein-bound. In a cell-free system McCord and Day (1987) found 
transferrin-chelated iron as efficient as EDTA-chelated iron in bringing about 
OH* production from a xanthine-xanthine oxidase system. Lactoferrin from 
specific granules could act as a source of iron (Ambruso and Johnstone 1981). 
Copper ions can also be utilized in the Fenton reaction and they, too, are found 
as an integral part of certain proteins, ( e.g. caeruloplasmin). Caeruloplasmin is 
very labile in vitro (Winyard et al 1987) which may suggest that it could release 
its copper ions and promote the Fenton reaction in vivo. Its role is difficult to 
determine, but it is generally thought to have a ferroxidase role. One of the 
laboratory parameters for RA is a high serum copper level (Mussalo-Rauhamaa 
et al 1988). The availability of iron may be of importance in ischaemic damage 
in particular, in which an accumulation of damaged red blood cells may make 
localized iron levels high, and reperfusion restore oxygen levels to that required 
for PMN respiratory burst activity. In rat lung (Ward et al 1983), in which 
complement was activated by infusion of cobra venom, damage to the vascular 
endothelium was found in the presence of PMN. Chelating iron with lactoferrin 
(which is released from PMN specific granules) protected the lungs from
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damage. Protection was almost total, regardless of the presence o f iron, if  the 
rats were first pretreated with an OH* scavenger, dimethylsulphoxide. The 
injury period was self-limiting and no damage was incurred if  the rats were 
first made neutropaenic.
e. Protection.
In vivo, in an acute inflammatory response an invasion by phagocytes 
eventually retreats leaving no lasting damage in its wake which supports the 
theory that phagocyte reactive products are normally confined either to the 
phagocytic vacuole or to a contained microenvironment such as that created by 
the cell closely adhering to an extracellular substrate. It is likely that the 
modifications seen to occur in vitro when free radicals are investigated do occur 
naturally, but in a manner which can be controlled by scavenger enzymes and 
contained by repair mechanisms. The protection mechanisms described are 
dependent on one another to maintain health and a deficiency in any one area 
will affect the whole. SH groups form part of this system. There are intra- and 
extra-cellular mechanisms for limiting free radical damage. However 
glutathione peroxidase is the only extracellular peroxidase (Maddipati et al
1987). In an interesting study designed to examine the relative role of various 
antioxidants in human plasma, Wayner and co-workers (1987) found the 
following proportional contributions to the total antioxidant activity; urate 35- 
65%, plasma proteins 10-50%, ascorbate 0-24% and alpha-tocopherol 5-10%. 
However, the serum SH groups were preferentially lost (oxidized) first, even 
before urate. This implies a major role for these groups in preventing 
peroxidative damage and they are found to be present in lesser amounts in the 
plasma from patients with R.A. (Lorber et al 1964) who also have lowered 
levels of serum albumin - the major contributor of SH groups in plasma. 
O’Donnell-Tomey and workers (1987) found that in human cell-line and normal 
human fibroblast cultures pyruvate scavenged H2 O2  and that the cells secreted
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pyruvate until the intra- and extra-cellular concentrations were the same, and 
were in the normal concentration range found in human plasma.
Ascorbate and alpha-tocopherol represent water soluble and lipid soluble 
protectants respectively. Ascorbate acts both intra- and extracellularly, whilst 
alpha-tocopherol resides in membranes. Ascorbate relies on an active transport 
mechanism to cross the plasma membrane, which has been found to be 
inhibited by activated complement in the fibroblast 3T6 cell-line (Padh and Aleo
1987). In disease states in which complement is activated, cells may be quite 
deficient in this important radical buffer whilst serum ascorbate levels are quite 
normal. As just mentioned, ascorbate has been thought to stabilize the ferritin 
shell, but it can also promote radical formation under certain conditions 
(Winterboum 1986). The effects of ascorbate deficiency seen in scurvy may be 
of relevance in joint damage; ascorbate is essential for adequate hydroxylation 
of collagen by prolyl hydroxylase. In scurvy inadequately formed arrays of 
collagen fibres lead to fragile blood vessels and skin lesions (Stryer 1981). 
Deficient collagen fibre arrays are seen in rheumatoid articular cartilage. The 
physiological role of ascorbate may be sensitive to its immediate environment 
which would dictate whether or not its activity were to scavenge free radicals or 
promote their formation or to be available for keeping the iron in prolyl 
hydroxylase reduced. Also, oxidative damage to cartilage matrix leads to 
reduced levels of hydration which may make it less accessible to this water 
soluble protectant.
Alpha-tocopherol, or vitamin E, has a cyclic structure which acts as a free 
radical trap, breaking possible chains of radical formation in the vulnerable 
hydrophobic fatty acyl region of membranes. It is found to protect cells in vitro 
from chemicals which induce oxidation and/or lipid peroxidation, such as that 
caused by the anticancer agent adriamycin (Pascoe et al 1987a; 1987b). This 
effect was mediated by maintaining cellular glutathione, which in turn
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maintained intracellular SH levels. The extracellular antioxidant role of alpha- 
tocopherol was the least contributary in plasma of those assayed and it seemed 
likely that the other extracellular protectants probably maintained alpha- 
tocopherol in its reducing state, for its crucial role in maintaining membrane 
integrity (Wayneretal 1987).
Lipid peroxidation may not only initially alter the fluidity of the membrane and 
its hydrophobicity and alter the availability of substrates for such enzymes as 
phospholipases and the mobility of substrate, regulatory and other enzymatic 
proteins, but also may cause a chain of peroxidation from lipids to proteins. 
Peroxidative damage of membrane proteins may result in loss of structure and 
function and in their rapid recycling, and may occur independently o f lipid 
peroxidation, SH groups being particularly vulnerable.
Although damage by reactive oxygen metabolites may not be causative o f 
rheumatic disease, they certainly contribute to the damage seen in the 
vasculature and joints in particular, in rheumatoid arthritis.
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E. RHEUM ATOID A R TH R ITIS.
In rheumatoid arthritis the balance between the inflammatory response and the 
immune response which is found in normal tissues is defective. The primary 
target of this disease is diarthrodial joints. The alterations found locally in acute 
inflammation arise in the articular joints, persist as the condition becomes 
chronic, and changes occur both inside and outside the local area as the disease 
progresses.
i.The svnovial Joint.
Diagram C illustrates the normal joint structure.
Changes seen in The Joint in Rheumatoid Arthritis:
A. Bone - Eroded at the cartilage-pannus interface.
B. Capsule - Ruptured.
C. Synovium - Hypertrophic synovial and fibroblast cell layers with 
increased vascularity of oedematous tissuewith immune cellular infiltrate; 
forming invasive pannus encroaching on bone and cartilage.
D. Cartilage - Thinned and eroded.
E. Synovial fluid - Volume in c re a se d , v is c o s ity  and  
complement components reduced and immune cellularinfiltrate present.
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Diagram C. The Rheumatoid Joint.
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Normal synovium is nourished by the vasculature. The thin layer o f synovial 
cells, or intima, is composed of A and B cells, which may be the same cell type 
at different stages of maturation. These cells supply the proteoglycans, core 
proteins and hyaluronic acid which give the fluid its characteristic viscocity, and 
also provide nutrients for the chondrocytes in the avascular cartilage, and 
remove debris. They rest on a lower, or subintimal, layer of less vascular 
connective tissue. The synovium ends where it meets the cartilage covering the 
opposing bone ends of the joint. This cartilage is aneuronal as well as avascular 
and is composed of type II collagen which surrounds the chondrocytes which 
synthesize it. The collagen is arranged parallel to the surface in the superficial 
layer, being less well organised further down, near the site of synthesis. It 
retains well-hydrated proteoglycans which give it its cushioning properties 
(Dieppe at al 1985).
The features of the rheumatoid synovial pannus in some respects may resemble 
lymphoid tissue, as the invading T lymphocytes and plasma cells can aggregate 
to form lymphoid follicles which secrete antibodies, namely rheumatoid factor. 
This forms a major part of the evidence for immune system involvement in the 
persistence of symptoms which typify RA (Dieppe et al 1985).
Activation of complement in synovial fluid by rheumatoid factor aggregates or 
immune complexes releases leukoattractants so a persistence of infiltrating PMN 
may be involved in alteration of and damage to joint structure and to the local 
vasculature, and eventually may lead to more widespread effects.
Inter-cell regulation can be found with HAGG-stimulated PMN and MNC 
(Appelboom et al 1988); low concentrations of HAGG induced a factor from 
MNC which inhibited adherence of PMN which were also directly inhibited by
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high concentrations ofHAGG. This factor was found in RA tissues and fluids. 
Blackburn et al (1987) also found a low molecular weight factor ( 10KD) in RA 
synovial fluid which enhanced immune complex-mediated degranulation and 
phagocytosis in PMN, also found in the supernatant from cultured monocytes. 
Soluble or fixed immune complexes induce TNF-alpha secretion by monocytes 
which is a powerful priming agent for PMN (Debets et al 1988). Regulation of 
FcR function can be seen to be complex and to have the potential for 
involvement in immune dysfunction in disease states such as RA. The 
attachment (Pi-linked or transmembrane protein) may be important in chronic 
inflammatory conditions because elastase, which is released from activated 
PMN, cleaves Pi-linked receptors (Tosi and Berger 1988). Both enzyme release 
and C>2 " production in PMN were markedly inhibited by hydrocortisone
treatment (Roos et al 1976). This may occur with steroid therapy in RA. This 
disease is a condition in which the immune system is persistently activated, and 
down regulation of FcR function maybe attributed to either premature release of 
FcRl 11, or internalization of FcRl 1.
Infiltration o f cells may be controlled by a number of interacting factors, 
amongst which are the products o f the cylo-oxygenase pathway and 
lipoxygenase pathway o f arachidonic acid metabolism (Zeitlin 1981). 
Prostaglandin E2  (PGE2 ) is primarily a powerful vasodilator, but it also
potentiates the activity of other factors such as bradykinin and histamine (Keele 
and Neil 1978). Indirectly it affects the chemotactic activity of leukotriene B4  
(LTB4 ), which is ineffective if  cells are unable to exit from the vasculature. 
These agents may also modulate the role o f other regulators o f the immune 
response which are active in inflammation, such as TNF-alpha (Renze et al
1988) and IL-2 (Flescher et al 1989) by PGE2 , and be regulated by others in
turn, such as IL-1 (Gilman et al 1988). The interactions of cytokines which may
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be involved in the immunomodulation of inflammation are reviewed by Balkwill 
and Burke (1989).
ii. Mediation of Damage.
As has been described in the previous section, damage to biological tissues can 
and does occur in the presence of free radicals; their action with respect to joint 
damage is under investigation, and so is their possible role in promoting the 
chronic state. When induced by a soluble stimulus the respiratory burst of 
neutrophils is not accompanied by the release of azurophilic granules. An 
important consequence of this could be that there a lack of competition from 
MPO for hydrogen peroxide, which can thus be freely available for the Haber- 
Weiss reaction with subsequent OH- formation. Also, it has been suggested 
(Thomas et al 1983) that some of the chloroamine products of MPO activity 
protect PMN from cytolysis and render them inactive, thereby controlling their 
contribution to inflammation and protecting the environment from the 
uncontrolled release of their contents.
In an inflammatory response in which infiltration of IgG occurs into the 
synovial fluid or its production occurs in the synovium, the invading phagocyte 
population is not activated by monomeric IgG. The presence of antigens causes 
small soluble complexes to form. These can activate PMN and be disposed of 
by phagocytosis. But there are at least two mechanisms for perpetuating the 
normally antigenically-induced response of PMN without the intrusion o f a 
foreign antigen; free radicals alter the antigenic properties of IgG molecules 
which may cause them to fix complement without the presence o f foreign 
antigen (Hewitt et al 1987) and the antibody-complement complex can activate 
the PMN respiratory burst. Also RF secreted by the rheumatoid pannus into the 
synovial fluid can bind circulating immunoglobulins which form part of the 
vascular infiltrate, to form complement-activating immune complexes, which
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not only activate PMN but also present to the phagocyte as an insoluble 
stimulus.
Anaemia in the R.A. patient may exacerbate the inflammatory condition if  MPO 
forms an important part of free radical regulation and thereby inflammatory 
control. A feature of anaemia in experimental animals is a reduction in MPO, 
which is a iron-containing enzyme, with no parallel drop in NADPH oxidase 
activity (Murakawa et al 1986). Work by Blake’s group on the possible role of 
iron in synovitis and joint damage, in rats with adjuvant induced arthritis, using 
desferrioxamine (DFX) to remove iron (Andrews et al 1987a), and using diet- 
induced mild iron-deficiency (Andrews et al 1987b) established that it was 
indeed iron removal by DFX, at a concentration which did not affect 
haemoglobin levels, which prevented the joint symptoms found in the controls 
(swelling, bone erosion), and in both papers showed that the immunological 
features, such as the acute local inflammatory response, raised serum levels of 
acute phase reactants and granulomas in peripheral lymph nodes, were still 
present. This suggests that the joint as such may be an iron-sensitive 
environment.
Blake et al (1989) also investigated the human knee joint. In the inflamed joint, 
there was found to be no means of compensating for the increase in pressure 
within the resting joint, and work done brought about a further increase in 
pressure with resulting exclusion of capillary flow and hypoxia. Hypoxic 
damage and that due to pressure itself was exacerbated by reperfusion when the 
joint was rested and pressure was relieved. A review by Levick (1990) 
discusses this work and supporting evidence o f hypoxia and acidosis from 
others. Membrane proteins are damaged and red blood cells become leaky under 
hypoxic conditions (Deuticke et al 1987), and iron released from damaged 
synoviocytes and capillary endothelial cells with oxyen supplied by the 
resumption of blood flow could combine to promote the formation of free
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radicals either in the presence of PMN or MNC, or utilizing released enzymes 
such as xanthine oxidase from capillaiy endothelia (Allen et al 1987). Blake and 
workers found evidence of lipid peroxidation and a change in IgG consistent 
with free radical activity within the reperfused inflamed joint. Work with cat 
intestine has increased the evidence for reperfusion injury, implicating free 
radical formation, iron and PMN, particularly in the primary step o f 
microvascular permeability (Granger 1988).
The rheumatoid joint is difficult to investigate for lack of an ethical control. 
Also, as the rheumatoid condition is immunosuppressive, there is an enhanced 
likelihood of infection when synovial fluid is withdrawn. The rat air pouch 
model provides a region of tissue which develops structural and histochemical 
similarities to the synovial cell layer. Morris et al (1987) found that antigenic 
challenge with bovine serum albumin induced an increase in the production of 
the iron binding protein apoferritin in parallel with the inflammatory response, 
in A cells (’macrophage-like’ synovial cells) in the pouch lining. In a second 
challenge with blood further apoferritin production took place, with deposition 
of iron in secondary lysosomes in conjunction with an increase in structural 
rearrangement o f cells to form a deep layer of lining cells, an organized 
connective tissue substratum and vascular proliferation. Blake et al (1984) noted 
that iron deposition correlated with persistent disease. These findings suggest 
that the inflammatory response and the response to iron load induce apoferritin 
synthesis, but that the iron may also induce features of the rheumatoid pannus. 
Other elements of the red cell cytoplasm were not excluded, and so although the 
evidence points to iron as the active agent in this pannus-like formation it is not 
conclusive.
Blake’s work in the human knee supports the finding of Hewitt et al (1987) in 
the rat air pouch model that altered IgG is to be found in inflammation. This 
finding in itself may show that such products, whilst indicative of damage by
70
radicals, may not be sufficient alone to induce chronicity, and can normally be 
removed by phagocytes from the area. However, their significance in the 
presence o f rheumatoid factor has already been described. Other factors may 
combine to induce tissue injury and a chronic disease condition, the presence of 
which may be promoted by free radicals. Fragmentation of the macromolecular 
complexes in cartilage by H2 Q2 has been found in vitro, using neonatal human
articular cartilage (Roberts et al 1989). This may reduce hydration and reveal 
new antigenic sites and sites which attract phagocytic cells intent on removal of 
damaged tissue. Roberts et al noted that the effects found with human tissue 
were not seen in rat tissue. Ugai et al (1983) investigated the activity of PMN in 
the presence of rheumatoid articular cartilage in vitro, compared with both 
normal cartilage and that removed from joints of patients with other articular 
disease, such as osteoarthritis. Although they found that large numbers of PMN 
attached to immune complexes embedded in the articular surface o f the 
rheumatoid samples compared to only a few attached on the other samples, in 
the presence of autologous synovial fluid (SF), either fresh or heat-inactivated, 
this attachment was not seen. The conclusion to be drawn from this anomalous 
result is not really clear. It suggests that SF contains a heat-stable protectant, 
and that PMN |n  vivo therefore do not indulge in the activity seen in its absence 
in v itro , even though attractive sites are present. Collagenase activity was 
localised in excised rheumatoid tissue to the pannus cartilage interface (Woolley 
et al 1977). Mohr et al 1981) found on electron microscopic analysis that PMN 
were present at the pannus cartilage interface in excised tissue from rheumatoid 
joints, and that they were deeply embedded in the cartilage matrix. At such a site 
they might be remote from a synovial fluid inhibitory factor. The rat pouch 
model suggests that the PMN production of reactive oxidants promotes the 
production of the pannus. Damage to the cartilage may be by cells in the pannus 
including synoviocytes, monocytes and macrophages. The localization o f active 
collagenase suggests that an interaction with a factor (activator) in synovial fluid
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may be required by these cell types, and it is at this pannus cartilage interface 
that damage to cartilage and to bone is seen to occur.
Free radicals may promote damage; they may also recruit more cells to the 
inflammatory site, either directly or by promoting the induction of chemotactic 
or other agents which contribute to damage or to inflammation. Cells found in 
acute inflammatory synovial fluid are initially PMN. These are later ( about six 
hours later) replaced by mononuclear cells, both monocytes, and lymphocytes. 
In chronic states, PMN persist, and both MNC and PMN are seen to invade the 
intimal and subintimal layers of the synovium. The process of inflammation 
includes not only attracting these cells to the synovium, but also diverse effects 
on other cell types such as vascular endothelia, which will alter the permeability 
of the vasculature to allow exit of blood, and will alter the adhesive interactions 
between blood cells, platelets and endothelial cells. These interactions in turn 
promote synthesis of inflammatory mediators such as vasoactive amines and 
prostaglandins, and cytokines such as the interleukins and interferons.
iii. Aetiology and Pathogenesis of RA.
The products of the major histcompatability locus (HLA antigens) are expressed 
as antigenic determinants on all cells and identify them as constituents o f the 
same organism. Normally, the class II, or la, antigens are expressed 
exclusively on cells of the immune system, and are required in particular for 
antigen presentation to T lymphocytes in the course of mounting a humoral 
immune response. HLA typing has led to the conclusion that certain tissue- 
types may predispose that element of the population to a certain disease, when 
they are exposed to the right "trigger”, which may include environmental 
factors. For instance Bantu people living in rural areas have a very low 
incidence of RA, whereas those who live in urban areas have the same, higher, 
prevalence as their white contemporaries (Dieppe et al 1985).
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In the Caucasian population (he incidence o f HLADR4 is twice as high in 
patients with RA than in the normal population (Lanchbury et al 1988). 
Population studies have ascertained that environmental factors probably 
determine whether or not the antigenically identified susceptible group will in 
fact develop disease in the case of RA, and a number of studies suggest primary 
triggers. The most overt symptom of RA which must define it as an 
autoimmune disease is the production of antibodies to the Fc portion o f the 
patient's own immunoglobulin G. However, patients who have no such 
antibodies (i.e. iheumatoid factor, RF, negative) often have no other symptom 
which distinguishes their disease from those who are RF positive, although 
their prognosis may be better. Antibodies to phagocytes have been identified 
and associated with damage to the vasculature (Specks et al 1988; Jennette et al
1988).
Sometimes a bacterial infection precedes the onset of RA, and one theory 
suggests (hat there is cross-reactivity of bacterial antigen and a component of the 
infected body. For instance monoclonal antibodies to Y e rs in ia  
pseudotuberculosis cross-react with cells expressing HLA-B27 - a phenotype 
which occurs in a significant proportion of patients with ankylosing spondylitis. 
Another theory suggests that an infecting mycoplasma may adsorb antibody to 
itself and alter it in some way, inducing antibodies to it, that is, induction o f 
iheumatoid factor. The influence of viral DNA expression in lymphocytes or 
expression o f viral antigen on cell surfaces is also under investigation (Mills
1989). These pathogenic triggers may lie dormant for years, and in the 
susceptible individual require a further environmental activator for the disease to 
manifest itself.
FcRs are important in immune complex clearance, and currently under 
investigation is any link between FcR activity and HLA haplotype (Salmon et al
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1986a; 1986b; Lawley et al 1981). Most clearance of immune complexes takes 
place in the spleen and liver where there are macrophages bearing large amounts 
of FcRl 11. In a patient with a disease involving excessive clearance of IgG- 
associated platelets, treatment with Mab 3G8 (anti-FcRl 11) was temporarily 
extremely effective (Clarkson et al 1986). There is considerable reproducable 
inter-person variation in the normal expression of FcR 11 on platelets, which 
affects their function in vitro. This could be genetic and could have important 
implications in disease states (Rosenfeld et al 1987). It has been found (hat FcR 
can be expressed on endothelial cells in vitro, after infection with Herpes 
simplex virus (Cines et al 1982). If  this is also the case m vivo it might be o f 
relevance in diseases where immune deposits are thought to be involved in 
mediating vascular damage, and introduce a new theoiy about the consiquence 
of infection in immune regulation, other than cross-reactive or genetically-linked 
autoimmunity.
It is likely that there is more than one phenotype which predisposes an 
individual to develop what is classified by the single diagnosis RA, under 
particular circumstances. The variations in symptoms, clinical outcome and 
response to treatment may reflect this but may depend on any number of other, 
unidentified, genetic factors.
iv. Non-Steroidal Anti-Inflammatorv Drugs.(NSAIDs)
This broad category of drugs is used in RA as a first line in control o f the 
symptoms attributable to inflammation but not erosive disease, such as pain and 
swelling and as such they improve motility and a feeling of well-being in the 
patient. They are quick-acting and their effects of short duration, only lasting 
while the drug is at an optimum concentration in the circulation. Patients taking 
NSAIDs provide the control patients for investigating second line therapy, as 
the disease process is not thought to be affected by these drugs and there are no
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drug-free RA patients. NSAIDs include several types of acid, which may 
contribute to their differing effects in vitro.
NSAIDs are lipophilic acids, which readily insert into the plasma membrane, 
especially under acidic conditions (Lombardino et al 1975). Most NSAIDs in 
plasma are protein-bound and when binding sites on albumin are saturated they 
may bind to other proteins, with unknown effects (Schlegel S .1 .1987). Dosage 
varies both with the particular drug and with the patient, an empyrically- 
determined dose being a balance between effect and side effects. NSAIDs are 
readily absorbed through the gut where gastrointestinal problems (bleeding, 
ulceration) are a particular problem. The range of dose is from the tens of 
milligrammes to several grammes a day. The drug level and availability in 
plasma may differ. Thus high concentrations used in work in vitro, may not 
reflect that available physiologically.
An effect o f NSAIDs is the inhibition of cyclo-oxygenase and thereby the 
production o f stable prostaglandins (PG) (Vane 1971). Aspirin irreversibly 
acetylates PG synthetase, thus routing arachidonic acid metabolism through the 
lipoxygenase pathway. Other NSAIDs inhibit PG synthesis but not by 
acetylation, and the effects in vitro may be reversed by washing (Moskowitz 
1986). NSAIDs directly inhibit vasodilation due to PG. PG also has influences 
such as suppressing the production of TNF-alpha by human MNC (Spengler et 
al 1989), and IL-2 by mouse spleen cells as seen with indomethacin treatment 
(Wolf et al 1985). The repression by NSAIDs* o f these actions of PG and the 
preferential channelling of arachidonic acid to produce lipoxygenase products 
may be equally as important for NSAID action as the inhibition o f the direct 
effects of PG inhibition. It may even be considered that the important effects of 
NSAIDs are those brought about in cell membranes by drug which has not been 
bound by serum proteins or utilized for prostaglandin modulation.
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NSAIDs have effects other than PG inhibition, and their differing effects 
depending on the stimuli used for the cellular response under examination may 
suggest selective effects on various activation pathways. |n  vitro Bell et al 
(1986) found piroxicam, inhibited opsonized zymosan-stimulated 02" from
MNC in a dose dependent manner, whereas four other NSAIDs tested had no 
effect below lO^M. Inhibition of FMLP binding and 0 2 ’ generation in MNC
by piroxicam, was not seen in activation by other stimuli such as opsonized 
zymosan and PMA (French et al 1987). These seemingly different results for 
the response to opsonized zymosan may be a dose effect; the first work using 
25ug/ml opsonized zymosan and the second using 2mg/ml. Using PMN taken 
from RA patients (from peripheral blood and from synovial fluid) and from 
controls after piroxicam administration Biemond and workers (1986) found O2 "
production depressed after either opsonized zymosan (concentration not 
specified) or PMA stimulation, and in PMN membrane preparations after 
pretreatment o f whole cells piroxicam was effective at inhibiting the NADPH 
oxidase activation step. Paradoxically piroxicam inhibition of FMLP-induced 
0 2 " production from PMN has been found to be greater in the presence of PG
than without it (Abramson and Weissman 1989).
Sodium salicylate may protect partially against the inhibitory effect of IAP on 
the PMN O2 " and aggregatory response to FMLP (Abramson and Weissman
1989), but in common with indomethacin it has been found in vitro to have no 
effect on proteoglycan synthesis, which can be derepressed by piroxicam 
interacting with an inhibitory factor in RA synovial tissue (Herman et al 1989). 
Thus the effects of NSAIDs would appear to be more diverse than simply 
inhibiting PG sythesis and their other effects may be dependent on the particular 
drug and dose and on the pathway being modulated. In some instances differing 
findings between drug effects may be irrelevant to their antiinflammatory role or 
may indicate that there are different routes which bring about the same end.
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may indicate that there are different routes which bring about the same end. 
They may also reflect only an in vitro situation not found in vivo depending on 
the dose of drug available at the site of action, namely the joint, as well as that 
available to peripheral blood leukocytes. So far only inhibition of PG has been 
found to correlate with potency (Flower et al 1972). Diverse modes of action 
maybe clinically useful in that patients who receive no relief from one drug, or 
who incur unpleasant side effects, may benefit from a different NSAID. It is 
significant that despite these diverse effects on cell function NSAIDs have no 
clear effect on the progression of rheumatic disease.
v. Gold Compounds.
In this country gold is usually administered as the injectable gold "salt** sodium 
aurothiomalate (GST), or is given orally as the lipid-soluble auranofin (AUR). 
In either case the effect of the drug is long-lasting and takes a correspondingly 
long time to take effect (4-5 weeks or longer). The difference in solubility may 
allow different sites of activity. Mechanisms of action may also be different; 
patients with adverse reactions to intramuscular gold being able to benefit from 
AUR (Manthorpe et al 1988). Intramuscular injections o f sodium 
aurothiomalate are usually given weekly in increasing amounts until a total of lg 
has been given, after which the injections are given at wider intervals, decided 
empyrically. A second course of gold is not usually effective and so avoidance 
of a flare is important. AUR is given once or twice daily in oral doses of less 
than lOmg (British National Formulary 1988). The serum concentrations reflect 
the lipid solubility of AUR, Herrlinger et al (1982) finding 600ug/l AUR and 
800ug/l GST in patients on these respective therapies for at least 3 months, with 
all the GST in the plasma, and about 40% of the AUR associated intracellularly. 
These workers found AUR five times more readily taken up than GST by 
leukocytes in vitro when incubated in physiological concentrations. Gottleib 
(1986) found weak binding of AUR SH groups, and Crook and Snyder (1986)
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suggested that the distribution of AUR could be explained by sequential 
sulphydryl exchanges. Preferential binding to thiophosphines and thioesters 
may radically affect cell function, and includes interaction with DNA. These 
workers found that all doses tested increased the activity of phospholipase C in 
vitro, suggesting also that the co-administration of NSAIDs may counteract the 
increase in intramembrane enzymic activity.
In rat adjuvant arthritis injected gold was not found to have any effect on the 
arthritis nor did it suppress non-specific inflammation (Jessop and Currey 
1968) indicating caution for extrapolation of work from animals. In vitro, gold 
can affect IL-1 production in various cell types, having a biphasic, dose- 
dependent effect on human mononuclear cell cultures (Epstein et al 1989), 
differentially affecting proliferation depending on the stimulus, IL-1 production 
and IL-2 receptor expression (Blitstein-Willinger 1987). It has been suggested 
to have a selective effect on collagenase activation (Martel-Pelletier et al 1989), 
activating that from chondrocytes and not that from monocytes, the suggested 
benefit of this being a reduction in the active life of the enzyme. However, AUR 
was not seen to activate collagenase. In mouse calvaria (Klaushofer et al 1989) 
luM AUR demonstrated PGE2 *mediated induction of bone resorption, and at 
higher doses (3uM) inhibiting that induced by PGE2  and other agents, and
having selective cytotoxic effects on bone cells. The inhibitory effect of AUR in 
vitro on PMN chemotaxis and LTB4  synthesis has been found to be dose-
dependent (Elmgreen et al 1989), and similar dose dependence has been found 
with its effect on PMA-stimulated PMN 02" production and the levels o f
phosphorylation induced (Hurst et al 1989).
Both gold and Dpen lower RF levels in vivo (Jaffe 1976). Gold (sodium au- 
glucose) interacted in \5tro with selenium on glutathione peroxidase (Dillard and 
Tappel 1986), an effect seen with Dpen also, which suggests that both the gold
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and the SH moieties of metabolised GST and AUR may be involved in the 
effects seen in vivo and in vitro.
AUR decreased chemotaxis in normal PMN and those from RA patients (Movat 
1976). Dpen had no effect. The relevance of investigating a parameter o f cell 
function in establishing the mode of action of a drug may be gauged in the light 
o f comparison with different drugs. The adverse effects o f gold therapy are 
closely mirrored by those o f Dpen (Day and Paulus 1987). It has been 
suggested (Epstein 1989) after thorough scrutiny of the literature and the 
statistical data in particular, that the clinical evidence does not reveal a net 
beneficial outcome of gold therapy and that its use may be outdated. However 
on an individual basis significant benefits may be seen in particular patients for 
many years (Davies J. personal communication).
vi. D-penicillamine.
Although Dpen is readily absorbed through the fasting gut, like the gold 
compounds it may take several weeks to show any beneficial effect in RA and a 
correspondingly long time after cessation o f drug therapy for side effects to 
disappear. As with the gold compounds, Dpen is introduced over several 
months in increasing doses until benefit is noted. It is given orally, a typical 
maintainance dose being 500mg daily.
DPen can reduce oxidized SH and so may inactivate or activate receptors and 
enzymes, depending on the particular role of accessible SH groups. This lack 
o f specificity could account for some of its side effects as well as its beneficial 
properties. Its beneficial actions in RA have not been precisely determined but 
thought to be relevant are formation of a) disulphide links b) thiazolidine rings 
and c) metal complexes and chelates (Howard-Lock 1986).
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thought to bring about clinical improvement in scleroderma by the thiazolidine 
ring formation with collagen preventing or dissociating cross-links (Steen et al 
1982). This could also be the case with collagen cross-linked after damage by 
hydroxyl radicals. Metal chelates or complexes formed with Dpen m ay 
contribute to the reduction seen in serum copper levels, an effect seen in 
common with gold. However, a dietary supplement of copper in RA had no 
effect on the effects of Dpen (Multicentre Trial Group 1973). Complexed to 
copper Dpen has SOD activity (Youns et al 1977), and as a weak iron chelator it 
may be protective in the iheumatoid joint. Dpen is ineffective in ankylosing 
spondylitis, in which copper levels are also raised, which suggests that any 
beneficial effect of copper depletion or sequestration by Dpen may be on the 
inflammatory aspects of the disease which are not significant in AS, rather than 
immunomodulatory ones. It has also been found to prevent continued 
periarticular bone erosion, but the mechanism for this important finding remains 
undefined (Gibson et al 1976).
In vitro. Dpen selectively affected survival of monocytes over lymphocytes in 
mixed cell cultures (De Vries et al 1982), and inhibited lymphocyte 
proliferation; an effect much more rapid in the presence of copper sulphate 
(Lipsky and Zeis 1980). Subsequently Dpen with either caeruloplasmin or 
copper ions inhibited T-cell proliferation and helper function, effects inhibitable 
by MPO or catalase (Lipsky 1984). Cuperus et al (1987) suggested that Dpen 
reacts with MPO in the presence of HOC1 to form a stable inactive form of the 
enzyme. Monocyte accessoiy cell function has been found to be normalised jn 
vitro in RA patients on Dpen compared with the deficient response o f patients 
on NSAID alone. The NSAID response was significantly improved by the 
addition of SH (2-mercaptoethanol) whereas it had no effect on the normal or 
Dpen cells, and PHMPSA incubation (SH blockade) of normal cells was 
inhibitory (McKeown et al 1984). Defective suppressor cell function o f IgM
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improved by the addition of SH (2-mercaptoethanol) whereas it had no effect on 
the normal or Dpen cells, and PHMPSA incubation (SH blockade) of normal 
cells was inhibitory (McKeown et al 1984). Defective suppressor cell function 
of IgM synthesis was noted in patients on NSAIDs, partially corrected by the 
addition of 2-ME, whereas the response of Dpen was already normal, and not 
affected by 2-ME (Brown-Galatola 1989).
v. SH-Containing Drugs.
When treatment of RA by non-steroidal anti-inflammatory drugs fails to prevent 
inflammation, or significant progressive erosion requires other treatment, the 
second line therapy includes gold-containing drugs and D-penicillamine (Dpen), 
antimalarials. All the effective gold-containing compounds contain SH, as does 
Dpen. None of these drugs is targetted to a specific tissue which may contribute 
to their toxic side effects. Why these should prevail in some patients and not in 
others is not predictable. Similarly tolerance varies from drug to drug with any 
one patient, which may suggest that despite their having some frequent side 
effects in common, such as skin rashes, mouth ulcers or temporary proteinurea, 
different drugs may bring them about by different mechanisms.
vi. Other Anti-rheumatic Drugs.
Further therapy may include the use of antimalarial drugs such as chloroquine 
and hydroxychloroquine, and treatment of more resistant disease by steroids or 
immunosuppressants. These will not be discussed here.
With all antirheumatic drugs the effects are a balance between beneficial effects 
and unwanted side effects which seem to emanate from the lack of specific 
targetting, a situation which cannot be resolved until the targets have been 
identified.
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F. SU LPH YD RYL G RO U PS.
i. The Role of SH Groups.
Modification of cell functions and molecular structure by free radicals and their 
derivatives has been described already in this introduction and modulation of 
these effects by sulphydryl groups has been indicated. SH can act as a buffer 
against oxidant activity and maintainance of the reduced state maybe necessary 
for normal functioning of membrane proteins. Albumin acounts for 8 6 % of SH 
in serum (Thomas and Evans 1975), and in RA serum albumin levels are 
decreased and globulins raised, with lowered SH on both, as is found in other 
disease states such as cancer and bronchitis. Serum thiols on albumin can be 
oxidized by activated PMN (Hall et al 1984). Any deficiency in the level of 
albumin or the reduced state of these SH may leave other SH, such as those 
exposed on cell surfaces, vulnerable to oxidation. Such plasma proteins as 
activated complement depend on free SH for normal function (Lambris 1988). 
C3b normally undergoes covalent binding at numerous sites through a cysteine 
residue and defective C3b activity may modulate immune function (Ochs et al
1986). Also PMN adhesion maybe dependent on the surrounding SH buffering 
system, through the leukocyte antigen CD 18 molecules which have disulphide- 
rich regions (Schwartz and Harlan 1989). The intracellular milieu is not a 
closed system, and events outside the cell will be reflected within it. To 
maintain SH in their reduced or oxidized state for normal functioning the main 
intracellular SH buffer is glutathione, where it is also important for reducing 
non-SH species such as organic peroxides (Stryer 1981). It is maintained in its 
reduced form by glutathione peroxidase, which requires NADPH supplied by 
the hexose monophosphate shunt. Glutathione peroxidase can be found in cells 
and in plasma as two distinct enzymes (Takahashi et al 1987). In normal tissues
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the level of GSH peroxidase is high enough to inhibit peroxide activation of 
cyclooxygenase (Hemler et al 1979). Mammalian cells also contain thioredoxin 
and its reductase to act as a further buffering system (Holmgren 1985). The 
section devoted to damage by free radicals and other oxidants has indicated the 
importance of serum SH in buffering against oxidative damage (Wayner et al
1987) and the vulnerability o f SH on proteins (Davies et al 1987a-f). Levels of 
the peroxidases are low in RA; selenium supplementation can increase the levels 
except in PMN (Tarp U. 1986). The significance o f the low serum levels o f 
reduced sulphydryls found in RA (Lorber et al 1964) cannot be ascertained 
without an understanding of what the role(s) of SH may be both extra- and 
intracellularly in maintaining healthy cell function. An indication o f the 
involvement of immune regulation in RA is the finding that serum SH levels 
correlate with in vitro synthesis of IgM and IgG (Brown-Galatola 1989), and 
that cells from patients on SH-containing drugs seem to function in vitro in a 
manner paralleled by treatment of cells from RA patients not on these drugs 
with SH-containing reagents such as 2-ME (McKeown et al 1984).
ii Effects of SH Modulation In Vitro.
Work has centred on altering SH groups and monitoring the effects, particularly 
because the most useful second line antirheumatic drugs, such as D- 
penicillamine and gold compounds contain SH groups. For investigating 
altered availability of SH, impermeant SH blockers have been used such as 
parachloromercuribenzene sulphonate (PCMBS) to demonstrate a lack of effect 
on PMN phagocytosis (Tsan et al 1976a), and adhesiveness (Giordano et al 
1973), the cell permeant agent N-ethylmaleimide (NEM) inhibiting both of these 
events and totally abolishing O2 " activity by all stimuli tested (Akard et al
1988). Parahydroxymercuriphenylsulphonic acid (PHMPSA) has been used to 
show lack of inhibition of FMLP binding (Hurst et al 1987). Cell permeant 2-
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mercaptoethanol (2-ME) has been used (McKeown et al 1984), as also has 
dithiothreitol (DTT) to reduce SH (Adunyah and Dean 1986).
In cytosolic preparations, peroxidation of glucocorticoid receptors inhibited 
their normal activity, a situation reversed by DTT (Tienrungroj et al 1987). 
Discussing the role of cysteine residues, Malbon et al (1987) noted that proteins 
from G protein-mediated receptors in particular, changed their electrophoretic 
mobility on SDS PAGE after reduction, suggesting altered conformation. 
Similarly, Dpen treatment has been found to alter the position o f alpha-1 
antitrypsin on isoelectric focusing by irreversible modification of a free cysteine 
residue (Whitehouse et al 1989). Pedersen and Ross (1985) found in 
phopholipid vesicles containing beta-adrenergic receptors and Gs proteins, that
DTT activated the receptor and that this indirectly potentiated GTP binding to 
Gs. This suggests that reduction of disulphide bonds could form part of the
receptor ligand interaction causing a G-activating conformational change. NEM 
blocked GTP binding and autokinase activity in p21 ras, an oncogene product 
with extensive sequence homology with G proteins in the GTP-binding region 
(Hattori et al 1986). In human fibroblast cultures insulin activation o f the 
hexose monophosphate shunt was found to be mimicked by serum in 
conditions of low extracellular glucose. This was sensitive to H 2O2 , an effect
which, in turn, could be reversed by DTT (Germinario and Vlachopoulou
1987). Blocking external SH groups had no effect on transport nor did it alter 
the effect of H2 O2 . These results suggest that hexose transport activation
involves oxidation of intracellular SH groups. However, D’Amore and Lo 
(1986a and b) found that glucose transport activation in undifferentiated L6  rat 
myoblasts was dependent on extracellular SH groups at a site distal to the 
binding and transport site itself. These differing results may be a reflection of 
the different cell-types used. Both, nonetheless, demonstrate essential roles for 
SH groups in hexose transport.
84
In PMN, the activity of the HMP and O2 ’ production could be impaired 
simultaneously by external SH blockade with PCMBS; however phagosytosis 
still occurred, unless the blockade was of intracellular SH using NEM (Tsan et 
al 1976a; 1976b). The PCMBS-inhibited glucose metabolism was preventable 
by pretreatment of cells with a high concentration of cysteine, which suggests 
that the inhibition seen was an indirect one perhaps affecting the GSH 
buffering system. Giordano et al (1973) found that PCMBS did not affect 
adherence or motility, whereas NEM did in a cysteine-reversible manner; the 
presence of serum required a tenfold increase in dose for the same effect as in 
phosphate buffered saline. SH-mediated effects have been found also in 
monocyte accessory cell function (McKeown et al 1984; Fidelus et al 1987); in 
platelet release of calcium (Adunyah and Dean 1986), and aggregation (Sugatani 
et al 1987) and on the biregulation of platelet alpha-adrenergic receptors by 
PGEj and adrenaline, in which only inhibition by adrenaline was prevented by 
NEM (Jakobs et al 1982); in intracellular calcium mobilization by [GSH]j in rat 
hepatocytes (Thor et al 1985); in T suppressor cell activity and in vitro Ig 
synthesis (Brown-Galatola 1989); in PMN adhesion (Schwartz and Harlan
1989) and respiratory burst (Rajkovic and Williams 1984); in hexose 
metabolism (Germinario and Vlachpoloulou 1987); and in lymphocyte 
activation and proliferation (Fidelus et al 1987). These diverse examples of SH 
involvement in cell function, and the benefits seen clinically in treatment of RA 
with SH-containing drugs make further investigation necessary to establish the 
relevant effects for disease modification to allow better targetting and a 
reduction in side effects.
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iii. SH in this protect.
This project has used blockade of PMN and MNC with the impermeant SH- 
blocker PHMPSA to determine whether or not SH groups are involved in the 
external events of signal transduction.
PMN have been studied for changes in internal calcium flux, and in azurophilic 
granule release. Assays for the production of C>2 ” and H2 O2  have been used to
monitor these phagocyte-specific functions, allowing the use o f mixed 
mononuclear cells for technical simplicity to study monocytes, and allowing a 
comparison o f PMN and monocyte activation. Cells from RA patients on 
NSAIDs or on SH-containing drugs have been used as in vivo models of a 
disease control group and SH-treated disease groups respectively and those 
from healthy volunteers used both as normal controls and for investigation in 
their own right. It was hoped that as well as demonstrating any SH involvement 
in the activation pathways investigated that the experiments as a whole might 
add usefully to knowledge of the pathways under scrutiny.
Note:- Membrane Fluidity.
Membrane fluidity has been measured to investigate cell membranes in health 
and disease. Fluidity of the plasma membrane is a function of its constituents, 
their relationship to one another, their structure and their activity. Alterations in 
plasma membranes have been found in disease states such as RA (Beccerica et 
al 1988), muscular dystrophy (Wilkerson et al 1978) and in leukaemia (Inbar et 
al 1973);at different stages of cell maturation (Roozemond and Urli 1979) and 
on ligand-binding (Heron et al 1980). Experimental probes have been used 
which penetrate the membrane to varying degrees and which undergo rotational 
and translational motion within the confines of the membrane as dictated by the
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fluidity o f the membrane region into which they have been incorporated. 
Incorporation is assumed to be in the ’’spaces” between the lipid moieties of 
phospholipids. This can be detected by an alteration in emission intensity of 
vertically and horizontally polarised fluorescence from which the microviscosity 
o f the membrane can be calculated. From the calculation a change in 
microviscosity may be detected under given circumstances.
A major restriction on the usefulness of this technique is that the complex 
plasma membrane is made up of multitudinous proteins, glycoproteins, 
plycolipids and phospholipids in microdomains. Probes such as diphenyl 
hexatriene (DPH) can give an overall picture of change throughout the 
membrane, small regional changes not being identifiable. However, other 
probes may be more specific and may measure fluidity at different depths in the 
membrane.
In this project it was not known to what PHMPSA would bind not what the 
effects(s) of this would be. DPH was used to determine if  any general effect 
could be detected, by measuring fluidity in cells with and without preincubation 
in PHMPSA. The method followed was that used by Beccerica et al (1988) for 
their investigation of fluidity in lymphocytes. Unfortunately the work was 
discontinued after a short time as the polarising lenses required alteration and it 
was not possible to regulate temperature as precisely as thought necessary. 
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All reagents and buffers supplied by Sigma Chemical Co Ltd., Poole. Dorset, 
except those listed below:
Hypaque90 Winthrop-Breon Laboratories,
New York. U.S.A.
Phosphate buffered saline Oxoid Ltd.,
tablets: Hampshire. England.
Potassium and Sodium Salt BDH Ltd.,
Bristol. England.






1. Ficoll-metrizoate gradient; 50ml Hypaque 90
2.95ml distH 2 0
+ 238.275ml 9% Ficoll 400
Filter sterilized and stored at room temperature in the dark.
2. Phosphate Buffered Saline; 1 PBS tablet (Oxoid)
with Glucose (PBSG) + 0.16g Glucose
to 100ml with dist H2O
Made fresh as required and not stored.
3. PBSG with Calcium (PBSG*) 
chloride




0.1M Na2H P04 (A)
0.1MKH2PO4 (B)
Added B to A with mixing until 
pH 7.4 - diluted resulting
solution xlO in dist H2 O and 
added 8.77g/l NaCl
2 .1M Acetic Acid; 6ml Glacial Acetic Acid
(Stored at 4°c) + 94ml dist H2 O
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Hydrogen Peroxide Assay Reagent
0.02g Phenol Red +0.0056g (200 U/mg ) Horseradish peroxidase to 100ml 
with PBSG.
Made up and used immediately as required.
(Desiccated horseradish peroxidase stored at -20®c.)
Suneroxide Assay Reagents
0 .197g Cytochrome C to 100ml with PBSG. [ 150jiM]
Made up and used immediately as required.
(Desiccated cytochrome C (type 3 from horse heart) stored at -20®c.) 
Superoxide dismutase was dissolved in dist H2 O and stored at 4^c
Myeloperoxidase Assay Reagents 
1 .Citrate Phosphate Buffer; (A) 2.101 g citric acid
(CPO) to 100ml with dist H 2 O
(B) 3.58g Na2H P 0 4 l2 H 2 0  
to 100ml with dist H2 O 
Mixed A and B approximately 50/50
and titrated to pH 5.5 
Added 50ul Triton X100 /100ml 
2.MPO Reaction Buffer; lOOul 1M HCL
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Lactate Dehydrogenase Assay Reagents
l.Tris/HCL; 110ml 0.05M HCL
+ 200ml 0.05M tris pH to7.5
2.Pyruvate Buffer; 1.2ml 0.63mM Pyruvate
in 0.05M tris/HCL
3. Substrate; 5mg NADH in 640ul Tris/HCL
Calcium Flux Assay Reagents
1. Total release reagent; 3mM Diethylenetriaminepentacetic
acid + 0.05% Triton X100
2. Chelator; 1.14g EGTA + 1.454g Tris
to 10ml with dist H 2 O
3. Hank/hepes buffer; 1 litre Hanks buffer (Gibco - phenol - 
and sodium carbonate-free)




A. Preparation of Stimuli
i. Heat Aggregated IgG
Plasma from a single donor with an IgG-secreting myeloma was used 
throughout this project, from which was isolated IgG for use, after aggregation, 
as a stimulus of cell activation.
Lipid was removed from a thawed aliquot of myeloma plasma by centrifugation 
and 2ml volumes of the resulting plasma were diluted x2 with 10/150 buffer 
(see materials section) and loaded onto a 5x1 cm Protein A affinity column. 
Unbound material was washed through with the same buffer and the bound IgG 
subsequently eluted with 1M acetic acid. After thorough washing of the column 
with 10/150 buffer until neutral pH of the eluent was restored, the process was 
repeated with further aliquots of plasma until approximately 10ml of the original 
plasma had been used. The aliquots of IgG in acetic acid were kept at 4®c until 
after the final collection and then were dialysed against PBS at 4^c, with two 
changes of buffer in the first hour and further dialysis overnight against a large 
volume o f buffer. When neutral pH was restored, the concentration o f the 
protein was established spectrophotometrically. After concentrating the 
preparation to 15mg/ml, 500ul aliquots were frozen and stored at -20^c until 
required.
For each experiment a fresh aliquot of IgG was thawed and heated at 65®c for 
30 minutes to induce aggregation, after which it was diluted with PBSG to the 
required concentration.
The components of this preparation were already established (Maslen 1985), 
and in this work inter-batch variation was not seen; this was established by
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overlapping use (not shown) of each batch and noting its effect on stimulating 
the same preparation of cells.
The unaggregated IgG was also used, from an aliquot stored at 4°c.
ii. Phorbol Myristate Acetate (PMA):
PMA was diluted to lmg/ml in dimethylsulphoxide (DMSO) and stored at room 
temperature. Working dilutions were made in PBSG.
ili. N-Formyl-Methionyl-Leucyl-Phenylalanine (FMLP):
FMLP was dissolved to 0.1M in DMSO and stored in small aliquots at -20®c. 
Aliquots were thawed and diluted in PBSG immediately prior to use.
iv. Fluoride:
Sodium fluoride was dissolved in distilled water containing sodium chloride 
and was stored at room temperature, in the dark, in a polypropylene container. 
A concentration of more than 250mM did not stay in solution and so a working 
solution of200mM fluoride was stored and used directly.
vii. Other Reagents:
i) 30mM calcium chloride in distilled water was kept at 4®c and added to 
working buffers where indicated.
ii) lOmM EGTA in distilled water was kept at 4®c, and was added to washing 
buffer (PBSG) to prevent aggregation of cells prepared for all assays except 
hydrogen peroxide and calcium flux. It was also present in preincubation 
mixtures (see later), but was always omitted from the final assay procedures.
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iii) 50mM Parahydroxymercuriphenylsulphonic acid (PHMPSA) in distilled 
water was stored in the dark at 4^c and diluted in the cell preincubation 
mixture.
iv) The Islet Activating fraction o fBordetella pertussis toxin (IAP) was stored, 
5ug lyophilized powder /m l H2 O, at 4®c and was added directly to
preincubation mixtures to the required concentration.
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B. Collection of Blood.
Venous blood was collected from consenting patients who attended the hospital 
out-patients clinic with an appropriate medical profile as deduced from the notes 
and as identified by the clinician on the day, and from normal healthy volunteers 
among the hospital and laboratory staff. The blood was used as soon as it had 
been collected. All collection, preparative and test procedures were carried out 
in polypropylene containers to minimize inappropriate activation of cells by 
either plastic or by glass, and to minimize cell loss due to adherence.
C. Cell Separation.
A one-step flcoll-metrizoate density centrifugation technique (Ferrante and 
Thong 1978) was used for separating neutrophils (PMN) and a mixed 
mononuclear cell fraction (MNC).
Whole, heparinized blood (125U hepariiVlOml blood) was layered onto a ficoll- 
metrizoate cushion in a polypropylene centrifuge tube at room temperature and 
left for 10 minutes, then spun at 500g for 30 minutes. The resulting layers were 
separated and the PMN and MNC bands were washed once in PBSG with 
EGTA (see materials section). The PMN pellet was resuspended for 10 seconds 
in ice cold distilled water, to lyse contaminating red blood cells, and an equal 
volume of double strength PBS was added to restore tonicity. Both PMN and 
MNC pellets were washed a further two times in PBSG, resuspended in a 1ml 
volume and counted. This method of isolation resulted in a fraction which was 
>98% pure PMN by moiphology and a similarly purified mixed mononuclear 
cell fraction o f which it was assumed approximatly 2 0 % were monocytes. 
Trypan blue exclusion established viability, as >95%. Preincubation  
Procedures: These were identical for PMN and MNC.
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D. Sulphvdrvl Blockade with PHMPSA:
Cells were resuspended in PBSG with lOpM EGTA at a concentration of 
5xl0^cells/inl and PHMPSA was added to give a final concentration of 50uM. 
Control cells were preincubated without PHMPSA. Incubation was carried out 
in a 37®c water bath for 30 minutes, following which the cells were washed 
once and resuspended in PBSG without EGTA to the test concentration.
E. IAP Blockade of G-Proteins:
Cells were resuspended to 5xl0^cells/ml in PBSG with EGTA and IAP was 
added to give a final concentration of 500ng/ml. Incubation at 37^c in a water 
bath for 60 minutes was followed by one wash and resuspension in PBSG for 
assay. Control cells were preincubated without IAP.
F. Indo-1 AM uptake for Calcium Assav:
PMN were preincubated at 17.5xl0^celVml in PBSG without EGTA and with 
15uM Indo-1 AM, incubated at 37®c for 30 minutes, followed by washing three 
times in PBSG and resuspension in 1 ml PBSG.
Monocytes were preincubated at 20x10^cells/ml in Hanks/hepes buffer and 
with lOuM Indo-1 AM, incubated at 37°c for 30 minutes, followed by three 




(The assay was based on that of Pick and Keisari (1980)).
Duplicate sets of 1.5ml polypropylene tubes were indelibly labelled.
To one set was added lOul 3M Sodium hydroxide.
To the second set was added the reaction mixture as follows;
800ul Phenol red with horseradish peroxidase (or without enzyme for the 
control)
lOOul stimulant or PBSG as control 
lOOul cell suspension
Where the test contained calcium, this was added to the phenol red assay 
reagent with the appropriate volume of PBSG omitted.
The reaction mixture was thoroughly vortex-mixed both before and after the 
addition of cells. The tubes were incubated in a 37°c water bath for 30 minutes, 
vortex-mixed again, put on ice for 5 minutes, and centrifuged at 500g at 4®c for 
5 minutes. The supernatants were tipped into the appropriate duplicate tubes 
containing sodium hydroxide to raise the pH of the reaction mixture to 12. At 
this pH the colour change seen is proportional to the amount o f hydrogen 
peroxide produced, as seen by performing the assay with hydrogen peroxide in 
the place of cells (Figure 1). This effect was seen to be linear to 30uM.
After another vortex-mix, 200ul aliquots of supernatant were read on an 
automated micro-ELISA reader at 610nm and the results obtained from the
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standard curve, Figure 1 ; the O.D. reading being the change in colour seen 
after deduction of the enzyme-free "blank”.
All results given in the figures and tables have had the quantity o f 
spontaneously-produced hydrogen peroxide deducted.
Cell-free experiments established no interaction o f reagents except for fluoride 
which was therefore not used in this assay.
In earlier work with this assay (Pick and Keisari 1980) use was made of 
catalase to abolish oxidation of phenol red in controls. These workers could not 
totally abolish activity. Later work on the nature of the oxidizing species 
(Maslen 1985) established that other peroxides were produced in a stimulus- 
dependent fashion. In this project catalase was not been used and the products 
assayed were probably a mixture of peroxides.
2. Suoeroxide:
(Babioretal 1973)
Duplicate sets of 1.5ml polypropylene tubes were prepared. One set was put to 
one side. To the second set was added the following:
700ul Assay reagent





When calcium was included it formed part of the assay reagent diluent, and 
where more than one stimulus was added this replaced part of the volume o f 
PBSG.
The tubes of reaction mixture were thoroughly vortex-mixed before and after 
addition of cells and incubated at 37°c for 30 minutes in a water bath. After this 
the tubes were mixed again, placed on ice for 5 minutes, mixed and centrifuged 
at 500g for 5 minutes. The supernatants were tipped off into the clean set of 
duplicate tubes and mixed. 2 0 0 ul aliquots were read on an automated micro- 
ELISA reader at 550nm and the results were expressed as nMol cytochrome C 
reduced by lxlO^cells as found using the following formula:
Absorbance at 550nm = 29.5*x concentration x 5.1**
Where * 88 extinction coefficient of reduced cytochrome C (Sigma)
and = the length of the lightpath through the assay mixture in the ELISA 
plate (millimetres).
No interference of the assay reagents was found, using a xanthine/xanthine 
oxidase system to generate superoxide.
3. Myeloperoxidase:
(Segal et al 1980)
This reaction measured the reduction of o-dianisidine in the presence of H2 O2  
by MPO, as seen by a change in absorbance at 560nm.
PMN (4xl0^cells/ml) were stimulated variously in 1ml PBSG for 30 minutes in 
polypropylene tubes in a 37^c water bath. The tubes were centrifuged at 500g 
for 5 minutes at 4^c and the supernatants removed. Aliquots of the supernatants 
were used as follows:
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50ul Supernatant was added to 3.2ml MPO reaction buffer and incubated, after 
mixing, for 5minutes at 37 °c. 1ml perchloric acid was added to stop the 
reaction, and after further mixing the test was read at 560nm. against a cell free 
blank.
The results were expressed as a percentage o f total MPO released from cells 
lysed with PBSG + 0.2% Triton X 100 at the beginning of the stimulation 
period.
4. Lactate Dehydrogenase:
(Wrobeloewzki and LaDue 1955)
This assay measured the release of the cytosolic enzyme by the rate of reduction 
of NADH in the presence of pyruvate as seen by the loss of absorbance at 
340nm, the rate being proportional to the amount o f enzyme in the reaction 
where the amount of substrate is not rate-limiting.
Cells were preincubated in either PBSG, IAP or PHMPSA for 1 hour and the 
supernatant removed for assay.
lOOul of supernatant was added to 1ml (2.5mg/ml) sodium pyruvate and 20ul 
(2.5mg/ml) NADH, mixed and the loss of absorbance read every 15 seconds 
for 5 minutes.
The results have been expressed as a percentage of the rate o f enzyme activity 
from cells lysed with 0.15% triton X100.
Allowance was also made for nonspecific loss of absorbance by performing the 
assay without adding NADH.
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5. Release of Internal Calcium:
(Bijsterbosch et al 1986)
In its acetomethoxy- form Indo-1 AM is taken up by the cell and metabolized 
whereupon it binds avidly to free calcium, in combination with which when 
excited at 355nm it emits fluorescence at 400 nm in direct proportion to the 
amount of calcium to which it has bound.
For these experiments, no EGTA was added to the washing buffer.
75ul PMN (2.6x10^) were incubated with 4ul (15uM) acetomethoxy ester of 
Indo-1 for 30 minutes at 37°c, with or without PHMPSA (50uM) and 
llOul PBSG followed by three washes in PBSG and resuspension in 1ml 
PBSG.
200ul monocytes (3x10^) were incubated with lOuM Indo-1 in Hanks/hepes 
buffer instead of PBSG, followed by preincubation, washing and resuspension 
in Hanks/hepes buffer.
The 1ml cell suspension was added to 1.9ml PBSG (PMN) or 1ml 
Hanks/hepes (monocytes), brought to 37°c in the spectrofluorimeter, and 
stimulated for a given amount of time. The total amount of cell calcium was 
established by addition of 0.05% Triton X100 in the presence o f lOuM 
diethyleneaminepentacetic acid, and minimal calcium reading was obtained by 
addition of lOOul of lOmM EGTA/40mM TRIS solution.
6 . Statistics.
Statistical significance was found using the Mann-Whitney U test for unpaired 
data or the Wilcoxon test for paired data. Where n= <5 results were expressed 







The ages o f the controls were compared with those o f the RA NSAID group 




Second line 60 63
Unpaired analysis o f the data showed that the difference between the normal 
and NSAID group was significant (P<0.001) but that between the NSAID 
group and those on second line therapy was not. Therefore any differences is 
responses seen between the normal and NSAID group might be a function of 
the aging process, but the differences between the NSAID group and those on 
second line therapy can reasonably be attributed to the therapeutic effect of the 
drugs.
Selection of Patients.
Patients were attending Dr Joan Davies* Out-patient's Clinic at the Royal 
National Hospital for Rheumatic Diseases. They were selected on the basis of 
their clinical notes and drug therapies:-
i.e. NSAID= No steroids for at least 6  months; no Dpen or other second line 
therapy.
Dpen* on Dpenicillamine for at least 6  months ; no previous second line 
therapy for 12  months, or steroids for at least 6  months.
Aur* on auranofin for at least 6  months; no previous second line therapy 
for 12 months, or steroids for at least 6  months.
Patients were all sero +ve for rheumatoid factor at the last visit and showed 
signs o f active disease when attending the Clinic at the time of blood collection.
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1L Lactate Dehydrogenase Assay.
The work o f Wroblewski and LaDue (1955) on myocardial infarction, 
demonstrated that the cytosolic enzyme lactate dehydrogenase (LDH) was 
released from damaged cells. This has led to the enzyme being used as a 
measure of the permeability of plasma membranes.
To ascertain the degree of permeability induced in the cells by the preparative 
procedures, and also to see if  PHMPSA or IAP affected permeability, release of 
LDH was measured in three types of experiment:
In the first PMN and MNC were isolated and then measured immediately for 
LDH release.
In the second cells were isolated and then given an hour’s preincubation in 
PBSG, PHMPSA or IAP, followed by washing and assay for LDH.
In the third cells were isolated and then incubated in a 37°c water bath for 30 
minutes with either PBSG, fluoride, FMLP or PMA, before being assayed.
The results in Table 3 show that after the initial isolation procedure PMN 
released negligible amounts of LDH (3%); MNC released slightly more (13%). 
The hour-long preincubation did not raise the amount of LDH released, but the 
cells preincubated in PHMPSA showed a slight toxic effect, release from both 
cell types being almost doubled. Usually, for other assays (such as those for 
superoxide or calcium flux), cells were preincubated in PHMPSA for 30 
minutes only, and the incubation time used here was only normal for IAP and 
its controls.
The third type of experiment, in which various stimulatory ligands were tested 
showed that these ligands induced no noticeable rise above that induced by the 
extra incubation time i.e. the PBSG control level o f release. The results are the 
mean o f three experiments done in duplicate, and brackets denote standard 
deviation.
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Tab1e3. : Release of Lactate Dehydrogenase from Normal PMN. 
Treatment % LDH Released
( where release in the presence of Triton xlOO * 100%)
PMN MNC
g. No treatment; 3 (2) 13 (7)
b. 1 Hour Preincubation;
PBSG 6  (2) 10 (4)
PHMPSA(50uM) 11 (5) 19 (10)
IAP(500ng/ml) 7 (4) 10 (6 )
c. 30min Stimulation;







This colorimetric assay for cell activity provided a vehicle for measuring SH- 
blockade with PHMPSA in both MNC and PMN using various stimuli. It was 
also used to investigate the effects of exogenous calcium (calciume) on
stimulation, both with and without PHMPSA, and for comparison of the effects 
on cells obtained from patients and from normal healthy volunteers.
This assay also measures other, unspecified peroxides, for which a catalase 
control can be included. However it was decided to omit these controls for two 
reasons: Firstly because cell-free experiments with catalase and H 2 O2  (not 
shown) determined that catalase did not inhibit H 2O2  totally, and secondly 
because their omission made more cells available for extra experiments in each 
assay; this was particularly important for obtaining sufficient MNC results. The 
results have therefore been reported as peroxide, rather than hydrogen peroxide. 
In the peroxide assays:-
1. Concentrations of cells were 2xl0^per ml unless otherwise stated.
2. The stimulated quantities of H2O2 displayed in the figures have already had
the spontaneous levels subtracted.
3. + calcium = 1.5mM calcium chloride in PBSG used to make up the 
horseradish peroxidase-phenol red reagent.
4. Unpaired analysis of the data, given on the figures, was obtained using the 
Mann Whitney U test for non-parametric data. Paired analysis was undertaken 
using the Wilcoxon test.
5. Bars ■ One Standard deviation.
A standard curve was produced for this assay, using known concentrations of 
hydrogen peroxide (Figure 1), from which all the results were read.
As with all results, the curve for Figure 1 was derived from four separate 
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A timecourse experiment was carried out to establish an incubation time for the 
blockade-effect of PHMPSA by using HAGG-stimulated production of 
peroxide by PMN (Figure 2). By 30 minutes the PHMPSA had achieved 
greater than 90% inhibition, and so this was chosen as the standard 













Note: HAGG -  500 Mg/ml
Figure 2
ijL Dose responses.
Dose response curves for each stimulus were produced for both cell types as 
follows:
FM LP: PMN Fig. 3 MNC Fig. 6
PMA : Fig. 4 Fig. 7
HAGG: Fig. 5 Fig. 8
From the standard deviation bars it can be seen that the deviation from the mean 
was sometimes quite large. This reflected the wide normal range of response. 





Peroxide Response of Normal PMN to FMLP
Stimulation.
10 120 2 4 6 8
[FMLP] jiM
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Figure 3
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Figure 4
115




200 400  600 800  1000 12000
[Hagg] pg/ml
Figure 5






5 62 3 A0
[FMLP] M
Figure 6









6 8 10 120 2 A
[PMA] ng/iml
Figure 7










There was an effect of fluoride on the H2O2  assay which precluded obtaining 
any consistent stimulation. The cell-free experiment (using dilutions of 
hydrogen peroxide) did not demonstrate any observable interaction (Figure 9), 
and the reason for this problem was not found. However, the need to use this 





Effect of Fluoride on Hydrogen Peroxide
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iii. Spontaneous Peroxide Production and the Effect of Exogenous Calcium.
Cells isolated from patients with sero +ve rheumatoid arthritis (RA) on various 
specified drug regimens - non-steroidal anti-inflamatory drugs, (NSAID); D- 
penicillamine, (Dpen); or Auranofin, (Aur) - were compared with each other 
and with those from normal volunteers. Comparison was made between the 
spontaneous production of peroxide by PMN and MNC (Figures 10 and 11 
respectively) in the presence and absence of calciume. Patients with psoriatic
arthritis were also used as another disease group to compare with rheumatoid 
patients on the same range of NSAID.
The paired data for spontaneous peroxide production in the presence and 
absence of calciume were analysed, as were the values obtained from the
different patient groups, compared to normals and to one another, in both PMN 
and MNC. Note: Where numbers were very low no statistics of significance 
have been calculated. Otherwise, where statistical significance has not been 
indicated on the figures there was none.
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Spontaneous Peroxide Release by PMN. 
A.ln the presence of Calcium.
Normal NSAID Dpen Aur Ps arth
B. In the absence of Calcium.
0  Normal NSAID Dpen A ur Ps arth 
n -  12 16 9 5 9
Paired analysis ~ and -  effect of calcium P<0.001 
Unpaired analysis +  -  P<0.05 * ■ P<0.01
Figure 10
Spontaneous Peroxide Release 
by M NC.
A. In the presence of 
Calcium.
Normal NSAID Dpen Aur Ps arth
B. In the absence of 
Calcium.
2
Normal NSAID Dpen Aur Ps arth
n -  10 10 7 4 6
Unpaired analysis *  -  P<0.03 + -  P<0.05
Figure 11
It can be seen from figure 10 that PMN from patients on second line drug 
therapies, Dpen and Aur, showed by unpaired analysis a significantly higher 
level of spontaneous peroxide generation than the NSAID group which did not 
differ from the normal group. In the presence of calciume only, the Dpen and
Aur groups released significantly more peroxide than the NSAID group 
(P<0.01).
Using paired analysis of PMN no additional effect in the normal, NSAID or 
Dpen group was seen when calciume was present, but there was a significant
enhancement of peroxide production by the psoriatic (P<0.001 ) and Aur 
(P<0.001) groups.
From the MNC data in figure 11, it can be seen that differences in spontaneous 
release were not significant in the absence of calcium^, but that in the presence 
of calciume the release by MNC from patients on Dpen was significantly higher 
than from the NSAID group (P<0.05), which was significantly lower than from 
the normal group (P<0.03).
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iv. Stimulation of MNC and PMN:
Cells were preincubated in PHMPSA or PBSG (see Materials and Methods) 
and then production of peroxide measured in response to FMLP, PMA or 
HAGG, and in some cases the assay included stimuli with and w ithout 
calciume. These results are given with significant statistical data in figures 12 to
15.
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Effect of PHMPSA Preincubation on 
FMLP-Stimulated PMN.








B. In the absence pf Calcium
5









Paired analysis « P<0.001 *  P<0.003
*  -  P <0.005 
Unpaired analysis -  P<0.01
Figure 12
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Effect of PHMPSA Preincubation on 
PMA-Stimulated PMN.
6 0  -I
5 0  -
20
Normal NSAID Dpen Psor arth
n - 7 9 5 5
(%%%) -phmpsa
□  ♦phmpsa
Unpaired analysis *  -  P<0.05 
( In the absence of calcium)
Figure 13
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Paired analysis * * *  -  P<0.001 * *  ■ P<0.005
( In the absence of calcium)
Figure 14
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Effect of PHMPSA on Normal MNC.
A. In the Presence of Calcium.
zn
HAGGFMLP PMA
n - 5 2 7
B. in the Absence of Calcium
FMLP HAGG PMA
n - 6 11 15
tSSM -PHMPSA
□  +PHMPSA
Paired analysis *  ■ P<0.005
"  -  p<0.02
Figure 15
From the histograms it can be seen that the FMLP response in PMN from all 
sources and in MNC was greatly inhibited by PHMPSA preincubation (Figures 
12 and 15). The HAGG response was also drastically reduced by PHMPSA 
(Figures 14 and 15). An interesting finding was that the PMA response, which 
remained unaffected by PHMPSA in PMN, was significantly lower in MNC 
preincubated in PHMPSA in the absence o f calciume , an effect which was 
overcome by calciume (Figure 15).
A comparison of the effect of calciume on FMLP-stimulated normal PMN and 
MNC (Figures 12 and 15), showed that it had no effect on the PMN response 





The lack o f a monitorable response of cells to the fluoride ion in the hydrogen 
peroxide assay, and the rather low sensitivity of the assay, caused work to 
continue using the superoxide dismutase-inhibitable one electron reduction of 
cytochrome C to measure O2', a direct product of activation of the respiratory
burst enzyme.
L Dose Responses.
Dose response curves were produced for each stimulus (Figures 16 to 21), for 
which cells were at a concentration of 2xl0^/ml except for the PMA-stimulated 
PMN which concentrated to 0.25x1 O^/ml. Cell concentrations remained the 
same throughout the O2 " experiments. Results are the means o f at least 3
separate experiments done in duplicate and the bars throughout the experiments 
represent one standard deviation. Calcium chloride ([300uM]) was added in all 
experiments.
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The concentration of FMLP used for this assay (5uM) was extrapolated from 
that used for the hydrogen peroxide assay. However it has since been found to 
be supramaximal, especially for MNC, where in the range lOuM to lOnM the 
response remained at a plateau (not shown).
In a dose response curve with and without 5ug/ml cyt B (fig 17) it can be seen 
that the responses diverge at the higher range of doses such as have been used 
throughout most of this work. In 4 out o f 8  experiments with PMN, cyt B 
elicited a O 2 '  response itself. Where tested (n~3) this was partly inhibited 
(23%) by PHMPSA. In all 5 experiments with MNC cyt B invoked a O2 " 
response, which again was inhibited by PHMPSA (n=3), by >40%. Cyt B was 
omitted from the majority of experiments using FMLP stimulation for simplicity 
of interpretation.
134












Effect of Cytochalasin B on the Superoxide 
Response of FMLP-Stimulated Normal PMN.
nmol cyt C 
reduced/10 
cells








□  - cytochalasin
Figure 17
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Superoxide Response of Normal PMN
to PMA Stimulation.













Superoxide Response of Normal PMN
to Fluoride Stimulation.












Superoxide Response of Normal MNC
to Fluoride Stimulation.




























Timecourses for 02" production were measured, for PMN and MNC stimulated 
by PMA, by FMLP or by fluoride, or by PMA and fluoride together. One 
representative curve for each stimulus is given in Figures 22 to 25.
iii. Lag times:
The results demonstrate that both PMN and MNC had veiy rapid response to 
FMLP which was complete by one minute (Figures 22B and 24B). Both cell 
types exhibited the same lag of 5 minutes before the onset o f the fluoride 
response (Figures 22A and 24A). The 2-3 minute lag time for the PMA 
responses was similar for both cell types (Figures 23A and 25A).
iv. Response curves.
The reaction of both cell types to FMLP was complete by the time 1 minute had 
elapsed. The large response of PMN to PMA reached a plateau after 40 minutes 
which may have been because of exhaustion of substrate, but as this was seen 
also in the MNC response after 30 minutes, it may be that the activity caused a 
negative feedback of toxic metabolites, including peroxides, which limited 
further activity. The fluoride response was complete in both cell types by 20 
minutes, having an initial lag time of 5 minutes.
The combined effect of PMA and fluoride was examined. In PMN the lag time 
was less than that of fluoride alone, the final response being greater than for 
fluoride alone, but less than for PMA (Figure 23). MNC similarly demonstrated 
a reduction in lag time compared with fluoride alone (Figure 25). The co­
stim ulation was not timed beyond 10 minutes in these cells.
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Timecourse for Superoxide Responses
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Timecourse for Superoxide Responses of 
Normal MNC.
A. PMA
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A. Preincubation with PHMPSA.
L Spontaneous CH-.
From the histograms of the spontaneous release of O2 " it can be seen that 
PHMPSA markedly inhibited this from cells of all groups except from Dpen 
PMN and from NSAID MNC (Figures 26 and 27). Mann-Whitney U analysis 
revealed no significant difference in the level of 0 2 ’ released by the different


















Effect of PHMPSA on Spontaneous 
Superoxide Release by MNC
4 - * * *
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1L Stimulated 0 2—Responses.
Comparison was made of 02" production in response to PMA and to FMLP by 
PMN and MNC from:
a) normal volunteers b) sero positive patients with rheumatiod arthritis on 
NSAIDs c) sero positive patients with rheumatiod arthritis on D-Penicillamine, 
each with and without prior preincubation with PHMPSA.
There was a significant inhibition of the FMLP response by PMN and MNC 
from all groups (Figures 29 and 31).
The PMA response of MNC was not affected by PHMPSA (Figure 32 note; no 
Dpen group), but the response of PMN was significantly enhanced in all three 
groups (Figure 30).
Mann-Whitney U analysis of the unpaired data, showed the NSAID group 
MNC response to PMA to be higher than the normal group both without 
(P<0.03) and with (P<0.05) PHMPSA preincubation. No other significant 
differences were found.
150
Effect of PHMPSA on the Superoxide
Response of FMLF-Stimulated PMN.
50 -
40 -



















* *  -  P<0.003
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Effect of PHMPSA on the Superoxide
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Effect of PHMPSA on the Superoxide
Response of FMLP-Stimulated MNC.
40
30 -












□  ♦PHM PSA
Paired analysis * * *  -  P<0.001
* *  -  P<0.01 
*  -  P<0.05
Figure 31
Effect of PHMPSA on the Superoxide
Response of PMA-Stimulated MNC.
120
100
nmol cyt C 
reduced/10  
cells






n - 13 6
I I -PHMPSA
| | +PHMPSA
Unpaired analysis * *  ■ P<0.03
*  -  P<0.05
Figure 32
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The response of PMN and MNC to fluoride stimulation was examined, with 
and without PHMPSA preincubation, in the three groups as for FMLP and 
PMA but the PMN data were also analysed for the possible effects of the sex of 
the donor.
In MNC from all groups PHMPSA significantly reduced the response (Figure 
35), more in normals (P<0.001) than in the NSAID group (P<0.002) and least 
in the Dpen group (P<0.04).
In PMN there appeared to be no significant effect overall of PHMPSA on the 
fluoride response. However on dividing the results according to the sex of the 
donor of the cells, some interesting data emerged. The normal data were divided 
into males, premenopausal and postmenopausal women (Figure 33). The cells 
from male donors were significantly enhanced by PHMPSA (P<0.05) whereas 
those from either group o f women were not affected. The patient groups were 
also divided (Figure 34). The results showed a significant enhancement o f 
response after PHMPSA preincubation from NSAID and Dpen groups 
regardless of the sex of the donor.
Thus these data on the effects of sulphydiyl blockade of the fluoride response 
demonstrate;
a) a difference due to the sex of the donor of normal PMN; b) a difference due 
to cell-type in all groups; and c) a difference in healthy PMN compared with 
those from rheumatoid patients.
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Figure 33
156
Effect ofPHMPSA on the Superoxide 
Response of Fluoride-Stimulated PMN from 
R.A. Patients.















































E = |  -PHMPSA  
□  +PHMPSA
Paired analysis * * *  -  P<0.001 





* *  -  P <0.002
iii. Costimulation.
It was decided to investigate possible interactions o f the different stimuli. 
Experiments were carried out in which cells were stimulated simultaneously 
with more than one reagent.
From Figures 36 and 37 it can be seen that the response with both PMA and 
fluoride together is considerably less than that found with PMA alone regardless 
of the presence or absence of PHMPSA, in both PMN and MNC, from either 
normal cells or those from the NSAID group. The PMN data given for the 
fluoride response were obtained from 2x10^cells/ml. The data for PMA and for 
PMA+fluoride were from 0.25xl0^cells4nl. Fluoride affected PMN at a cell 
concentration at which no (>2 ~ response to fluoride alone was detectable.
Using FMLP and fluoride stimulation together (figure 38) the effect was seen to 
be cumulative.
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Effect of Costimulation of PMN Superoxide
Production with PMA and Fluoride.
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B. Preincubation with IAP.
Blockade with the Islet Activating Protein of Bordetella pertussis toxin was 
used in a preincubation step before stimulation o f cells in the 0 2 " assay to
investigate the involvement of G Proteins in the activation pathways.
L IAP and Spontaneous Oo—Release.
The effect of IAP on spontaneous O2 " release was analysed. From Figures 
and$0 it can be seen that IAP reduced spontaneous 0 2 " release significantly in 
all groups of PMN and MNC except the Dpen PMN. Analysis of the unpaired 
data did not show any significant difference between the levels o f spontaneous 
release from cells of different groups, with or without IAP, nor did it show any 
difference between the effect of IAP on the PMN from any of the groups. It did 
however reveal a significant difference in the percentage of activity remaining 
after IAP preincubation of NSAID MNC compared with normal MNC (P<0.05) 
and no difference between the NSAID group and the Dpen group (Figure 41).
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Figure 39
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Figure 41
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1L IAP and Stimulated Cb-Release.
The effect of IAP on stimulated levels o f O2 '  from PMN and MNC and the 
statistical analysis of these data is shown in Figures 43. to 47.
Wilcoxon analysis of the paired data showed that IAP significantly reduced the 
amount of 0 2 ' released from PMN by FMLP stimulation in all three groups
(Figure 41), the normal group most of all (P<0.001) the Dpen group slightly 
less so (P,0.005) and the NSAID group less still (P<0.01). It had no effect on 
PMA stimulation (Figure 43). The fluoride response o f normal PMN was 
significantly inhibited (P<0.001), but neither that of the NSAID group nor the 
Dpen group was significantly affected (Figure 44).
MNC data showed a significant repression o f the FMLP response from the 
normal group (P<0.002), numbers from the NSAID and Dpen groups being too 
small to analyse (Figure 45). No effect was seen on the PMA response (Figure 
4 (>). The fluoride response (Figure 47) was significantly reduced in the normal 
(P<0.05) and Dpen groups (P<0.05) but not in the NSAID group.
IAP also inhibited cyt B stimulation of MNC (n=3) by 38%, and PMN 
(n*3) by 36% (not shown).
Mann-Whitney U analysis of the unpaired data was carried out to examine the 
effect of IAP.
PMN: No significant difference was found between the effect on FMLP 
stimulation in comparison of any of the groups.
MNC: The inhibitory effect of IAP on the fluoride response was significantly 
greater in the Dpen group compared with the NSAID group (P<0.05).
The fluoride data was divided up into the sexes for analysis (not shown), but no 
difference was seen with IAP.
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Effect of IAP Preincubation on Superoxide
Production by FMLP-Stimulated PMN.
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Figure 42
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Figure 44
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Figure 47
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C* PHMPSA and IAP Co-preincubation.
The effects of preincubating PMN with PHMPSA and IAP were investigated in 
normal cells to see if  there was any interaction between their sites of action. The 
results (Figure 4®) showed that in the case of fluoride-stimulated cells there was 
a significant difference in the effect of PHMPSA and IAP preincubation on the 
cells (P<0.003) but no significant difference between those cells and the ones 
preincubated with both reagents at once. The FMLP results showed no 
significant difference in any o f the three preincubation groups.
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Figure 48
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It was decided to find out if  the pathways activated by the chosen ligands and 






Indo-1 AM requires intracellular de-esterification of its acetomethoxy group to 
fluoresce in the presence of calcium. Adding calcium to the cell suspension does 
not raise fluorescence unless calcium is internalized - or unless metabolised, 
calcium-bound Indo-1 leaks out.
The release of intracellular calcium by normal PMN is presented below in 
tabular form and results are expressed as nMol calcium per 2.6 x 10& cells, with 
the basal levels deducted from the stimulated responses.
Results from this assay have been expressed both as the ratio of basal level of 




Calcium Release expressed as P/B Ratio.
n -PHMPSA +PHMPSA %Activity Remaining
(s.d.) (s.d.)
Calcium 6 3.1 2 .0 65
(0.7) (0 .6 )
FMLP 3 10.3 1.3 13
(8.5) (0.3)
FMLP+Ca 4 63.2 5.1 8
(51.3) (2.3)
FMLP+Ca+cyt B 2 75.9 12.3 16
(29.4) (13.9)
FMLP+cyt B 2 2.5 1.5 60
(0 . 1) (0 . 1)
FM LP2  +Ca 4 62 4.2 7
(49.5) (1.5)
HAGGi 1 2.7 2 74
HAGG i+Ca+cyt B 2 2 2 .6 5.6 25
(4.6) ( 1.8 )
H A G G j+Ca 3 39.6 6.9 17
(31.8) (2 .6 )
H A G G 2 +Ca 1 7.8 2.5 32
H A G G 3 +Ca 1 186 4.3 2
Fluoride peak} 2 2.7 0 0
(1.9) (0 )
” peak2 3.2 2.3 72
(0 .6 ) ( 1.6 )
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Table 4B.
Change in Internal Calcium Concentration with and without PHMPSA 
Preincubation.
nMoi Calcium.
Stimulus n -PHMPSA +PHMPSA %Activity
(SD) (SD) Remaining
1. None (basal level) 7 175 (73) 284 (90) 162
2. Calcium 6 235 (35) 158 (49) 67
3. FMLPi 3 4997 (4543) 125 (138) 2
4. FMLPi + calcium 4 7468 (4040) 546 (172) 7
5. FMLPi +ca+cyt B 2 9139 (4827) 1303 (1364) 14
6 . FMLPi + cyt B 2 364 (19) 192 (83) 53
7. FMLP2  +calcium 4 8809 (8649) 759 (390) 9
8 . HAGGi 1 305 231 76
9. HAGGi+ca+cyt B 2 1942 (936) 493 (148) 25
10. HAGGi + ca 3 4330 (3423) 1115 (743) 26
1 1 . HAGG2  + ca 1 852 1333 156
12. HAGG3 + ca 1 16660 2500 15
13. Fluoride peakl 2 379 (445) 0  (0 ) 0
14. ” peak2 487 (182) 283 (334) 58
kev: FMLPi = [5uM] FMLP2  = [lOOnM]
HAGGi = [500ug/ml] HAGG2 = [250ug/ml] HAGG3 = [lmg/ml]
Fluoride = [20mM]
Note: the responses for fluoride in the table are those found in experiments 
carried out in Hanks4iepes buffer.
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1 = 20 mM fluoride
2 = 5 mM FMLP
3 = 300 mM Calcium
4 = 500 jug/ml HAGG 
B = Basal level
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L Basal
Overall basal levels of stimulation were seen to be enhanced to 162% by the 
PHMPSA preincubation:
Note: The decrease in the FMLP and HAGG responses is greater than can be 
accounted for by the increase in the basal level o f response after PHMPSA 
preincubation, 
ii FMLP
In a comparison of the response from FMLP-stimulated PMN with no calcium 
added and those similarly stimulated but in the presence of 300jjM exogenous 
calcium (calciume), deduction of the response due to the calcium itself revealed 
that the FMLP response is nearly doubled by the presence of calciume, an effect
which was still seen in the small response of the PHMPSA-preincubated cells. 
Thus calciume increased the level of the FMLP-induced response, but it did not
affect the inhibition seen by PHMPSA.
The inhibitory effect o f PHMPSA on the FMLP-stimulated response was 
almost total and was greater than that seen with the 0 2 " and peroxide responses.
The effect of FMLP stimulation was almost immediate, having reached a 
maximum by 5 seconds with no lag period. This rapid response was not 
maintained, the peak being followed by a sharp decline as the calcium was 
sequestered back into internal stores. The decline from the maximal response 
was not as rapid in the PHMPSA-preincubated cells. PHMPSA was as 
inhibitory for cells stimulated with 5uM FMLP as for those stimulated with 
lOOnM FMLP.
iii. Cvtochalasin B
Cytochalasin B, whilst not eliciting a response itself (not shown) enhanced the 
FMLP response in the presence of calciume.
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iv. HAGG.
In the presence of 300uM calciume, response to HAGG was not as large as 
that induced by FMLP, and whereas with the FMLP response only 7% activity 
remained after PHMPSA, there still remained 26% of the HAGG response.
Vj_ PMA.
PMA did not elicit a response (not shown).
vi. Calciume.
C alcium e induced a slight stimulatory response, which was PHMPSA 
sensitive, 67% activity remaining after PHMPSA preincubation.
vii. Fluoride.
Fluoride uniquely induced two peaks of calcium release from PMN, one almost 
immediate and, after a return to basal level, a second more gradual one. This 
biphasic response was more marked when the buffer was Hanks/hepes (calcium 
[1.5mM]) rather than PBSG with added calcium ([300jjM]) (not shown). No 
fluoride response was seen in the absence of calciume. A dose response curve
in Hanks/hepes buffer demonstrated that the two peaks were o f the same 
magnitude, differing only in the timecourse o f the response, and that it 
demonstrated the same range as that found for the O2 " response, both peaks
showing maximal response at [20mM] and decreasing again with greater 
concentrations. The peaks were both affected by PHMPSA preincubation of 
cells, the first peak being totally abolished and the second much diminished 





PHMPSA preincubation almost doubled both the lag time seen in the HAGG 
response, and the time taken for the response to reach maximum.
b. FMLP.
The FMLP response had no measurable lag time, with or without PHMPSA, 
but after PHMPSA the time taken for response to return to a plateau was 
considerably increased (-PHMPSA 13sec; +PHMPSA >60sec).
c. Calcium.
The calcium-induced response had no lag period, and the response was a steady 
increase which, on reaching a plateau did not fall off in the 3 minutes allowed 
before termination of the experiment. PHMPSA did not affect the timecourse of 
the response.
d. Fluoride.
The initial peak was abolished by PHMPSA and the time taken to reach a 
plateau in the second response was nearly doubled.
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Table 5.
Timing of Calcium Flux (seconds).
Stimulus. -PHMPSA (s.d.) +PHMPSA (s.d.)
Lag. To max. response Lag. To max. response 
HAGGi: 17(10) 69(35) 29(10) 114(30)
<n-3)




peak one: 0  8 -
peak two: 107 185
Note: * This represents only those experiments in which the response was not
completely abolished.
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ix. Pilot studies were carried out using more than one stimulus in the same 
experiment which suggested the following:
1. The first fluoride-induced peak was abolished if  the cells were first 
stimulated by another ligand, such as FMLP, PMA, or cross-linked monoclonal 
antibody 1V.3 (directed against FcRl 1), whilst the second peak still occurred.
2. An initial stimulation with fluoride abolished the FMLP response.
3. Prior stimulation with PMA did not affect the FMLP response.
4. PMA added to cells before FMLP had no effect on the level of stimulation 
induced by the FMLP, nor did it affect the inhibition due to PHMPSA 
preincubation. However the recovery of the FMLP response to a plateau was 
quicker.
5. When monoclonal antibody 1V.3 was used PHMPSA was found to cause 
an inhibition of the same order of magnitude as for HAGG.
6 . Use of monoclonal antibodies directed against FcRs 1, 11 and 111, in 
experiments with PMN or purified monocytes showed that occupancy of any 
of the three receptor subtypes did not trigger release of internal calcium until 
they were cross-linked. Also, cross-linked IgG} activated FcRl on purified
monocytes was effective at inducing release of calcium, and this was the same 





It was decided to measure another parameter o f PMN activation, namely 
azurophilic degranulation. Cells were preincubated with PHMPSA in PBSG or 
in PBSG alone, for 30 minutes at 37°c, and their supernatants assayed for 
myeloperoxidase (MPO). The results in Table 6a demonstrate that unlike the 
©2 ’ response and the calcium flux, MPO release stimulated by FMLP was
enhanced by the SH blockade. Cytochalasin B induced a significant stimulation 
in its own right, which was also enhanced by PHMPSA. Either PMA or 
fluoride, neither o f which released MPO, caused a slight repression of 
spontaneous MPO release.
PHMPSA reduced the total MPO released by Triton X I00 lysis. This effect 
required the whole cells or the cell lysate to be in contact with the PHMPSA for 
at least 30 minutes and was not seen if PHMPSA was added to the cell lysate 
directly before assay. PHMPSA had no effect on the cell free reagents (not 
shown).
Table 6a shows the percentage MPO released by various stimuli, where 100% 
is the amount of MPO released by triton X100 lysis. In these results the 
spontaneous level of release has not been deducted from the stimulated levels. 
In Table 6b is shown the effect of PHMPSA on total MPO release, expressed as 
the change in absorbance at 560 nm.
Three experiments were carried out using PMA and fluoride, although they 
were not expected to induce MPO release. From the table it can be seen that 
fluoride, PMA and a combination of fluoride and PMA reduced the release 
compared with that from the unstimulated cells, an effect overidden by 
PHMPSA except when both agents were used together.
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Table 6 a.


































Total MPO Release by Triton X I00 Lvsis. 






Use of receptor-mediated ligands and of PMA in the 0 2 ’ peroxide and MPO
assays allowed the conclusion that the PHMPSA blockade occurred after ligand 
binding but before PKC activation, and fluoride further confined the likelihood 
o f the blockade to its occurring before G-protein interaction. Cytochalasin B- 
induced activity raised the possibility that the relevant SH involvement could be 
on a site other than the receptor or G-protein molecules themselves, the MPO 
enhancement by PHMPSA further suggesting no inhibitory modulation of the 
receptor itself, at least in the case of FMLP.
Use of autologous PMN and MNC in the same assays showed that these cells 
were differentially affected by PHMPSA; the PMA response demonstrating an 
enhancement of PMN O2 " release and not affecting monocytes, and the fluoride
response only being inhibited in monocytes.
Use o f cells from RA patients on NSAID and on SH-containing drugs did not 
indicate any obvious effect of the SH-containing drugs on receptor-mediated 
responses, and indications of SH group modulation of spontaneous release of 
reactive oxygen species were inconclusive. Increased spontaneous peroxide 
release by PMN and MNC was significantly higher in cells from patients, 
effects not seen in the absence of Ca^+e , which may indicate that disease
modifies calcium regulation.






The project’s overall aim, of determining the involvement of SH groups in 
phagocyte activation and of further defining the mechanism of activation by 
specific ligands, met with some success. Two pathways were expected to 
contribute to activation, namely the PLA2  and PIP2 -specific PLC pathways,
with possible modification by the activity of adenylate cyclase. The project has 
compared the activation of PMN and of MNC by a number o f ligands. The 
initial discussion will be of FMLP-receptor-mediated signal transduction and its 
modulation by PHMPSA and IAP and this will necessarily include calcium and 
cyt B. From this will procede the events involving HAGG, PMA and fluoride, 
followed by the RA study.
In this project, the neutrophils and monocytes from normal peripheral blood 
were each a microheterogeneous population with respect to maturation, and in 
the RA cells to both maturation and activation. The normal cells were not 
distinguishable in this respect. The isolation procedure based on buoyant 
density could result in significant contamination of the mononuclear fraction by 
activated (or primed) PMN, and occasionally contamination (of >10%) resulted 
in the cells being abandoned. The use of a mixed mononuclear fraction had an 
advantage over monocytes which have been further purified in that the whole 
monocyte population present in the blood was represented. It also allowed the 
comparison of autologous PMN and MNC in concurrent experiments. It is still 
possible that the normal and patient groups represent an unbalanced analysis. In 
RA the cell population isolated from whole blood may be different from 
normals in that chronic activation may result in more adherent cells and so a 
specifically less adherent population being examined. In this project it was 
noted that cell yield varied, but this variation in number was not restricted to the 
patient groups, and no analysis of sub-populations of monocytes or PMN was
193
undertaken (such a may be carried out by buoyant density analysis (Froebel et al 
1984).
Investigation of the intracellular events proceeding from receptor-mediated 
activation by others has included monitoring phospholipid metabolism, calcium 
mobilization and changes in phosphorylation profiles. Much work is dependent 
on the use of specific inhibitors such as the PKC inhibitor H7 (Hidaka et al 
1984), the PLA2  inhibitors p-bromophenacyl bromide (Duque et al 1986),
deazoadenosine (Pick and Mizel 1982) or mepacrine (Bokoch and Gilman
1984), and the PLC inhibitor neomycin (Nakashima et al 1988). A wealth of 
different cell-types has been used, sometimes as whole cells, sometimes as 
permeabilized cells and sometimes as isolated fractions. When comparing one 
system to another each may only indicate what to investigate in the other. For 
instance, repression of GTP-gamma-S-induced secretion with H7 (Smolen 
1989) by permeabilized PMN suggested that PKC activation did not promote 
degranulation. These workers found that PMA induced beta-glucuronidase 
release and this is not the case in whole cells. Also, effects o f calciumg on
inositol phospholipid metabolism differ in whole and in permeabilized human 
PMN (Bradford and Rubin 1986). The fine regulation of G-protein-mediated 
systems may be tissue and species specific at the transcriptional and 
translational level (Milligan 1989) which may alter with the developmental stage 
of the cell (Gierschik et al 1986; Luetje et al 1987) and with age (Milligan 
1987b). Monoclonal antibodies to alpha-subunits form more specific probes 
than the fluoride used in this project. However the use of fluoride has made a 
general contribution to recognising G-protein involvement. This project for 
instance, has demonstrated that there is a difference in the mechanism by which 
PMN and MNC are activated in that only in MNC is there an SH group 
accessible to modification by PHMPSA. This thiol is either not present or is 
inaccessible on PMN. The effect of PHMPSA on the activity of G-proteins may
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be indirect because of their cytoplasmic siting either in the plasma membrane or 
situated proximally to it. PHMPSA does not enter the cell and some of its 
effects are not the same as permeant SH-modifying agents such as N- 
ethylmaleimide (NEM). For instance, PCMBS, another impermeant SH reagent 
did not affect phagocytosis (Tsan et al 1976a) or PMN adhesiveness (Giordano 
et al 1973) whereas NEM inhibited both of these events, and NEM totally 
abolished 02* activity by all stimuli (Akard et al 1988). In rat myoblasts
(D'Amore and Lo 1986) cell surface SH blockade was found to inhibit hexose 
uptake, and this could have been a contributing factor to the deterioration of the 
cells in the presence o f PHMPSA as seen by LDH release in this project. 
Cytoskeletal involvement in the FMLP activation process is suggested in this 
project to be modified by PHMPSA and to be critical in determining the 
activation events which follow stimulation, as witnessed by the differential 
effect of PHMPSA on the release of reactive oxygen species and of MPO from 
azurophil granules in response to FMLP + cyt B. A difficulty of determining the 
effect of cyt B is that it is so generally disruptive. However, the response to 
FMLP + cyt B was just enhanced by cyt B, not prolonged; so the activation step 
benefitted from the lack o f microfilamentous control, but the cessation of 
response was not affected. Downey et al (1989) have found that FMLP-induced 
microfilament assembly was 60% inhibited by IAP in intact cells (human 
PMN). Fluoride also induced actin polymerization, demonstrating that G- 
proteins are cytoskeletally associated. In this project limited use of was made of 
cyt B, always in a direct comparison with cells without it and only intact cells 
were used. Cyt B was considered to alter FMLP signalling in a manner which it 
was not initially intended to investigate and so it was usually omitted from 
experiments. Cyt B prevents actin polymerization. It has no known effect on 
actin-linking proteins e.g. spectrin (Carraway and Carraway 1989) by which 
the cytoskeletal network is formed and bound to the plasma membrane and to 
intracellular structures such as granules. Although the cytoskeleton has been
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described as independent of NADPH oxidase (Naccache et al 1989) this is not 
the case indirectly as the signalling of 0 2 " release is activated by cytoskeletal
disruption and NADPH oxidase has been found to co-sediment with an actin- 
fodrin-rich cytoskeletal membrane vesicle fraction (Jesaitis 1988). The same 
group has reported FMLP receptors in membrane vesicles as cytoskeletally- 
related and disassociated from their regulatory G-proteins; receptor activation in 
whole PMN being dependent on their being cytoskeletally unassociated. 
Potentiation of FMLP activity by cyt B may include increased mobility o f 
granules bearing subunits of the oxidase, and expression o f new FM LP 
receptors at the cell surface from granule membranes.
Other work on PMN activation by FMLP is a mixture of data obtained from 
permeabilized cells, which may not be directly comparable with work on intact 
cells, and those which have or have not been preincubated with cyt B. In the 
use of cyt B it is important to note when the events seen do not occur in cells 
with an intact cytoskeleton. Organisation of the cytoskeleton is important. It is 
controlled by a number o f cross-linking and membrane-associated molecules 
which may be rearranged on activation. For instance, Roos et al (1985) 
localized gold-labelled glycoproteins on the plasma membrane to interconnected 
regions of the filamentous network of the cytoskeleton. Secretory granules have 
binding sites for the actin cross-linking protein, fodrin, in chromaffin cells, the 
proteins in the cytoskeleton being cell-type specific (Aunis and Bader 1988) and 
thus the cytoskeleton forms the means of regulating selective granule release 
and other interactions such as those with G-proteins, with enzyme substrate, 
and with interactions with other ligand-binding as in priming. In chromaffin 
cells, G-protein-mediated secretion is accompanied by a decrease in cytoskeletal 
actin, both events being inhibited by neomycin. The decrease in cytoskeletal 
actin can be mimicked by PKC stimulation (Burgoyne et al 1989). The 
assumption that events may be similar in phagocytes may end here, unless it is
196
assumed that secretion thereby is of discrete populations of granules which are 
differentially controlled because, as found in this project, PKC (PMA) does not 
induce azurophil granule release. Calcium may be the key to normal 
reorganization of the cytoskeleton, for cross linking, for instance. Others have 
found that on ligand-binding a transient and calmodulin-dependent association 
o f the FMLP receptor occurs which could account for some if  not all of the 
calcium requirement of FMLP-mediated activation (Jesaitis et al 1988). A theory 
put forward here is that FMLP may normally induce a respiratory burst, 
NADPH oxidase activity and release of specific granules. In the absence of a 
priming stimulus no release o f azurophilic granules occurs. The differential 
release o f granules is dependent on the nature o f a priming agent and the 
cytoskeleton is the link co-ordinating the events which follow the two signals. 
Such differential regulation may involve for instance a protein which is required 
for 5-lipoxygenase activity and which must be involved in the receptor-mediated 
activation of LTB4  synthesis (Dixon et al 1989; Miller et al 1989). TNF-alpha 
priming allows FMLP stimulation of O2 ’ in a manner independent of 
exogenous calcium but has no effect on FMLP-induced actin polymerisation or 
MPO release with or without cyt B, but does enhance lysozyme release 
(Berkow et al 1987). It is possible that the modification of FMLP-induced 
activity by PHMPSA is cytoskeletally related, the membrane attachment sites of 
the cytoskeleton being modified so that the FMLP signal is compromised. This 
would leave the receptor itself intact, overcoming the problem of explaining 
major modification of the protein (by PHMPSA) without affecting binding, and 
would also leave the G-protein similarly unmodified as would be expected of a 
cytoplasmically sited protein. Differential regulation by PHMPSA of pathways 
activated by FMLP, that is o f selective degranulation and NADPH oxidase 
activation, could thus be explained, reflecting their degree of dependence on the 
cytoskeleton. SH modulation would be likely to cause a conformational change 
and alter the function o f the molecule to which it bound, and it may be
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significant therefore that after PHMPSA preincubation, FMLP receptor binding 
was found to be intact by the MPO assay, G-protein function was unimpaired in 
fluoride-stimulated PMN, and NADPH oxidase and the proton pump were still 
activated by PMA stimulation. The order which can be assumed to be imposed 
on the plasma membrane by cytoplasmic linkage could be altered by PHMPSA 
binding. FMLP has been found to activate both PLA2  and PLC (Duque et al
1986; Cockcroft et al 1985b) and whereas these pathways may act in concert, 
they do seem able to be activated mutually exclusively. It has been beyond the 
scope of this project to investigate this thoroughly, but it is thought that calcium 
may influence the activation which follows FMLP binding. Adding calcium to 
the reaction mixture potentiated the effect of FMLP and the effect of FMLP + 
cyt B. The stimulation of a calcium flux by calcium alone was also blocked by 
PHMPSA and had no modulating effect on the PHMPSA inhibition of the 
peroxide response to FMLP. The role o f calcium is not clear but it is not 
necessary for actin polymerisation (Bengtsson et al 1986). Although FMLP 
induces a calcium flux with little delay, it may be that more immediate 
availability of calcium is necessary for a process which must occur in a calcium- 
dependent manner before activation o f the IP 3 ~induced calcium release. 
Calcium e may be necessary for PLA2  activation. It may be required for 
maintaining the functional integrity of another element in the activation process 
such as external enzymes or transport proteins required for a normal energy 
supply, or for a step in which activation of PKC and non-calcium-releasing 
isomers of IP3  is inappropriate. Others have found that blocking cytosolic
calcium release with TMB-8  blocked FMLP-induced arachidonic acid release 
(Ohta et al 1985). FMLP can induce O2 ’ production without added calcium
(Okajima and Ui 1984), as also found in this project, but it is much lower than 
in its presence. There was a noticeable enhancing effect induced by the addition 
of 1.5mM calcium in the peroxide experiments. In both PMN and monocytes 
two small proteins have been found (P8 and P I4) o f which P14 is
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phosphorylated when calciume enters, but not by PKC, and which is thought to
be concerned with motility (Edgeworth et al 1989). Dose-dependent effects of 
FMLP-induced PLA2  activity have been shown to be species-specific. The 
calcium-dependent, biphasic response of rabbit PMN P L A 2  to FMLP
(Bormann et al 1984) suggests that at the doses used in this project FMLP 
might not have activated PLA2  at all, maximal responsiveness being found at
10“ ^ M ( which also corresponded to their maximal chemotactic activity). The 
chemotactic dose responsiveness of human cells is in the same range (Dillon et 
al 1987). However FMLP-induced activation o f PLA2  in rat PMN has been 
found at 10’^M (Duque et al 1986), a dose at which rabbit PMN PLA2  is 
inactive. If  PLA2  activity is a primary and descrete requirement in the sequence
of events activated by FMLP, either the elevation of cAMP or the elevation of 
calcium induced by calciume entry might be required for PLA2  regulation. Its
indirect activation after PLC activation could be different, in that PKC would be 
active also. Activation of cAMP- or calcium-requiring kinases may be necessary 
for activation of PLA2 , if  it is repressed by unphosphorylated lipocortin 1 for
instance (Hirata et al 1981; 1984). The PHMPSA inhibition of the PMN calcium 
flux induced by calciume may suggest that the entry of calciume is unrelated to
the ability of the cells to produce reactive oxygen species, as its presence or 
absence did not alter the effect of PHMPSA on the FMLP or HAGG responses.
FMLP-binding leads to receptor-cytoskeletal association, and dissociation from 
G-proteins (Jesaitis 1988). Blocking this by using cyt B should lead to 
inhibition as associated G-proteins would not undergo the normal cycle and nor 
would GTPase activity ensue. This would not necessarily be the case if  there 
was also a G-protein-independent pathway activated by FMLP. In the 
experiments using IAP or PHMPSA there was a small but persistent residual 
release which was affected by neither blocker. This activity indicated that the 
FMLP receptor protein itself activated internal events independently of SH-
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dependent mechanisms and G-proteins. Could this be the primary, receptor- 
mediated event required for raising intracellular calcium? The small release of 
O2 " could be induced by the partial disturbance (rather than activation per se) of
the system, a full response being dependent upon activation of the SH- and 
IAP-dependent pathway(s). It has been suggested (Cockcroft 1987) that 
calcium release by IP3 can account for the initial peak in internal calcium release 
found in response to stimulation of PIP2 -PLC and that a subsequent further, 
more prolonged response is a function of the metabolism of IP3 , including the 
isomers which do not themselves induce calcium release. Just as some isomers 
do not induce calcium release (Spat et al 1986), so also the production of 
specific isomers may be a function of calciumj concentration at the time of PLC
activation (Dillon 1987).
The costimulation experiments with clonidine and salbutamol in conduction with 
FMLP, PMA or fluoride were rather general, in that only a single dose each of 
clonidine and salbutamol was used and numbers were low. No significant 
effects were seen either by blocking cAMP or by raising it, suggesting that the 
brief rise seen with FMLP stimulation may be independent o f peroxide 
production. There was no effect on the responses by PHMPSA preincubation. 
Futher investigation of cAMP regulation was considered inappropriate in this 
project but it would be interesting to see if the enhancement by salbutamol of the 
fluoride response reached significance with increased numbers (P=0.1 in this 
project) and to see if this was seen also using salbutamol in conjunction with 
FMLP or HAGG.
In the MPO assay, PHMPSA affected the responses by enhancement. This 
could be a significant indicator of the SH interaction being an effect on an 
element which controls the predominant production pathway by a given 
stimulus, rather than the receptor itself. The cytoskeleton seems a logical target 
in this case. Neither PMA nor fluoride was expected to induce release of MPO,
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but neither were they expected to lower the basal amount released. This effect 
was overcome by PHMPSA, except when the two agents had been added 
together. Without being able to contribute any evidence why these responses 
should occur, the effect of PMA in particular must support a lack of a direct 
effect of PHMPSA on either receptor proteins in the plasma membrane or on G- 
proteins.
Activation of both PLA2  an(* PLC is affected by LAP, after FMLP stimulation, 
this may be because both enzymes are controlled directly by Gj-like G-proteins, 
or because one is and it indirectly controls activation of the other, or because 
they are both controlled by different subunits of the same G-protein. No definite 
evidence has been reported so far that both the G-alpha subunit and the beta- 
gamma moiety of the same G-protein complex have regulatory activity, but in 
independent, descrete systems each has been found to be active (Jelsema and 
Axelrod 1987; Okajima et al 1987); the idea of both elements from the same G- 
protein being active at once has been suggested elsewhere as being worthy of 
further consideration (Bourne 1987). The IAP inhibition of the FMLP- 
stimulated 0 2 ’ production by PMN and MNC in this project implicates a Gi-like
G-protein in this signal transduction pathway. Others have found PMN 
responses to FMLP to be IAP-inhibited including IP3  production and lysozyme
release (Bradford and Rubin 1985b), release of calcium from internal stores 
(Ohta et al 1985), arachidonic acid release (Bokoch and Gilman 1984) and actin 
polymerisation (Bengtsson et al 1986). The proton pump has been found to be 
inactivated during IAP inhibition of FMLP-stimulated activity, however this 
was indirect as PMA activated the pump under the same conditions (Volpi et al
1985). In this project the pump was also only indirectly affected by PHMPSA 
as determined by the continued activity of NADPH oxidase stimulated by PMA 
after PHMPSA preincubation. Although the proton pump activity was not
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measured directly it has been found by others to be essential for NADPH 
oxidase to function (Henderson et al 1988).
PHMPSA has been found in this project to modulate the effects of calcium^ on 
internal calcium flux and not to affect NADPH oxidase or the proton pump nor 
to affect all G-protein signalling; to leave the FMLP receptor still capable of 
signalling azurophil granule release but to prevent activation of NADPH oxidase 
by either FMLP or KAGG. This suggests that the effects may be multiple but 
that they are specific.
Whilst demonstrating a link between SH and activation, use of HAGG as a 
gross stimulus of Fc receptors had the disadvantage of stimulating two 
different receptor types both on PMN and on MNC. This maybe significant in 
the case of PMN in particular, where the FcR ll and F c R lll expressed are 
known to have different membrane linkage; FcRl 11 being covalently attached 
to a phosphatidyl inositol in the outer side of the plasma membrane bilayer, and 
FcRl 1 being a transmembrane protein. Although both MNC FcR receptors are 
transmembrane proteins, it is notable that the level of inhibition by PHMPSA of 
the HAGG response is of the same order in both cell types and considerably 
less than the inhibition of the FMLP response. The results from HAGG- 
mediated activation are therefore a more general indication of events than those 
from FMLP; carrying out the peroxide, O2 " or the MPO assay using
monoclonal antibodies would be more specific and reveal any receptor sub­
type-specific differences. Recent work following the cessation of the PhD 
project has monitored the internal calcium flux in response to monoclonal 
antibodies against the separate FcR on PMN and on MNC, but this has not yet 
been done including PHMPSA blockade. In the case of each receptor type, 
release of internal calcium was found in response to cross-linking the 
appropriate monoclonal antibody, and also MNC were found to release internal 
calcium in response to cross-linking human IgGl bound to FcRl - the IgGj
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being from the same source as that used for the HAGG experiments in this 
project.
The response of cells in vivo to FMLP or to immune complexes (HAGG in 
vitro) can be expected to be different. FMLP must induce a sequence of events 
designed to locate and destroy a bacterial invasion. Immune complex contact 
must involve the phagocyte in an already active humoral response, for instance 
altering adherence of both PMN and MNC (Appelboom et al 1988) and 
stimulating ADCC (Petroni et al 1988). Chemotaxis and degranulation of 
bactericides may therefore have a higher priority in the order o f events in 
response to FMLP. Both ligands appear to activate an interaction between PLA2
and PLC pathways, and therefore the fine regulation required to meet the 
different responses needs to be considered. In this project FMLP stimulation of 
0 2 “ has been found to be IAP-sensitive in both PMN and MNC. Only one
experiment was carried out blocking PMN with IAP and using HAGG 
stimulation; no effect was seen on 0 2 “ release. A regulatory difference via G-
protein linkage is thus revealed in the FMLP and HAGG-mediated control of 
the two enzyme pathways in PMN. This could be either from a lack of G- 
protein mediation of FcR stimulation or from the mediation of this by a G- 
protein which is not ADP-ribosylated by IAP. The Fc receptors do not have the 
structural characteristics which are associated with other receptors known to be 
G-protein-mediated (Dohlman 1987). Partial inhibition of the 0 2 “ response to 
FcR stimulation has been found using PKC inhibition, with PLA2  blockade 
causing more complete inhibition (Sakata et al 1987). However this work was 
carried out on guinea pig peritoneal macrophages and PMN, preincubated with 
cyt B. As cyt B inhibits phagocytosis (Roos et al 1976), and must totally 
disorganise the subplasmalemma, the normal sequence of events cannot be 
determined. The effect of IAP on IgG-induced 0 2 “ release by PMN has been
found to inhibit in some studies (Feister et al 1988) but not in others (Blackburn
2 0 3
and Heck 1989), whereas there is agreement by the same authors on the lack of 
effect on degranulation. As with FMLP, activation of more than one pathway is 
indicated. Similarly also, cyt B has been found to enhance some Fc-gamma-R- 
mediated effects such as lysozyme release and azurophil granule release 
(Ferreri et al 1986) and 02" production (Roos et al 1976). More parallels can be
drawn between FMLP- and Fc-gamma-R-mediated pathways; PMA inhibits 
azurophil degranulation induced by either stimulus in PMN (Blackburn and 
Heck 1989) and there is co-operation with other receptor-mediated stimuli; 
FMLP with TNF-alpha (Berkow et al 1987) and IgG with C3b (Malbran et al 
1987) for instance. In this project both FMLP- and HAGG-stimulated systems 
have been subject to SH blockade which inhibited peroxide and 02" production.
Other workers have found parallel activation and effects of cyt B. An element 
which may differ particularly between activation by the two systems is the 
necessity for calcium^ different methods of activating PLA2  could be a reason 
for this. It was suggested earlier that calciume could be a requirement for 
discrete release of a PLA2 repressor without activation of other functions o f 
FMLP stimulation. Fc-gamma-R may have intrinsic PLA2  activity (Suzuki et al 
1980) which would negate the need for calciume.
In this project, lack of PHMPSA effect on the PMA response seen in normal 
PMN demonstrated that the SH involvement in receptor-mediated responses 
occurred prior to PKC activation, and also demonstrated that neither the 
NADPH oxidase complex itself, nor the Na+/H+ proton pump were affected 
directly by the external SH blockade. A comparison between the effect of PMA 
with and without calcium present was not carried out with PMN. The fact that 
the MNC response to PMA was slightly inhibited in the absence of calciume,
but not in its presence, may indicate a relationship between SH, PKC and 
calciume in MNC.
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The project did not set out to investigate any effects of calcium in particular, and 
so from the outset calcium was not specifically excluded (by the addition of 
EGTA to washing buffers for instance), and as previously mentioned it was 
probably evident at all times as a contaminant. However despite the levels being 
only in the miciomolar range even when added, it appeared to have effects in its 
own right. Extracellular calcium is normally in the millimolar range, perhaps 
suggesting that it is the difference between extra- and intracellular levels or a 
localized change in the vicinity o f the cell which is relevant, rather than the 
absolute amount. Here, calciume was been found to cause an elevation in the
internal basal level of calcium which was SH-dependent, and the addition of 
calcium e brought about a release o f MPO which was also inhibited by
PHMPSA (not shown). No calcium flux experiments were carried out on cells 
from RA patients, but a comparison of the calciume-induced flux in patients on
NSAID with that from those on Dpen might make a useful avenue to 
investigate.
In contrast to the major blockade of FMLP-induced activity by IAP or 
PHMPSA the PMN fluoride-induced 0 2 “ response was not inhibited. That of 
MNC was. From the FMLP experiments it is clear that a Gj -like G-protein 
does mediate 0 2 “ production and can be inhibited by IAP in both PMN and 
MNC. Fluoride must in PMN, be assumed to activate a second pathway to 0 2 “ 
production mediated by an IAP-insensitive G-protein, the in vivo activator of 
which is unknown. It could be HAGG. Others (Bokoch and Gilman 1984) 
have found (calcium-dependent) fluoride stimulation of arachidonic acid was 
inhibited by IAP, suggesting that the fluoride pathway to NADPH oxidase 
activation in this project was not mediated by arachidonic acid. Also Bokoch 
and Gilman found the arachidonic acid released by fluoride was subject to a lag 
time of 5 minutes with 0 2 “ release not occurring for another 5 minutes. The
timecourses of PMN and MNC stimulation in this project also showed a long
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lag time before 0 2 “ production, although production was near maximal by 10 
minutes.
As MNC activation by fluoride was only partly inhibited by IAP this could have 
been because the G-protein was not all available for ADP-ribosylation, but as 
the FMLP-stimulated G-protein was significantly affected in the hour-long 
preincubation period it is more likely that it was accessible but was a poorer 
substrate for IAP. More than one Gj-like G-protein has been identified in PMN
(Kanaho et al 1989) and IAP- and cholera toxin-insensitive G in other tissues 
by others (Higashijima et al 1987;Evans et al 1986). It is likely that there is a 
cell-type specific discrepancy between those found in PMN and MNC, 
especially as PMN are terminally differentiated and MNC are not. It is also 
possible that fluoride activated another GTP-dependent system which is not 
subject to ADP-ribosylation by IAP. In permeabilized PMN GTP-gamma-S has 
been found to have another site of action which stimulated secretion in an IAP- 
independent manner (Barrowman et al 1986).
The calcium flux induced by fluoride in this project was induced under two sets 
of conditions. Firstly it was induced from PMN in PBSG containing 300uM 
calcium. In the second series of experiments the PMN were in Hanks/hepes 
buffer which contained 1.4 mM calcium. Under either of these conditions an 
initial, immediate peak of calcium release was seen which terminated rapidly, 
calcium returning to the basal level, followed by a lag then a second curve of 
long (slow) duration, which at its peak released the same amount of calcium 
again. The dose response mimicked the range for O2 " release. It is possible that
the first peak was caused by precipitated calcium fluoride acting as a non­
specific particulate stimulus. Previously calcium had been kept low (300uM) to 
prevent such precipitation. Whether particulate or more specific, this peak 
showed a dose dependence in magnitude, and was PHMPSA inhibitable. The 
second peak was not inhibited by PHMPSA, but the time taken for it to reach
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maximum was nearly doubled and the release was enhanced. Some pilot 
experiments were carried out (not shown) in which fluoride stimulation of the 
calcium flux was combined with other stimuli. The initial peak was abolished 
by prestimulation of cells with either FMLP or with PMA. The FMLP response 
had returned to basal before the addition of fluoride, and PMA did not stimulate 
calcium release at all. There is no reason for an effect o f either FMLP or PMA 
to be the prevention of calcium fluoride precipitation, if  such there was. Another 
explanation could be that the FMLP stimulus resequestered internal calcium into 
pools which were not then subject to release by the mechanism seen in the first 
fluoride-induced calcium peak, and the effect of the PMA may have been to 
bring about a modulation (phosphorylation) which made the calcium pool(s) 
inaccessible to release by fluoride. This in turn may indicate that there are not 
two discrete pools, but one pool, which is modified by activation to resist a 
second stimulus. The effect of fluoride as the first stimulus and FMLP as the 
second one showed a complete abolition of the FMLP response which supports 
the theory that the calcium released by FMLP and the first fluoride peak is from 
the same pool, which then becomes inaccessible after stimulation. The PMA 
effect suggested that PKC had a role in this; however PMA did not affect the 
calcium flux induced by FMLP. Other workers have found that PKC may 
negatively feedback on PLC to modulate the release o f calcium by IP3
(Muldoon et al 1987), and have found that PMA inhibited fluoride-induced 
PIP2  hydrolysis and IP3  accumulation (Blackmore and Exton 1986). The lack
of effect by PMA found here on the FMLP induced flux may indicate that either 
FMLP does not induce the calcium flux by activation of PIP2  hydrolysis, which
is not likely in view o f the other evidence o f activation o f this pathway 
previously mentioned, or that the PKC substrate which regulates the response is 
not available until after FMLP-induced activation; which would apply, for 
instance, to G-alpha subunits and this would accommodate the results of 
Blackmore and Exton. Hypotheses on the regulation of calcium by interacting
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pools have been illustrated by Gill et al (1988) and by Berridge and Irvine 
(1989). The inability of PMA to stimulate azurophilic degranulation and its 
ability to suppress both FMLP-induced degranulation and calcium release 
(Smith et al 1988) may suggest that the calcium could be in a granule fraction -  £ / 
itself, as opposed to in endoplasmic reticulum for instance. The complex series 
o f events in FMLP stimulation involve activation of PIP2 -specific PLC and
subsequent activation of PKC and the respiratory burst, but inhibition of PKC 
does not necessarily inhibit 0 2 ’ production (Balazovich et al 1986). However
using PMA to activate PKC only monitors the phosphorylation events 
associated with PKC activation, which m vivo may be quite different as calcium 
would be released at the same time by IP3 ; this may alter the substrate
preference for the PKC dictating whether or not phosphorylation by the 
membrane bound or cytosolic fraction predominates. It seems that there is a 
balance operating in internal calcium regulation and release by PKC and IP3 . 
Potentiation of FMLP O2 " release by PMA preincubation suggests that
phosphorylation by PKC may selectively depress aspects o f the FMLP 
response in favour of a O2 " generating pathway (Smith et al 1988); the calcium
flux induced by FMLP was depressed by PMA priming. The calcium flux 
induced by FMLP as seen in this project is both rapid and rapidly resolved. The 
method for monitoring the O2 '  response delineates a plateau in the timecourse
which is also reached rapidly. The sequestration of calcium back into internal 
stores may only be delayed for instance by the time taken for PKC to 
translocate, if jt controls this process.
Recent work with monoclonal antibody stimulation of FcR has shown that it is 
possible to stimulate two receptor sub-types on monocytes and induce a calcium 
flux with each in turn. Calcium may be regulated differently after IgG 
stimulation. The stimulation of PMN seen with HAGG which has been 
described in the results section here, as well as the monoclonal stimulation of
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monocytes, demonstrated that after stimulation calcium was not taken up again 
rapidly as in FMLP-stimulated cells, and although the level of calcium did go 
down, it did not return to the original basal level. It is not possible that the lack 
o f FMLP-induced response after fluoride was due to phagocytosis of the FMLP 
receptors, as fluoride inhibits phagocytosis (Roos and Balm 1978). These 
results suggest that fluoride will make a useful tool for further investigation of 
regulation of internal calcium by different activating ligands. For instance a 
particular study could involve activation through FcR by IgG or monoclonal 
antibodies (as appropriate), in which the significance of cross-linking could be 
determined with respect to the order of activation events and the interaction with 
G-proteins. It may also be possible to use the inhibitory properties which 
fluoride has with respect to phagocytosis and degranulation to investigate 
receptor tunover using a fluorescence-activated cell sorter. The multiple 
properties of fluoride may have consequences overlooked in its use as a G- 
protein agonist.
PMA was seen in this project to interact with the fluoride stimulated production 
of 02" in PMN, the response to both ligands added together being greater than
that found on addition of fluoride alone but considerably less than the response 
to PMA alone. The timecourse experiments demonstrated that the lag period of 
the PMA/fluoride-stimulated cells was reduced by the PMA compared to the lag 
seen with fluoride alone, and that the cessation of a response coincided with the 
end of the lag phase for the fluoride response. It could be that if  the cells had 
been exposed to fluoride first, for a period exceeding the lag phase, the PMA 
response may have been totally inhibited. As well as inhibiting degranulation, 
fluoride could be inhibiting the translocation of cytosolic enzymes to the plasma 
membrane, and if this is its effect on PKC, fluoride stimulation of O2 " would
suggest that NADPH oxidase activation can be an event totally independent of 
PKC activation. There is evidence that one of the proteins found to be
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phosphorylated by PKC activation may be part of the NADPH oxidase complex 
(Heyworth et al 1989). I f  this is so then it may be a negative feedback event 
(Nishizuka 1984). G-alpha subunits are also substrates for PKC (Matsumoto et 
al 1986). It has been found that fluoride does not induce phosphorylation of any 
protein found to be phosphorylated by all other activators of NADPH oxidase 
but in common with these (FMLP included) it does induce dephosphorylation 
o f a particular protein band seen on polyacrylamide gel electrophoresis 
(Andrews and Babior 1983). Geny et al (1989) found that PMA inhibited 
fluoride-stimulated PLC activity in permeabilised HL60 cells (a human 
leukaemic cell line). Evidence from platelets in which PMA did not affect the 
fluoride-stimulated release of IP3  (Fuse and Tai 1987) suggests cell-specific
differences. The effect of fluoride need not be related to its activity with G- 
proteins, but could be connected to another function effected with phosphate 
group substitution by AIF4 . There are small molecular weight G-proteins with
unknown functions which are GTP-binding (Haidar et al 1989). Some have 
been found to be associated with cytochrome B in PMN and so may be 
concerned with NADPH oxidase activity (Quinn et al 1989). The slight but 
significant enhancement of O2 " induced by PMA from PMN indicated a
difference in SH availability on PMN compared with MNC, in which no effect 
of PHMPSA was seen, in normal cells. Nothing investigated in this project 
indicates what might be affected on the plasma membrane which could affect 
PKC activity. Translocation of the enzyme to the cytosolic surface is coincident 
with PKC activity but not essential for O2 " production following its stimulation
with PMA (in which translocation is found) or TPA ( in which it is not) 
although the pattern of phosphorylation differs in each case (Balazovich et al
1986), and an indirect effect on either its binding site (phosphatidylserine) or 
substrate availability could occur.
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Production of peroxide in response to HAGG and to FMLP in normal MNC 
demonstrated an almost twofold increase in stimulation in the presence of 
calcium, PMA stimulation being much less affected in this respect. Other 
workers have noted an increase O2 ’ produced by RA MNC stimulated with 
opsonized zymosan in the presence o f calciume (Bell et al 1986a). In this 
project no comparison was made with MNC from patients. However the 
significant inhibition of the MNC PMA response by PHMPSA was lost in the 
presence of ca1ciume which had no effect on the lack of inhibition seen in PMA
stimulated PMN (Figures 13,15 and So). The conclusions drawn from these 
findings were that regulation of PKC activity in MNC and PMN differs, and 
that regulation in MNC may be related to SH availability in a calcium-dependent 
manner.
The absolute amounts of reactive oxygen species from PMN and MNC shown 
in the results section have been presented as the amount produced by a million 
cells in thirty minutes. In the case of the MNC, this can be assumed to represent 
production by fivefold fewer monocytes than PMN. Scrutiny of the peroxide 
dose response curves shows that the monocyte production in response to 
HAGG and FMLP is comparable. This may be a function o f receptor number 
required for activation or of duration o f response. From the 02* timecourse
curves it can be seen that the timecourses are similar in each cell type. Also that 
the FMLP-induced release by MNC can be multiplied by five to give a very 
similar result. This comparison cannot be made using the PMA results as the 
response was not found to be linear with respect to cell number (not shown). 
The plateau reached by the PMA dose response curves may represent either 
negative feedback o f the response at the given doses or the exhaustion of 
substrate in the reaction. The latter is unlikely as there is a one to one 
relationship with cytochrome c reduction and production o f O2 ’, and the 
cytochrome C concentration was 150jiM.
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A preliminary investigation of membrane fluidity in this project may suggest 
that it is increased by PHMPSA preincubation of PMN, although this is 
suggested only tentatively as the conditions of the assay fell short o f the ideal, 
temperature regulation in particular being less controlled than necessary. The 
results from the three experiments carried out (see below) are inconclusive, and 




PMN 1 0.1433 0.1356
PMN 2 0.1589 0.1537
PMN 3 0.1595 0.1567
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Rheumatoid arthritis patients on Dpen or Aur were compared with those on 
NSAID alone to examine the possible effects of second line drugs on cell 
responses. Patients on second line therapy were all also taking NSAID. No 
distinction was made between the different NSAID because they do not affect 
the overall disease process and it was not their function which was under study. 
Also the numbers of patients would have been too low in each group to allow 
any useful analysis as such a wide range of drugs is taken. The inclusion of the 
psoriatic arthritis group in a limited number of experiments allowed comparison 
of another inflammatory condition, all of these patients also being on NSAID.
RA patients were included in the study of the spontaneous release o f peroxide 
with and without calcium. The PMN and MNC from patients with treatment 
including SH-containing drugs showed a marked elevation o f spontaneous 
peroxide release compared with those on NSAID alone. This may suggest that 
Dpen and Aur alter the entry of calciume as the difference in release was 
dependent on calciume. Alternatively it could be a function of the disease 
process, those patients on the second line drugs being representative of a more 
severely affected group than those on NSAID alone, their cells being in a 
chronically activated state. Other effects due to cellular localization of the drugs 
could be contributing to the increase. As spontaneous O2 '  release did not differ
significantly between the control and disease groups in either PMN or MNC it 
may be that Dpen and Aur have an effect on the transduction pathway resulting 
in more peroxidation, unrelated to 02" production. Auranofin was found to 
decrease the level of 02" released by PMA stimulation or by FMLP stimulation 
of normal PMN at concentrations thought to be attained in vivo (Hurst et al 
1989). This suggests that the increase seen in the spontaneous peroxide release 
in this project by PMN from patients on Aur may be a function of the disease 
process.
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There was no significant difference in the inhibition by PHMPSA between any 
PMN or MNC group peroxide release (not shown). This (less sensitive) assay 
indicated that the SH available for modification by PHMPSA were equally 
subject to blockade in either cell type and regardless of disease or drug regimen. 
The spontaneous release of 02* by MNC was not found to be significantly
inhibited by PHMPSA in the NSAID group whereas it was in the normal and 
Dpen groups. Dpen may make more SH available for blockade by PHMPSA 
by disulphide exchange reactions, compared with the NSAID treatment
The inhibition of the spontaneous 02* by IAP was not seen in Dpen PMN. The 
statistics were carried out on the absolute values for O2 * release in which there 
was a wide range of values (vis. s.d.), but when comparing the percentages of 
activity remaining IAP had no significantly different inhibitory effect on any 
group.
Fluoride stimulation of normal MNC and PMN was sensitive to IAP inhibition, 
whereas the cells from the patients groups were less so. Dpen appeared to 
restore RA MNC sensitivity to IAP. Previously the effect of fluoride stimulation 
with and without PHMPSA revealed a difference in the SH blockade on normal 
PMN and MNC G-proteins, and these results with IAP also demonstrate that 
there is a further difference, between MNC from normals and RA groups. RA 
G-proteins could be altered in their availability but alternatively could have a 
change in the structure of the G-proteins themselves. The cell-specificity o f the 
defect mitigates against it being an overall effect of reactive oxygen species on 
plasma membranes. It is considered here that despite the evidence being based 
on a small sample number, these results warrant further investigation.
FMLP-induced levels o f peroxide and O2 '  were inhibited by either IAP or 
PHMPSA in RA cells as in normals. Also the effect of PHMPSA on PMA- 
stimulated PMN (a slight enhancement) and of IAP (no effect) was the same in
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RA as in normal cells. PMA stimulation of MNC only included normal and 
NSAID groups. The NSAID MNC responded to PMA with a significantly 
greater production of O2 ", both with and without PHMPSA, with no effect of
either PHMPSA or IAP on the stimulation. Thus inhibition of cyclooxygenase 
activity by NSAID could be an example here of preferential pathway activation. 
The comparison of PMA stimulation was not made with Dpen MNC, and it 
would have been interesting to see if the indicated increase in PKC activity was 
affected by second line treatment bearing in mind that such patients would also 
be taking NSAID. Aur has been found to increase PLC activity in vitro (Snyder 
et al 1986) others finding a biphasic, dose-dependent effect of Aur on PMA 
stimulation of C>2 ’ (Hurst et al 1989), suggesting that the effect seen might be
an even greater enhancement.
The response to fluoride stimulation indicated again that G-proteins may be 
involved in the RA disease process. In normal PMN it was found that only cells 
from male donors reacted with an enhanced 02" response after PHMPSA
preincubation. All PMN from both the NSAID and Dpen groups showed this 
enhancement. The effect of IAP on the PMN fluoride response was also 
different from normal, neither NSAID nor Dpen groups showing the inhibition 
found in normal PMN. The significance o f both the difference in 
PHMPSA/fluoride response of PMN from male and female donors and of the 
finding that this difference was lost in RA PMN is entirely open to speculation. 
There has been no report o f any sex-related differences in G-proteins in any 
species. It is possible that hormonal regulation alters cell membranes in cells 
from males and females however, and this may include a difference in the 
number of G-proteins o f a particular sub-type. Support for this hypothesis is to 
be found in the lack o f IAP inhibition of the RA PMN fluoride response. These 
could be Go G-proteins rather than defective Gj.like G-proteins.
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The fluoride response of MNC from all sources was inhibited by PHMPSA, 
although the degree of significance was largest in the normal group, less so in 
the NSAID group and least in the Dpen group. Analysis of absolute amounts of 
O2 " released showed no significant difference between the groups. Whereas
normal and Dpen MNC were inhibited by IAP, NSAID MNC were not, 
suggesting that Dpen modified the fluoride-G interaction. As there is a cysteine 
at the site of ADP-ribosylation in G-alpha subunits (Milligan 1989) this site 
could be deficient (oxidized) in RA.
In the presence of calciume the level of peroxide stimulation by FMLP was 
significantly increased in the NSAID group compared with the control, and 
although numbers were too low for statistical analysis it can be seen from the 
histogram (Figure 1 lb) that the Dpen stimulated levels fell into the same range 
as the NSAID group. It was not decided to add calcium until after the HAGG 
experiments ceased and so the comparison cannot be made using this stimulus 
and as with the FMLP data, no difference was seen in the levels of stimulation 
between the groups without calciume. This has revealed that the increase in
levels of stimulation are both in the spontaneous and stimulated production of 
peroxide, and that they are dependent on calciume. An increased number of
experiments could determine if  this was as SH-dependent in RA groups as in 
controls.
PMN peroxide release induced by FMLP or HAGG stimulation was inhibited 
by PHMPSA equally in all groups, which suggests that the affected SH are not 
instrumental in the disease process with respect to activation by these ligands. 
There was no statistically significant difference in the 02" release by FMLP
stimulation of normal, Dpen or NSAID PMN but there was significantly more 
peroxide released in response to FMLP by NSAID and Dpen cells. Similar
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comparison cannot be made with MNC as the peroxide experiments did not all 
include calciume.
The field for investigation of pathways to cell activation has been broadened by 
the effects seen using PHMPSA or IAP preincubation and by the actions and 
interactions of the different stimuli used in this project.
G-proteins have been found to differ in PMN and MNC in both their 
susceptibility to PHMPSA and to IAP, in pathways activated by the same 
ligand. PMN G-proteins may differ in men and women and these may be 
altered in RA. MNC G-proteins may be affected by the disease process in RA in 
a manner modified by Dpen.
Calcium decreased normal cellular sensitivity to SH blockade and spontaneous 
and stimulated activity of PMN and MNC was seen to be enhanced by RA in a 
calcium-dependent manner.
PHMPSA preincubation showed that a SH group in receptor-mediated 
activation which is modifiable by impermeant agent is likely to be located at a 




PHMPSA preincubation demonstrated differential effects on PMN and MNC 
and on some responses of cells from Rheumatoid Arthritis patients compared 
with those from normal donors.
IAP preincubation demonstrated a difference in PMN and MNC G-protein 
activation and a modifying effect of Dpen on MNC.
1. PHMPSA inhibited receptor-mediated peroxide and 02" production in both 
PMN and MNC and internal calcium release in PMN.
2. PHMPSA enhanced receptor-mediated MPO release from PMN.
3. PHMPSA differentially affected fluoride stimulated 0 2 ' production. The 
stimulatory effect on PMN was evident in RA donor cells of both sexes but 
absent in PMN from normal females.
4. PHMPSA caused a slight enhancement of the PMN 0 2 ' response to PMA 
and did not affect the MNC response.
5. IAP inhibited spontaneous and receptor-mediated 0 2 ' release by PMN and 
MNC.
6 . IAP did not affect PMA release of 02".
7. IAP inhibited fluoride-induced 02" release by PMN and MNC. The effect 
was reduced in PMN from both NSAID and Dpen groups but only the NSAID 
MNC group.
8 . Calciume modulated spontaneous peroxide release by PMN and MNC.
9. Calciume overcame PHMPSA blockade of PMA-stimulated peroxide release 
from MNC.
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